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Abstract
Intranasal infection of gamma interferon receptor knockout (IFNyR"7") mice with
murine gammaherpesvirus - 68 (MHV-68) causes unique pathological changes in the
spleen characterised by development and resolution of fibrosis. Delineation of
virological, cellular and molecular events taking place in the spleen during these
pathological changes was the main objective of this study.
Sequential histopathological and cellular characterisation studies showed early
invasion of lymphoid follicles (harbouring latently infected B-lymphocytes) with
CD4+ and CD8+ T lymphocytes. Concomitantly, invasion of alternatively activated
macrophages characterised by arginase -1 expression was observed. These events
were followed by a reduction in the number of B-lymphocytes and development of a
'fibrotic cage' around the shrinking lymphoid follicles. In spite of the decrease in the
number of B-lymphocytes, the number of latently infected cells showed a
progressive increase until the development of fibrosis. During fibrosis, a dramatic
reduction in the number of latently infected cells was observed followed by
repopulation of lymphoid follicles with B-lymphocytes indicating a recovery phase
of the fibrotic response. These observations suggest that: 1) the progressive
reduction and repopulation of B-lymphocytes in the lymphoid follicles of the spleen
constituted the primary events during the development and resolution of fibrosis
respectively. 2) Fibrosis as a host response mechanism is able to contain the
expansion of latently infected cells in the spleen. 3) Presence of latently infected
cells might be the trigger for fibrosis development by preventing the repopulation of
lymphoid follicles.
The role of IFNy responsiveness of bone marrow derived cells in the pathogenesis of
splenic fibrosis was investigated by generating radiation bone marrow chimera mice
and subsequent infection with MHV-68. The study showed that, replacing the bone
marrow derived cells in IFNyR"7" mice with bone marrow derived cells from wild
type mice prevented the development of splenic fibrosis following MHV-68
infection.
iv
Other pathological changes occurred in the lung, liver, aorta and spleen of IFNyR""
mice infected with MHV-68. 1) Focal areas of interstitial fibrosis were observed in
the lung during day 12-16 post infection. At the same time, cuffing of pulmonary
vessels with primarily mononuclear cells was observed. A few of the infiltrating cells
were productively infected with MHV-68 which coincided with clearing of
productive infection from alveolar epithelial cells. The change in the tropism of viral
infection may be related to the development of fibrosis. 2) The pathological changes
observed in the liver was characterised by proliferation of intrahepatic bile ducts and
infiltration of mononuclear cells around them. Productively and latently infected
mononuclear cells were present among the infiltrating cells. At later stages, some of
the lesions progressed to degeneration and necrosis of intrahepatic bile ducts and
encircling 'onion skin' type fibrosis. The pathological changes observed in the liver
mimic the changes observed in primary sclerosing cholangitis. 3) The incidence of
bony metaplasia in the spleen of IFNyR"'" mice infected with MHV-68 was higher in
comparison to mock infected IFNyR"'" mice and MHV-68 infected wild type mice.
Bony metaplasia was observed in the spleen of IFNyR"'" mice before the development
of fibrosis. These observations suggest that development of bony metaplasia is
independent of fibrosis. There was no direct correlation between the expression of
bone morphogenic protein-4 and development of bony metaplasia in the spleen. 4)
The incidence of chronic arteritis at the base of aorta was in the range of 6-11% and
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1.6. ROLE OF MACROPHAGES IN FIBROSIS
CHAPTER:! INTRODUCTION
1.1. THE HERPESVIRUS
The Herpesviridae represent a large family of viruses, which cause life-
threatening disease in man and animals throughout the world. More than 130
different herpesviruses have been identified to date which include viruses
infecting vertebrates and at least one invertebrate (Arzul et al., 2002). The size of
herpes virions varies from 120 - 300 nm in diameter. The structure of a typical
herpes virion consists of a linear double stranded deoxyribonucleic acid (dsDNA)
genome encased in the central core. The size of the viral genome is characteristic
of each virus, which varies from approximately 120 - 250 kilo base (kb). The core
is surrounded by an icosadeltahedral capsid, which is approximately 100 - 110
nm in diameter containing 162 capsomeres. Tightly adherent to the outside of the
capsid is a structure known as the tegument, which appears to consist of
amorphous protein material. The tegument is encircled by a lipid bilayer of
envelope derived from host cell membranes. The envelope contains cellular
polyamines, lipids and viral glycoproteins (Roizman and Pellett, 2001).
In addition to sharing a common structure, the herpesviruses also share the
following biological properties: 1) encoding of enzymes involved in nucleic acid
synthesis and metabolism (e.g. DNA polymerase, helicase, thymidine kinase, and
ribonucleotide reductase) 2) synthesis of viral DNA and assembly of capsids
occurs in the nucleus of infected cell 3) production of infectious progeny is
accompanied by death of the infected cell and 4) ability to establish latency in
their natural host. Inspite of sharing a common structure and key biological
properties, they differ substantially in their host range, tissue tropism and growth
characteristics in tissue culture. Based on these features, the family of
herpesviridae is classified into three subfamilies namely, alphaherpesvirinae,
betaherpesvirinae and gammaherpesvirinae (Roizman and Pellett, 2001).
Classification of herpesviridae and type species in each genus along with their
associated diseases are presented in table 1.1. Ihttp: // www, ncbi. nlm .nih .gov
/ICTYdb/ Ictv/index.htm and (Knipe et al., 2001;Percy and Bartholh, 2001)].
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CHAPTER: 1 INTRODUCTION
Table.1.1.Classification of Herpesviridae and disease associations





[Herpes simplex virus - 1 (HSV-1)]
Human Cold sores, keratitis
Genus: Varicellovirus
Human herpesvirus - 3 (HHV-3)
[Varicella -zoster virus (VZV)]
Human Chicken pox and shingles
Genus: Mardivirus
Gallid Herpesvirus - 2 (GaHV-2)
[Marek's Disease Herpesvirus -1]




Chickens Infectious Laryngotracheitis (ILT)
Sub family: Betaherpesvirinae
Genus: Cytomegalovirus
Human Herpesvirus - 5 (HHV-5)
[Human cytomegalovirus (HCMV)]
Human Mononucleosis, multi-system disease in
immunocompromised patients
Genus: Muromegalovirus
Murid Cytomegalovirus -1 (MCMV -1) Mouse Cytomegalic inclusion disease
Genus: Roseolavirus




Human herpesvirus - 4 (HHV-4)
[Epstein - Barr virus (EBV)]
Human Infectious mononucleosis (IM), Burkitt's
lymphoma (BL), Post Transplantation
Lymphoproliferative Disorder (PTLD),
nasopharyngeal carcinoma (NPC),







Fatal lymphoproliferations in cottontail




The distinguishing characteristics of alphaherpesviruses include their extremely
short reproductive cycle (hours), ability to infect a wide variety of host tissues and
rapid destruction of susceptible infected cells. Sensory ganglia are the preferred
sites of latency, although this is not the exclusive site. Members of the
betaherpesvirus subfamily have a restricted host range, a long reproductive cycle
(days) and very slow growth in tissue culture system. Cytomegalia of infected
cells is a common feature. Secretary glands, lymphoreticular cells and kidney are
the known sites of viral latency. Gammaherpesviruses have the most restricted
host range. All members are capable of replication in lymphoblastoid cells, but
some produce lytic infection in epithelial and fibroblastic cells as well.
Gammaherpesvirus establish latency mainly in lymphocytes.
1. 1. 1. REPLICATION OF HERPESVIRUSES
Replication of herpesviruses is a multistep process. Schematic representation of
productive virus replication of herpesvirus is presented in figure 1.1. Attachment
of virion envelope glycoprotein with receptors on the cell surface is the first step
in the process of lytic replication [Reviewed in (Spear and Longnecker, 2003)].
Following the attachment phase, fusion of the virion envelope and plasma
membrane takes place and the virion is internalised leading to release of capsid
and tegument proteins into the cytoplasm. The information on tegument and
capsid dissolution and transport of genome to the nucleus is limited. In the case of
HSV, the tegument protein VP 16 moves to the nucleus of the cell and it is
involved in the stimulation of immediate early (IE) gene transcription. The cell
cytoskeleton probably mediates the transport of nucleocapsids to the nucleus for
the release of viral deoxyribonucleic acid (DNA) into the nucleus (Mabit et al.,
2002). Following the release of viral DNA into the nucleus, it undergoes
circularisation (Lindahl et al., 1978). The host ribonucleic acid (RNA) polymerase
II mediates the transcription of viral DNA in a well co - ordinated cascade of
events (Takada and Ono, 1989;Costanzo et al., 1977). There are three kinetic
groups of genes encoded by herpesviruses: the immediate early genes (IE), the
early genes (E) and the late genes (L). They are also referred as a,p and y genes
respectively.
4
Figure 1.1. Schematic representation of lytic replication of herpesvirus.
(1) The entry of the virus is through the attachment of glycoprotein
molecules and receptors on the cell surface (CD21 in the case of EBV)
(2) Attachment follows fusion of viral envelope with host cell membrane
and internalisation of virion resulting in the release of viral capsid proteins
and teguments into the cytoplasm.
(3) Cellular proteins (?) drive the trafficking of nucleocapsid into the
nuclear pores and viral genome is released into the nucleus.
(4) Circularisation of linear genome occurs on entering the nucleus.
(5) Viral gene expression ensues in a temporal pattern of immediate early
(IE ora), Early (E orp) and Late (L ory) genes.
(6) Viral DNA replication and it is packaged into the newly formed
nucleocapsids. P gene products are mainly involved in viral DNA synthesis
and the y gene products are required for nucleocapsid synthesis.
(7) Some of the y gene products are responsible for viral glycoprotein and
are matured and processed in the Golgi complex
(8) Initial envelope and tegument layer is acquired during budding through
the nuclear membrane.
(9) The egress of the enveloped virion particle takes place through lumenal
pathway of rolling through the Golgi apparatus and transported to the
surface by vesicular transport
(10) The reenvelopment pathway of egress suggests that, the de-enveloped
nucleocapsids buds into the Golgi derived vesicles, forms an enveloped
virion and it is transported to the surface by vesicular transport.
(11) Another theory of virion egress suggest that, the de -enveloped
nucleocapsids bud through the plasma membrane by acquiring envelope
with viral glycoproteins.




The IE genes regulate the sequential expression of E and L genes. The E genes
encode the viral proteins necessary for nucleic acid metabolism, DNA replication
and virus assembly (e.g. DNA polymerase, dUTPase and thymidine kinase). The
L genes encode the virus structural proteins. Replication of the viral genome
occurs by a rolling circle mechanism leading to the production of head to tail
concatemers that are cleaved at specific points of DNA sequences into single
genome units. Such single genome units are subsequently packaged into newly
synthesised capsids (Jacob and Roizman, 1977;Deiss and Frenkel, 1986). The
envelopment and egress of the virion particle from the infected cell is not clearly
defined. The tegument is acquired during the budding of nucleocapsid through the
inner nuclear membrane. The initial envelope is acquired during budding through
the nuclear membrane. De-envelopment occurs in the cytoplasmic vesicles
leading to the release of nucleocapsids into the cytoplasm. The nucleocapsids then
bud through the Golgi network, forming an enveloped virion, acquire processed
glycoproteins, and move to the surface of the cell in a Golgi-derived vesicle and
are released from the cell by a process of reverse exocytosis. This pathway is
usually referred to as the re-envelopment pathway. The second pathway, which is
commonly referred to as the lumenal pathway of virion egress, follows the
budding of enveloped virions through the outer nuclear membrane and it is
transported through a vesicular movement through the Golgi apparatus to the
exterior of the cell (Roizman and Knipe, 2001). Another argument in the case of
EBV favours acquiring the envelope at the plasma membrane and release of virion
(Gong and Kieff, 1990).
1.1.2. LATENT INFECTION OF HERPESVIRUS
Establishment of latency during infection is a characteristic biological feature of
herpesviruses. During latent infection, the virus genome is maintained as a
circular episome with restricted expression of viral genes. The latent virus uses
the host cell machinery for its own genome replication. The latent virus retains the
ability for productive replication, which occurs during reactivation of infection.
The factors controlling this level of suppression of productive replication and
events leading to the trigger of reactivation are poorly understood. Stress, tissue
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damage and immunosuppression are implicated as factors responsible for
reactivation from latent HSV infection (Wagner and Bloom, 1997). The cellular
tropism, mechanism of establishment and gene expression profde during latency
vary between viruses. The details of the latency programme will be discussed later
with relevance to individual viruses.
1.2. GAMMAHERPESVIRUS
The gammaherpesvirinae consist of two genera: Lymphocryptovirus and
Rhadinovirus. Lymphocryptovirus means virus hidden in lymphocytes ('Cryptos'
originated from a Greek word 'Kryptos' meaning 'hidden'). EBV is the type
species of this genus. Rhadinoviruses share a common genome structure. The
linear dsDNA has a central segment of low GC DNA (LDNA) that is flanked by
multirepetitive high GC DNA (HDNA) (Bornkamm et al., 1976). This extreme
intragenomic GC heterogeneity resulting in fragmentation during density
centrifugation led to the coining of the term Rhadinovirus (Roizman et al., 1981).
Important members of this genera are: Kaposi's sarcoma associated herpesvirus
(KSHV) or Human herpesvirus - 8 (HHV -8), Alcelaphine herpesvirus -1 (A1HV
-1), Ovine herpesvirus-2 (OvHv-2), Herpesvirus saimiri (HVS), Bovine
herpesvirus^- (BoHV^l), Equine herpesvirus-2 (EHV-2), Herpes virus saimiri
(HVS) and Murine gammaherpesvirus - 68 (MHV-68).
1.2.1. HUMAN GAMMAHERPESVIRUS
Two important viral pathogens causing major disease in humans are EBV and
KSHV. These two important gammaherpesviruses are associated with a variety of
fatal human diseases and hence the biology of the viruses and pathogenic
mechanisms associated with these viruses has been the subject of intense study
in recent years [Reviewed in (Young and Rickinson, 2004;Cathomas, 2003)].
1.2.1.1. EPSTEIN - BARR VIRUS (EBV)
EBV or HHV -4 was discovered as the aetiological agent of Burkitt's Lymphoma
(BL), which is the first human tumour virus to be discovered (Epstein et al.,
1964). Recent estimates show that more than 95% of the world adult population
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are seropositive for the virus [Reviewed in (Rickinson, 2002)]. Primary infection
usually occurs early in childhood and persists in the host throughout their lifetime.
If the exposure is delayed to early adult life, it leads to the development of disease
condition called infectious mononucleosis (IM) or glandular fever. EBV is also
the aetiological agent of X-linked lymphoproliferative disease (XLP), Hodgkin's
disease, nasopharyngeal carcinoma (NPC) and post transplantation
lymphoproliferative disorder (PTLD) (Wolf et al., 1973;Tanner and Alfieri,
2001).
1.2.1.1.1 EBV GENOME
The EBV genome was the first herpesvirus genome to be sequenced in full (Baer
et al., 1984;Hatfull et al., 1988). The EBV genome structure is characterised by
terminal repeats and many unrelated internal repeats in the body of the genome.
The genome size is around 172 kb and comprises long and short unique regions
interspersed by internal repeats of 3kb in length. The terminal repeats are 500 base
pair (bp) in size. The immediate early gene, Bam HI Z leftward open reading
frame -1 (BZLF1) is closely related to the jun/fos family of transcriptional
activators (Farrell et al., 1989). The Bam HI C rightward open reading frame -1
(BCRF1) shares 90% amino acid homology to human interleukin -10 (IL-10)
sequence (Moore et al., 1990).
1.2.1.1.2. LYTIC REPLICATION
Lytic replication of EBV is usually studied by inducing lytic infection in latently
infected cell lines such as BL cell lines. Treatment of cell lines with phorbol
esters such as 12 - O - tetradeconyl phorbol 13 - acetate (TPA) is the common
method for inducing reactivation (Baumann et al., 1998). Entry of EBV into B-
lymphocytes is mainly through the interaction of viral envelope glycoprotein
350/220 (gp350/220) with the complement receptor -2 (CD21) (Fingeroth et al.,
1984). It has also been shown that a complex of three glycoproteins namely; the
gH, gL, and gp42 are also required for the entry of virus into host cells
(Molesworth et al., 2000) . The proteins encoded by BZLF-1 or Zta and Bam HI
R leftward open reading frame - 1 (BRLF-1) or Reactivation and transcriptional
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activator (Rta) genes are key transactivators to induce the cascade of lytic EBV
gene expression. Bam HI H rightward open reading frame -1 (BHRF1) is thought
to be important in preventing apoptotic cell death during lytic replication
(Henderson et al., 1993).
1.2.1.1.3. EBV LATENCY
EBV encodes nine latency-associated proteins. Six of them are nuclear associated
and referred to as EBV nuclear associated antigens (EBNA). They include EBNA-
1, EBNA -2, EBNA-3A, EBNA -3B, EBNA3C and EBNA-LP. The other three
latency-associated genes are membrane associated and hence called as latent
membrane proteins (LMP). The LMP genes are LMP-1, LMP2A and LMP2B.
EBNA -1 tethers the viral episomal genome to the host chromosome (Yates et al.,
1985) EBNA-2 is a transcriptional activator and turns on all the other latency
associated genes in the growth programme of latency. The proposed function of
EBNA-3C is to inactivate the retinoblastoma (Rb) tumour suppressor gene similar
to adenovirus El A and papillomavirus E7 proteins (Parker et al., 1996). EBV
latency is complex and has been classified into three types. Table 1.2. shows the
gene transcription pattern observed in different forms of EBV latency.
Table. 1.2. Gene transcription pattern and associated functions
during different forms of EBV latency [Adapted from
(Thorley-Lawson, 2001) ]





















Persistence of the virus in
memory B-lymphocytes and
avoids immune recognition
During primary infection of B lymphocytes, EBV uses the growth programme
with expression of full complement of latency associated genes and then switches
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to the default programme to promote differentiation of infected B-lymphocytes
into memory B-cell phenotype (Babcock et al., 2000). How this shift takes place
from growth programme to default programme is not known. Probably, turning
off of EBNA-2 is involved in this shift. As shown in table 1.2, three viral proteins
are expressed during the default programme. Tethering of viral genome through
EBNA-1 to the host chromosome ensures the replication of viral genome during
cell division. LMP -1 is the functional homologue of CD40 (Kilger et al., 1998).
LMP-1 signalling rescues B-lymphocytes from apoptosis and drives their
proliferation. LMP-2A signalling shows similarity to the downstream signals
following B-cell receptor (BCR) signalling that are essential for the survival of B
- lymphocytes (Caldwell et al., 1998). Activation of PI3K/AKT pathway by
LMP2A favours blocking apoptotic signals and EBV infected cell survival
(Fukuda and Longnecker, 2004). In addition to the latency-associated genes
described above, non-polyadenylated (non - coding) RNA molecules such as
EBV encoded RNA (EBER1 and EBER2) and BAM HI A RNA transcripts or
BART are also expressed during latency.
1.2.1.1.4. BURKITT'S LYMPHOMA (BL)
BL was identified in endemic proportions among the children from equatorial
Africa and Papua New Guinea in late 1950's and early 1960's (Burkitt, 1963).
This B-lymphocyte specific tumour most often affects the jaw and abdominal
organs of children. The endemic area of BL falls in the endemic area for malaria
and the relationship between the two conditions is poorly understood. The adult
population is resistant to the infection and the reason for the increased childhood
susceptibility also is not well characterised. There are two other forms of BL
reported from different geographical locations throughout the world. They are
termed as sporadic and acquired immunodeficiency syndrome (AIDS) associated
BL. Almost 97% of the endemic tumour tissue carry EBV genome whereas in
sporadic BL tissues, virus is detected in only 12 - 25% of the samples (Ziegler et
al., 1976). 30 - 40 % of the AIDS associated BL are EBV related. Deregulation
of c-myc gene is shown in the tumour cells derived from endemic and sporadic BL
and it is believed to be the major molecular mechanism responsible for
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oncogenesis. The vast majority of EBV positive BL cells show a highly restricted
latency I type of gene expression (Rowe et al., 1987).
1.2.1.1.5. POST - TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
(PTLD)
Lymphoid neoplasm is a serious problem in patients undergoing organ transplants
along with the risk of rejection of the graft. EBV is considered as the major cause
of such neoplastic diseases. PTLD arise in the first year of transplantation and
almost all of them are EBV positive and express latency III type of gene
expression. Adoptive immunotherapy with EBV specific cytotoxic T-lymphocytes
from human leukocyte antigen (HLA) matched healthy blood donors has been
successfully used to treat PTLD patients (Haque et al., 2002). Terminal AIDS
patients also develop PTLD like B-cell lymphomas and confirms the notion that
immunosuppression is a primary trigger for the development of this type of
neoplasm [Reviewed in (Gaidano et al., 1998)].
1.2.1.1.6. HODGKIN'S DISEASE (HD)
Approximately 30 - 50% of the classic HD in the western world is associated with
EBV [Reviewed in (Gandhi et al., 2004)] . In EBV positive HD tumours, the EBV
genome is present in every Hodgkin's and Reed-Sternberg cells (HRS cells) and
expresses latency II type of gene expression. HRS cells show many characteristics
of LMP1 - induced phenotypic changes including strong activation of nuclear
factor -kB (NF -kB) (Pallesen et al., 1991 ;Krappmann et al., 1999).
1.2.1.1.7. NASOPHARYNGEAL CARCINOMA (NPC)
NPC is an epithelial undifferentiated tumour arising from nasopharyngeal
epithelium [Reviewed in (Chan et al., 2004)]. A small proportion of tumours
show the phenotype of squamous cell carcinoma. The incidence of this neoplastic
condition is unusually high in southeast China and in emigrant Chinese population
elsewhere in the world (Ablashi et al., 1983). The precise role of EBV in the
tumourogenesis of NPC is not well established. EBV was detected in tumour
tissues by in situ techniques (Brooks et al., 1992). Circumstantial evidence
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suggests the contribution from other chemical factors like nitroso - dimethyl
amine in carcinogenesis. A variety of other co-factors are also suggested to
contribute to tumourogenesis.
1.2.1.1.8. INFECTIOUS MONONUCLEOSIS (IM)
IM is the most common manifestation of EBV infection in the western world. As
mentioned earlier, this condition is the result of delayed exposure of young adults
to the virus. The productive replication of the virus occurs in the oropharyngeal
epithelium and contact with saliva is the most common route of virus transmission
(Yao et al., 1989). General lymphadenopathy, especially at the pharyngeal region,
splenomegaly and hepatomegaly are common manifestations of this condition. A
key laboratory diagnostic feature of this condition is the presence of 'atypical
mononuclear cells' in the peripheral circulation. There is expansion of a specific
subset of CD8+ T-lymphocytes which are specific for lytic and latent viral antigen
epitopes in peripheral circulation (Callan et al., 1996). The specific reason for this
disease manifestation in young adults is not clearly defined. However, exposure to
a massive dose of virus through heavy kissing is considered as one of the reason
for this selective susceptibility.
1.2.1.1.9. X-LINKED LYMPHOPROLIFERATIVE DISEASE (XLP)
An XLP affected individual dies rapidly. A simple mutation in the signalling
lymphocyte activation molecule - (SLAM) - associated protein (SAP) is the basic
defect which diverts EBV infection from benign persistence to a fatal disease
(Coffey et al., 1998). The disease is characterised by immune disregulation,
lymphoproliferation and resulting massive infiltration of bone marrow and liver
by CD8+ T lymphocytes, macrophages and EBV infected B-lymphocytes.
1.2.1.1.10. IMMUNE RESPONSE
Immune control of primary EBV infection is mediated by the induction of EBV
specific CD8+T-lymphocytes. The huge expansion of CD8+ cytotoxic T-
lymphocytes (CTLs) is directed against a wide variety of lytic and latent viral
antigens and is capable of destroying the infected cells (Moss et al., 1981). CD4+
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T-cells also contribute to immune regulation against EBV infection (Leen et al.,
2001). Antibody response against EBV infection is well studied in IM patients. At
the time of clinical onset of disease, the patients develop immunoglobulin M
(IgM) antibodies against viral capsid antigen (VCA). Virus neutralising antibodies
(IgM and IgG) develop relatively late in disease and are targeted against the
glycoprotein antigen gp350. Antibodies against EBNA -1 develop late in disease
and healthy carriers of the virus have antibodies (IgG) against VCA, gp350 and
EBNA -1 (Rickinson and Kieff, 2001).
1.2.1.2. KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS (KSHV)
KSHV or HHV-8 is the most recently identified human gammaherpesvirus. Viral
DNA fragments of KSHV were isolated from Kaposi's sarcoma (KS) lesions of
immunosuppressed patients (Chang et al., 1994). In addition to KS, KSHV is also
etiologically associated with body cavity based lymphoma (BCBL) or primary
effusion lymphoma (PEL) and some plasma cell forms of multicentric
Castleman's disease (MCD).
1.2.1.2.1. KSHV GENOME
The KSHV genome is about 145 kb in size and contains about 87 genes, which
are flanked by terminal repeats (Russo et al., 1996;Moore and Chang, 2001). In
common with rhadinoviruses, varying numbers of terminal repeats are present.
The genomic arrangement of KSHV is similar to that of HVS, the prototype
rhadinovirus. The genes that are not homologous to HVS genes are given the K
prefix (K1 - K15). The cellular homologues encoded by KSHV are v-fas-
associated death domain (FADD) interleukin (IL)-l|3-converting enzyme (FLICE)
inhibitory protein (FLIP) [open reading frame -71 (ORF71)] (Thome et al., 1997),
v cyclin (ORF72), v-G-protein-coupled receptor (ORF74), v-interferon regulatory
factors (v-IRF) (e.g. K9 -IRF1), v- B-cell lymphoma (Bel) -2 (Bcl-2) (ORF16)
(Cheng et al., 1997b), v - dihydrofolate reductase (DHFR) (Cinquina et al., 2000)
and v-IL-6 (Neipel et al., 1997). ORF4 is a homologue of complement binding
protein. K14 encodes a neural cell adhesion molecule (NCAM) like protein,
which is homologous to human OX-2 membrane antigens (recently designated as
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CD200). Homologues of the macrophage inflammatory protein (MIP)-I, II and III
are encoded by K6, K4, and K4.I respectively [Reviewed in (Jenner and Boshoff,
2002)] .
1.2.1.2.2. LYTIC REPLICATION
The information on mode of cell entry or cellular receptor for KSHV is limited.
KSHV has structural glycoproteins like gB used by other herpesviruses for cell
entry (Pertel et al., 1998). Direct transmission from KS lesions and PEL cell lines
to 293 cells demonstrates that tumour-derived virus is fully permissive for
productive infection (Foreman et al., 1997;Renne et al., 1998).
1.2.1.2.3. KSHV LATENCY
The primary reservoir for persistent asymptomatic KSHV infection appears to be
B-lymphocytes. Other reported sites of natural infection include endothelium,
CD68+ monocyte - macrophage cells, prostate epithelia and dorsal root sensory
ganglion (Blasig et al., 1997;Corbellino et al., 1996;Diamond et al., 1998).
During latency, the viral genome is tethered to the host DNA molecule as closed
circular episomal DNA (Renne et al., 1996). Latent nuclear antigen (LANA)
encoded by ORF 73 facilitates the tethering of viral genome to the host genome
(Ballestas et al., 1999). Along with LANA, v-FLIP and v-Cyclin are located
adjacent in the genome and transcribed as polycystronic messages (Talbot et al.,
1999;Sarid et al., 1999;Sarid et al., 1998;Dittmer et al., 1998).
1.2.1.2.4. KAPOSI'S SARCOMA (KS)
Moritz Kaposi described KS in 1872 as an 'idiopathic multiple pigmented
sarcoma of the skin' [Reviewed in (Antman and Chang, 2000)]. There are four
distinct clinical variants of KS. The classic KS predominantly affect elderly men
of Mediterranean, eastern European and Jewish descent. The endemic KS is
prevalent in equatorial, eastern and southern Africa. The classic KS lesion is more
indolent in nature and less clinically aggressive than endemic KS. Iatrogenic or
post-transplant KS is seen in organ transplant patients receiving
immunosuppressive therapy. The most aggressive form of the disease is AIDS
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associated [Reviewed in (Verma and Robertson, 2003)]. The pathogenesis of this
vascular tumour is not clearly understood and the histogenesis of the tumour is
from spindle shaped cells derived from endothelial origins.
1.2.1.2.5. PRIMARY EFFUSION LYMPHOMA (PEL)
PEL is a rare, rapidly fatal, non-Hodgkin's lymphoma found in pleural or
pericardial effusions. Rarely such tumour mass was found in the lymph nodes,
lungs or gastrointestinal tract. Presence of hyper-mutated immunoglubulin genes
and surface expression of syndecan -1 along with lack of Bcl-6 expression in the
tumour cells suggest that histogenesis of the tumour is from post-germinal centre
B-lymphocytes (Carbone etal., 1998).
1.2.1.2.6. MULTICENTRIC CASTLEMAN'S DISEASE (MCD)
MCD is a lymphoproliferative disorder characterised by expanded germinal
centres and proliferating endothelial vessels in affected lymph node. Based on the
histological feature there are two variants namely the plasmacytoid and hyaline
vascular form. Most of the KSHV associated MCD are plasmacytoid type (Dupin
et al., 2000). KSHV encoded v-IL-6 is thought to be a key initiator of this
proliferative disorder (Parravicini et al., 2000).
1.2.2. ANIMAL GAMMAHERPESVIRUS
An important disease condition-affecting cattle caused by gammaherpesvirus is
malignant catarrhal fever (MCF). There are two main viruses responsible for this
condition namely A1HV - 1 and OvHV -2 [Reviewed in (Coulter et al., 2001)].
Other members of the gammaherpesvirinae, which are associated with disease
condition in animals, are EHV-2 and BoHV- 4. (Telford et al., 1995;Lomonte et
al., 1996). EHV-2 is widespread in horses and has been associated with
immunosuppression in foals and respiratory tract disease. BoHV-4 has been
isolated from cattle with respiratory and ocular disease, abortion, metritis,
pneumonia, diarrhoea and mammary pustular dermatitis.
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A1HV -1 is a gammaherpesvirus isolated from wildebeest (Connochaetes
taurinus) in Africa (Plowright et al., 1960). The genome of the A1HV-1 has been
sequenced (Ensser et al., 1997). A1HV -1 does not cause disease in its natural
host. Sheep carry OvHV -2 asymptomatically (Bridgen and Reid, 1991). Recent
evidence suggest that experimental infection of sheep with ovHV-2 can result in
MCF like disease (Li et al., 2005;Taus et al., 2005). Lymphoblastoid cell lines
(LCL) propagated from naturally infected cattle and experimentally infected
rabbits are being used for molecular characterisation of the virus. OvHV-2
genome is very similar to that of A1HV -1 (Rosbottom, 2003).
1.2.2.1. MALIGNANT CATARRHAL FEVER (MCF)
MCF affects cattle, deer and other ruminants throughout the world. The outbreak
of the disease is generally sporadic. However, severe herd outbreaks affecting
large numbers of animals have been reported. The disease caused by A1HV-1 and
OvHV-2 are usually referred as Wildebeest associated MCF (WA - MCF) and
Sheep associated MCF (SA - MCF) respectively. The clinical signs of both forms
of disease are similar and indistinguishable. High fluctuating fever, nasal
discharge, corneal ulceration and lymphadenopathy are consistent clinical signs. It
is generally believed that MCF is a fatal disease. However, there are reports of
domestic cattle showing mild clinical symptoms and remaining as chronically
infected with occasional recrudescence (O'Toole et al., 1997).
The most consistent histopathological lesion in almost all organs derived from
infected animals is marked perivascular and intramural infiltration of
mononuclear cells. The infiltrating cells are mainly lymphocytes with large nuclei
and prominent nucleoli. Medial necrosis and endothelial swelling are also
observed. These lesions may be segmental or involve the entire wall of the blood
vessel (Liggitt and DeMartini, 1980). The infiltrating lymphocytes were
characterised as CD8+ T lymphocytes (Ellis et al., 1992;Nakajima et al., 1992).
Recently it has been shown that CD8+ T cells infiltrating the perivascular sites
carry virus genome (Simon et al., 2003).
17
CHAPTER:! INTRODUCTION
Experimental transmission of A1HV-1 to hamsters, rats and guinea pigs (Jacoby
et al., 1988a) and OvHV-2 to rabbits and hamsters (Buxton et al., 1988) has
been reported. Laboratory mice are refractory to both viruses (Jacoby et al.,
1988b). The clinical symptoms and lesions shown by the experimentally infected
rabbits are similar to those seen in natural disease (Buxton and Reid, 1980;Reid et
al., 1984). Lymphoblastoid cell lines have been derived from the tissues of
naturally infected cattle and experimentally infected rabbits with both viruses
(Cook and Splitter, 1988;Reid et al., 1983). The cells were morphologically
classified as large granular lymphocytes (LGL).
1.2.2.2. HERPESVIRUS SAIMIRI (HVS)
HVS or Saimiriine Herpesvirus -2 (SaHV-2) is the prototype rhadinovirus. Like
A1HV-1, HVS does not cause any overt disease in its natural host, the squirrel
monkey (Saimiri scinreus). However, infection of new world primates results in
rapid development of T - cell lymphoma. A permissive tissue culture system is
available for virus propagation. Consistent production of lymphomas in
susceptible animal models has made it a popular system to study virus-mediated
oncogenesis. The HVS genome is approximately 140kb in size and contains up to
77 ORFs (Albrecht et al., 1992). In agreement with the general features of
gammaherpesviruses, HVS also encode for several genes homologous to cellular
genes (Fickenscher and Fleckenstein, 2001). The oncogenic viral proteins
involved in transformation, proliferation, cell signalling and episome maintenance
encoded by HVS are homologous to those found in KSHV and EBV [reviewed in
(Damania, 2004)].
1.3. MURINE GAMMAHERPESVIRUS - 68 (MHV-68)
MHV-68 is a tractable small animal model for studying the pathogenesis of
gammaherpesvirus infections [Reviewed in (Virgin and Speck, 1999;Stewart et
al., 1998a;Simas and Efstathiou, 1998;Doherty et al., 2001;Nash et al., 2001)].
MHV -68 is being used as a small animal model for studying the pathogenesis of
gammaherpesviruses by virtue of its following features: 1) Ability to grow in a
variety of tissue culture system. 2) Infectivity of different strains of laboratory
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mice (close to natural host) and cause disease mirroring EBV infection. 3) Known
structure and relative ease to manipulate the genome.
1.3.1. ISOLATION AND CHARACTERISATION OF THE VIRUS
MHV - 68 was originally isolated from a Bank Vole (Clethrionomys glareolus) in
Slovakia (Blaskovic et al., 1980). The electron microscopic studies of the rabbit
embryo fibroblast infected by the virus revealed morphological changes
resembling that induced by herpesviruses (Ciampor et al., 1981). Different cell
cultures of human and animal origin (birds, rodents, carnivore, pigs, monkeys and
human) were found to support the growth of virus (Svobodova et al., 1982).
Recently, wood mice (Apodemus sylvaticus) captured from around Liverpool, UK
was shown to carry MHV - 68 DNA, primarily in the lung (Blasdell et al., 2003).
The International committee on Taxonomy of viruses (1CTV) officially named
MHV-68 as Murid herpesvirus - 4 (MuHV-4).
1.3.2. GENOME
The MHV-68 genome consists of a unique stretch of DNA of 118.2 kb, which is
flanked, by a variable numbers of 1.23 kb repeat units (Efstathiou et al.,
1990a;Efstathiou et al., 1990b). The unique stretch of the DNA has a G+C
content of 45%. The complete DNA sequence of the MHV-68 genome has been
determined by two independent groups and deposited in the gene bank (Gene
bank data base accession number: AF105037 and U97553). The published
genome sequence is derived from strain WUMS which was plaque purified from
g2.4 strain (Virgin et al., 1997). The sequences are very similar except for few
differences (Nash et al., 2001) . The majority of the genes encoded by MHV-68
are collinear and homologous with those of other gammaherpesviruses such as
HVS and KSHV. The organisation of MHV-68 genome is presented in figure. 1.2.





Pathogenesis of MHV-68 infection was studied by infecting one-day-old baby
mice via the oral route (with suggested inhalation of the virus). Virus titres were
observed in the lung on day 1, in the liver in traces on day 2, in blood on day 3, in
brain and heart on day 4 and in kidney and spleen on day 5 post infections (p.i.).
In all the above organs, virus titres peaked between day 7 and 9 p.i. Characteristic
pathological lesion in the lung was small foci of inflammation with desquamation
of epithelial cells and exudates rich in macrophages. Some epithelial cells of
alveolar ducts and bronchioles revealed typical inclusion bodies. Focal necrosis of
alveolar septa was prominent and was associated with mononuclear infiltration. In
the liver, necrosis of hepatocytes with occasional intranuclear inclusion bodies
was reported. The hepatic sinusoids were widened and contained macrophages,
lymphocytes and the nests of extramedullary haematopoiesis (Blaskovic et al.,
1984).
Pathogenesis in outbred laboratory mice aged 5, 10, and 21 days and infected by
oral and/or intra nasal route was investigated (Rajcani et al., 1985). The lung
showed severe exudative pneumonia. The alveoli were filled with oedema fluid,
fibrin, macrophages and necrotic alveolar cells. Lymphocytic infiltration was
abundant in the peribronchial connective tissue and the septal walls. Ventricular
musculature showed focal necrotic changes associated with mononuclear
infiltration at the edge of the lesion. Minimal lymphocytic infiltration was noticed
in the portal areas of the liver. The meninges around the brain stem showed round
cell infiltration. The anterior horn of the spinal cord revealed small nodular
infiltrates and few neurons were showing necrotic changes.
Primary infection of three to four weeks old BALB/c mice with MHV-68 showed
that pathological features are in common with that of EBV infection of man and
that lung and lymphoid tissue are the major sites of pathology and persistence
(Sunil-Chandra et al., 1992a). In mice infected intranasally, a peak virus titre was
observed in lung, spleen and thymus on third day p.i. The virus presence in heart
and kidney showed a sudden peak on day 10 p.i. Whole blood showed traces of
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virus on day 10 p.i, whereas the adrenal gland showed traces of virus on day 3 and
5 p.i. The presence of virus in the mesenteric lymph node was insignificant.
Liver, serum, brain or trigeminal ganglia did not show any presence of virus.
When the virus was administered through the intravenous route, virus was
observed on day 3 p.i. in lung, spleen, thymus, liver and mesenteric lymph node,
on day 5 p.i. in the adrenal and on day 10 p.i. in heart and kidney. The presence of
virus in the whole blood, trigeminal ganglia and brain was insignificant. This
study established the intranasal route of infection as the best route for studying the
pathogenesis of MHV-68. Probably, this may be the natural route of infection.
1.3.4. LATENT INFECTION
In an attempt to determine the site of viral latency, a variety of tissues from
infected mice were co-cultivated with permissive cells to isolate latent virus
(Infective centre assay). Latent virus was readily isolated by this method from
spleen of mice killed at day 3, 5, 10, 36 and 90 days p.i. Infectious virus could not
be detected from spleen of mice at 90 days p.i by conventional plaque assay. This
data implied that, spleen is a major site of latency for MHV-68. Infectious or
latent virus could not be recovered from non - lymphoid organs at later time
points (Day 90 p.i.). However, improvement in the sensitivity of the assay could
recover infectious virus from lung of two out of five mice after 90 days p.i. This
suggests that the lung in addition to spleen also is a site of latent/persistent
infection (Sunil-Chandra et al., 1992a).
The consistent recovery and enrichment of latent virus in the B-cell fraction of
splenocytes recovered from MHV-68 infected mice clearly demonstrated that B-
cells are the major site of virus latency (Sunil-Chandra et al., 1992b). Further
evidence to confirm the B-cell tropism of the virus during latent infection was
obtained from a study of in vitro infection of different cell lines (Sunil-Chandra et
al., 1993). Persistent infection could be established in mouse myeloma cells (B-
cell - NSO cell line) but not in mouse thymoma cells (T cell - BW 5247 cell line).
The virus persists indefinitely in myeloma cells, without any apparent cytopathic
effect, but with production of infectious virus. Acylcyclovir (ACV) abolished the
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productive infection, but large number of cells continued to harbor virus in a
latent form.
This observation was further confirmed by demonstrating the absence of splenic
latency in B-cell deficient mice (Usherwood et al., 1996c). Transgenic pMT
mice, which lacked mature B-cells, were used in this study. No infective centres
or viral DNA was detected in the spleen of pMT mice following intranasal
infection. In addition, the infected pMT mice failed to develop splenomegaly
suggesting that latently infected B-cells are required for the establishment of
splenomegaly. Viral DNA could be detected in both control mice and pMT mice
at late time intervals from lung, which, confirmed the earlier observation that
lung, is a site of viral persistence/latency. However, in a separate study, it was
reported that pMT mice infected via intraperitoneal route developed latently
infected cells in the spleen at a level about 100 fold higher than that in wild type
mice (Week et al., 1996). Combined In situ hybridisation studies with viral tRNA
probe and immunohistochemistry with monoclonal antibodies for cytokeratin
proved that the cell type in the lung harbouring MHV-68 genome was epithelial in
nature. By adoptive transfer experiments, it was also shown that virus resident in
splenic B-cells is able to spread infection to the lung. In the presence of B-cells,
virus present in lungs can establish infection in spleen. This two-way movement
of the virus between lymphoid and non-lymphoid tissue during latent infection
may be a part of the survival strategy of the virus (Stewart et al., 1998b).
Latent infection of macrophages occurs in the peritoneum of normal and B-cell
deficient C57BL/6 mice (Week et al., 1999a). This indicates that MHV-68 has
broader cellular tropism for the establishment of latency. The F4/80 positive
macrophage harboured most of the viral genome and efficiently reactivated from
latency. Whereas, CD 19 positive, B-cell enriched peritoneal exudate cells (PEC)
harboured about 10 fold lower frequencies of virus. It has been shown that latent
infection in the spleen after intranasal infection with MHV-68 is harboured in B-
cells, macrophages and dendritic cells (Flano et al., 2000). Among B-cells,
latency was preferentially associated with activated B-cells expressing the
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phenotype of germinal centre B-cells. Long-term latency is preferentially
maintained in two different subsets of isotype switched B-cells, germinal centre
and memory B-cells. Cell cycle analysis indicated that MHV-68 is located in both
cycling and resting isotype switched B-cells (Flano et al., 2002a) . In a separate
study, it was also shown that long term latency is maintained in immunoglobulin
D negative B-cells which exhibit features of memory B-cells (Wilier and Speck,
2003). The requirement of CD40 on the surface of B-cells for establishment of
latency was tested by developing bone marrow chimera mice containing CD40+ve
or CD40-ve B-cells and monitoring latent infection. CD40-ve B-cells
progressively lost MHV - 68 latency whereas isotype- switched CD40+ve B-
cells maintained latent infection (Kim et al., 2003).
1.3.5. INFECTIOUS MONONUCLEOSIS LIKE SYNDROME
Another characteristic feature of MHV - 68 infection is the massive expansion of
CD8+ T-lymphocyte population expressing V(34 T-cell receptor (TCR) in
conjunction with variety of other TCR a chains (Tripp et al., 1997;Hardy et al.,
2000;Flano et al., 2004). The timing of this T- cell response also is significant as
it appears subsequent to the resolution of acute phase of infection and persists for
more than a month. It is suggested that this expansion of the T- cell population
may be comparable to the IM syndrome shown by young adults exposed to EBV
[Reviewed in (Doherty et al., 1997;Flano et al., 2002b)]. However, there is a
major difference between this T- cell response and T -cell response shown by IM
patients. Tetramer studies of the T-cell response from IM patients have shown
that CD8+ T- cell population largely consist of EBV specific major
histocompatability complex (MHC) class I restricted T-cells, whereas in MHV-68
induced T-cell responses are not completely viral antigen specific (Callan et al.,
1998;Callan et al., 2000). It was suggested that the non-viral antigen specific T-
cell response shown by mice infected with MHV -68 might be in response to a
'super antigen' encoded by the virus (Tripp et al., 1997). However, there are
classical differences between a 'super antigen' driven response and the V(34
restricted CD8+ T-cell response shown in response to MHV-68 infection: The
MHV-68 driven response is oligoclonal in nature and this response is not
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mediated by binding to MHC glycoproteins which distinguishes it from other
'super antigen' driven responses (Hardy et al., 2000;Coppola et al., 1999).
1.3.6. IN VIVO REACTIVATION
As discussed above, spleen is a major organ harbouring latently infected cells
following intranasal infection of mice with MHV-68 (Sunil-Chandra et al.,
1992b;Sunil-Chandra et al., 1992a). It has been shown that the latently infected
cell load in the spleen reaches a concentration of l/104-spleen cells at two weeks
p.i. and then drops to 1/106 spleen cells and is maintained at this level throughout
the life of mice (Cardin et al., 1996). Recently, limiting dilution assays coupled
with polymerase chain reaction (PCR) for viral DNA have shown that, the actual
number of latently infected cells in the spleen is much higher than that detected by
the conventional assays depending on ex vivo reactivation (Week et al.,
1999b;Flano et al., 2000).
Establishment of latency and periodic reactivation are the key events in the
persistence of gammaherpesvirus infection (Tibbetts et al., 2002). It has been very
difficult to detect and quantify this low level of reactivating virus in the lymphoid
compartment with the conventional plaque assay (Week et al., 1999b;Flano et al.,
2000). Modifications to the conventional assay were successful in detecting low
levels of infectious MHV-68 in the range of less than 100 PFU / whole spleen or
lung (Flano et al., 1999). Other evidence for the low level of productive
replication/reactivation of virus is the detection of activated CD8+ T-cells specific
for epitopes in lytic cycle viral proteins long after the clearance of acute infection
(Liu et al., 1999;Stevenson et al., 1999).
Recently, it has been shown that gamma interferon (IFNy) regulates the
reactivation from latency: there was 30 fold increase in reactivation from latency
in PEC from IFNy knock out animals compared with control animals infected
with MHV-68 (Tibbetts et al., 2002). Interestingly, the reactivation from latency
in splenocytes in this system was slightly decreased in comparison to control
mice. This discrepancy may be due to the type of cells harbouring latent virus
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between PEC and splenocytes. It has been shown recently that there are
differences in viral gene transcription and reactivation efficiency among latently
infected dendritic cells, macrophages and different subsets of B- lymphocytes at
early stages of latent infection (Marques et al., 2003) . The viral genes transcribed
during latency in spleen included M2, M3, M8, M9, Mil, ORF 73 and K3 (Simas
et al., 1999;Virgin et al., 1999;de Lima et al., 2005;Husain et al., 1999;Rochford
et al., 2001). Whereas, it is shown that ORF50 (which is associated with lytic
infection) transcription was detected in macrophages and dendritic cells of latently
infected mice at day 14 p.i. In addition to ORF50, transcription of ORF6 in
macrophages and ORF6 and M7 in dendritic cells is consistent with a pattern of
lytic replication (Marques et al., 2003). Along with the transcription of lytic
replication associated genes, the latently infected macrophages did not show
transcription of ORF73, which is a latency-associated gene (Fowler et al., 2003).
These observations suggest that viral gene transcription during latency is
dependent on the type of cell harbouring latent virus.
1.3.7. THE ROLE OF VIRAL GENES IN PATHOGENESIS
The knock out strategy employing homologous recombination technique is widely
employed to knock out specific gene expression in order to study their role in
pathogenesis. The cloning of MHV-68 genome into a bacterial artificial
chromosome (BAC) has greatly enhanced the ability to manipulate the viral
genome (Adler et al., 2000;Adler et al., 2001). More recently, a natural deletion
mutant of MHV-68 called MHV-76 was utilised to successfully create 'knock in'
mutants with specific genes to study their role in pathogenesis (Townsley et al.,
2004). MHV-76 is a natural deletion mutant of MHV-68 lacking left hand end of
the genome encoding Ml - M4 genes and vtRNA sequences (Macrae et al., 2001).
The viral genes expressed during latency are intimately associated with the
pathogenesis of disease caused by gammaherpesvirus such as EBV and KSHV.
The putative latency associated genes of MHV-68 include tRNA like molecules,
Ml, M2, M3, M4, v-Bcl-2 (Mil), K3 (ORF12), v-Cyclin (ORF72), LANA
(ORF73) and v G- protein coupled receptor (GPCR) (ORF74) (Fowler et al.,
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2003;Gangappa et al., 2002;Jacoby et al., 2002;Macrae et al., 2003;Moorman et
al., 2003a;Simas et al., 1998;Townsley et al., 2004;van Dyk et al., 2000;Virgin et
al., 1999;Wakeling et al., 2001;Hoge et al., 2000;Moorman et al.,
2003b;Bridgeman et al., 2001;Clambey et al., 2000;Lee et al., 2003;Marques et
al., 2003;Stevenson et al., 2002;Van Berkel et al., 2000).
1.3.7.1. tRNA LIKE MOLECULES
There are eight tRNA like molecules encoded in the left hand end of the genome.
The tRNA molecules are not aminoacylated and their function is currently
unknown. Deletion of four of the tRNA like sequences along with Ml from the
virus genome does not affect the ability of the virus to replicate in vitro or to
establish and reactivate from latency in vivo (Simas et al., 1998). The recombinant
virus was also able to establish a persistent/latent infection in NSO cells (Murine
B-cell myeloma cell line) in a manner indistinguishable from the parental virus.
1.3.7.2. M1
Ml gene exhibits sequence homology to poxvirus serine protease inhibitor -1 (SPI
-l)(Bowden et al., 1997;Virgin et al., 1997). Disruption of MHV-68 Ml
(Ml.LacZ) leads to enhanced reactivation from latency (Clambey et al., 2000).
Although Ml.LacZ replicated normally in tissue culture, it exhibited decreased
splenic titres at days 4 and 9 p.i in both immunocompetent and immunodeficient
mice on a B6 background. Despite the decreased level of acute virus replication,
the recombinant virus established latent infection comparable to the normal wild
type virus and it exhibited approximately five-fold increase in efficiency of
reactivation from latency.
1.3.7.3. M2
Study of the transcription profile of latent genes in SI 1 cell line [a B-lymphocyte
cell line latently infected with MHV-68 (Usherwood et al., 1996b) and spleen of
latently infected mice identified M2 as a latency associated gene (Husain et al.,
1999). The M2 protein is found to have an epitope recognised by CD8+ T-
lymphocytes. Disruption of M2 gene of MHV-68 resulted in altered splenic
28
CHAPTER:! INTRODUCTION
latency following intranasal but not intraperitoneal inoculation in mice (Jacoby et
al., 2002). In another study, introduction of a frame shift mutation in the M2 ORF
did not show any defect in productive replication in tissue culture system or lungs
after intranasal inoculation of mice (Macrae et al., 2003). This mutant virus also
showed no difference in transient increase in spleen cell number, IM like
syndrome and establishment of latency in the spleen in comparison to the normal
virus following intranasal infection in mice. However, this mutant virus showed a
defect in its ability to produce transient increase in the latent viral load in the
spleen. This study also demonstrated restricted expression of M2 to B-cells in the
spleen. The localisation of protein was found to be predominantly in the plasma
membrane and cytoplasm of B-cells. A recent study showed that M2 gene product
might be required for efficient latent infection of splenic follicles (Simas et al.,
2004).
Another study suggested that M2 might be involved in inhibiting the interferon
response elicited by infected cells (Liang et al., 2004). The mechanism through
which inhibition of interferon response is carried out is through the
downregulation of signal transducers and activators of transcription (STAT)
expression. Interestingly, in addition to downregulation of STAT-1 and STAT-2
in a cell type dependent manner, M2 protein could downregulate the expression of
STAT-6 as well, which is involved in the Th2 mediated immune response. The
property of M2 protein to downregulate interferon response is homologues to the
property of BZLF1, the immediate early gene product of EBV. BZLF1
downregulates the interferon response through a variety of mechanisms including
the downregulation of expression of IFNy receptor (Morrison et al., 2001).
1.3.7.4. M3
M3 is a secreted protein of 44-kDa size encoded by MHV-68 which is a high
affinity broad-spectrum chemokine binding protein. The M3 protein lacks
homology to known chemokines, chemokine receptors or chemokine binding
proteins suggesting the involvement of this protein in a novel herpesvirus
mechanism of immune evasion (Van Berkel et al., 1999;Parry et al., 2000).
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Encoding homologues of cytokines, chemokines, their receptors and binding
proteins by viruses represent a molecular 'cat and mouse' game designed to upset
immune regulation of infection. The importance of this 'molecular mimicry'
operated by viruses are recognised as a major strategy utilised by viruses for
immune evasion [Reviewed in (Alcami, 2003)]. Considering the co - evolution
theory of herpesviruses, it is reasonable to conclude that herpesviruses would have
acquired these genes from their host during the process of evolution to circumvent
the host immune response.
Targeted disruption of M3 gene had little effect on the lytic cycle replication of
virus in the respiratory tract or the initial spread of virus to lymphoid tissues.
However, there was a marked reduction in latent virus recoverable by in vitro
reactivation. In vivo CD8+ T- cell depletion largely reversed this deficiency.
Thus, it is suggested that, chemokine neutralisation afforded by M3 may function
to block effective CD8+ T-cell recruitment into lymphoid tissue during the
expansion of latently infected B-lymphocytes (Bridgeman et al., 2001) . M3 gene
is essential for the efficient induction of lethal meningitis by MHV- 68. An M3
mutant MHV- 68 virus was 100 fold less virulent than wild type or rescue virus
after intracerebral inoculation (Van Berkel et al., 2002). M3 protein blocks
chemotaxis induced by CCL19 and CCL21, the chemokines constitutively
expressed by lymphoid tissue and peripheral lymphatic vessels in an in vitro
system. A very significant observation with regard to the in vivo role of this
protein was also provided by studies using double transgenic mice expressing
CCL21 and M3 in the pancreatic islets of mice. This system showed that M3
protein prevented the chemotaxis induced by the expression of CCL21 into the
islets of pancreas (Jensen et al., 2003). It appears that selective disruption of
leukocyte trafficking in tissues may be a strategy employed by MHV-68 to evade
the immune response.
Transgenic mice with conditional expression of M3 protein was generated (Pyo et
al., 2004). Conditional induction of M3 resulted in 67% reduction in intimal area
and a 68% reduction in intimal/medial ratio in femoral artery injury model in
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these transgenic mice. It suggests that chemokines regulate intimal hyperplasia
and M3 has a role in controlling this.
1.3.7.5. M4
The role of M4 gene in the biology of MHV-68 infection was studied by a novel
strategy of "knocking in' the gene along with its putative promoter at the 5' end
of MHV-76 genome (Townsley et al., 2004). Studies with this recombinant virus
showed that the M4 gene has a role in regulating establishment of acute infection
in the lung, as the 'knock in' virus showed higher titer in the lung compared to
MHV-76 at early time points after infection. More significantly, there was
elevated level of latent viral load in the spleen at days 17 and 21 p.i. in mice
infected with 'knock in' virus compared to the wild type MHV-76 viruses
suggesting a role for this protein in modulation of latency .
1.3.7.6. M11
Mil protein is predicted to encode a 171 amino acid protein with homology to
Bcl-2. It has a well-conserved Bcl-2 homology (BH)-l domain and the BH2
domain is apparently absent. This is a major difference with the Bcl-2 homologue
proteins encoded by other known gammaherpesviruses. Ml 1 protein of MHV -68
could protect cells from apoptosis (Wang et al., 1999). Ml 1 gene expression was
noticed during lytic and persistent infection in mice infected with MHV-68. This
suggests that MHV-68 Bcl-2 homologue promotes virus survival by protecting
not only the productively infected but also the persistently infected cells from
apoptotic death (Roy et al., 2000). Caspases are a family of apoptosis inducing
proteases and are capable of converting Bcl-2 and Bel - x (L) proteins of
mammals into potent pro-apoptotic factors (Cheng et al., 1997a). The viral Bcl-2
protein encoded by MHV-68 is susceptible to caspase digestion. However, the
cleavage product lacked pro -apoptotic activity (Bellows et al., 2000).
The in vivo role of M11 gene product during infection was studied by constructing
a mutant virus with insertion of stop codons in the coding region of the gene.
Intraperitoneal infection of immunocompetent mice showed the mutant virus
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established normal levels of latency in the PEC in comparison to wild type MHV-
68. However, the ex vivo reactivation of latently infected cells was 4-5 fold less
efficient in comparison to the wild type virus (Gangappa et al., 2002). It was also
shown that, the mutant virus failed to establish persistent replication in PEC of
IFNy knock out (IFNy"7") mice. It demonstrated that the viral genes required for
acute and persistent replication of the virus in IFNy"7" mice are different. Another
mutant virus with disruption of BH-1 domain or C-terminal domain of Mil
protein was created and phenotype of the virus in immunocompetent mice via
intranasal route was assessed. The study showed the role of Mil protein in
establishment of peak latent viral load. However, the long term latent levels were
unaffected (de Lima et al., 2005).
1.3.7.7. K3
The K3 gene product of MHV-68 is a KSHV K3 / K5 homologue (Virgin et al.,
1997). K3 transcription occurs in the lung during lytic infection and lymphoid
tissue during latent infection following intranasal infection of mice. K3 protein of
MHV-68 downregulates the expression of MHC class I molecule (Stevenson et
al., 2000;Stevenson et al., 2002). The downregulation of MHC class I expression
by K3 gene product is through binding of nascent MHC class I heavy chains that
associate with transporter associated with antigen processing (TAP) in the
endoplasmic reticulum and catalysing their ubiquitination leading to proteosome
dependent degradation (Boname and Stevenson, 2001). K3 protein is
predominantly detected in association with incompletely assembled class I
molecules implying that K3 may block interaction of class I heavy chains with
molecular chaperones to prevent their assembly. It is also possible that K3 may be
using molecular chaperones to target incompletely assembled class I molecules
for their destruction (Yu et al., 2002). K3 deletion mutant virus is deficient in
amplification of latency and this phenotype can be reversed by supplementing
with CD8+T-lymphocytes (Stevenson et al., 2002). This data along with
observations made with M3 deletion mutants argue for an important role for




MHV-68 v-Cyclin gene (ORF 72) is an oncogene that promotes cell cycle
progression in primary lymphocytes (van Dyk et al., 1999) . A transgenic line of
mice was generated by using lck proximal promoter to express the MHV-68 v-
cyclin in early T-lymphocytes. Expression of MHV-68 v-cyclin gene significantly
increased the number of thymocytes in cell culture and it interfered with
thymocyte maturation, as shown by increased numbers of CD4+ and CD8+
double positive thymocytes. There was a striking difference in the architecture of
thymus in transgenic mice. The thymus of transgenic mice showed an increase in
the percentage of the cortex and a greatly reduced medullary area. There was an
increased rate of apoptosis in the thymus of transgenic mice. About 50% of
transgenic mice developed lymphoid neoplasm within 3 to 12 months of age.
Based on these observations, it was concluded that MHV68 v- cyclin gene is an
oncogene (van Dyk et al., 1999).
A recombinant virus that lacks the cyclin homologue and expresses (3-
galactosidase as a marker (MHV-68cy) was generated to study its effect on
pathogenesis. Infection of BALB/c mice and severe combined immunodeficiency
(SCID) mice indicated that cyclin D homologue mediates important functions
during acute infection and it is required for efficient reactivation from latency
(Hoge et al., 2000) . Another mutant virus with insertion of lacz cassette within
the gene also showed defect in reactivation from latency (van Dyk et al., 2000). It
was also shown that ORF72 is required for maintenance of latency in B-
lymphocyte deficient mice (van Dyk et al., 2003).
1.3.7.9. ORF 73
ORF73 is well conserved among gammaherpesviruses and they encode latency
associated nuclear antigen (LANA) in KSHV and HVS (Smith et al.,
2001;Ballestas et al., 1999). EBNA -1 is the homologue of LANA in EBV (Lee et
al., 1999). Two independent mutant viruses involving deletion of the gene and
frame shift showed no difference in in vitro and in vivo productive replication.
Whereas, consistent with its expected function, the mutant virus showed severe
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defect in establishment of latency (Fowler et al., 2003). In a separate study,
another mutant MHV-68 virus with insertion of stop codon in the ORF73 was
created and showed similar defect in establishment of latency (Moorman et al.,
2003b).
1.3.7.10. ORF 74
ORF74 of gammaherpesviruses has significant sequence homology with
mammalian GPCR. MHV-68 ORF74 is encoded on multiple early transcripts and
expressed during acute and persistent infection of the lung as well as latent
infection of the spleen. Expression of MHV-68 ORF74 also resulted in
transformation of NIH 3T3 cells (Wakeling et al., 2001). Chemokines like KC
and MIP-2 acts as agonists of MHV-68 ORF74; whereas, IFNy inducible protein-
10 (IP-10)/CXCL10 bind to MHV-68 ORF74 and behaves as an antagonist
(Verzijl et al., 2004).
A mutant virus with deletion in ORF74 region of MHV-68 genome was
generated. The growth of the mutant viruses in NIH 3T3 cells was similar to that
of wild type virus. The mutant viruses showed significantly reduced reactivation
from latently infected mouse splenocytes. Chemokines such as KC and MIP-2
significantly contributed to the replication of the wild type virus but not the
mutant viruses. This property was not observed with IP—10. Utilisation of a GPCR
homologue to enhance replication and reactivation from latency by MHV-68
represent a novel mechanism utilised by gammaherpesviruses to subvert the
immune response (Lee et al., 2003). Another mutant with deletion of 440 bp of
ORF74 was also created. This mutant virus did not show any defect during in
vitro and in vivo acute replication, establishment of latency or reactivation from
latency at day 16 p.i. However, there was significant decrease in the efficiency of
virus reactivation by day 42 p.i. (Moorman et al., 2003a).
1.3.8. IMMUNE RESPONSE
Transgenic mice defective in specific arms of immune response have been used
extensively to delineate the immune response against MHV-68. Conclusions from
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such studies showed that, there is considerable redundancy in their capacity to
prevent exacerbated disease. Surprisingly, even organised secondary lymphoid
tissue is not essential to successfully clear MHV-68 infections. Lymphotoxin a
knock out (LTA"/_) mice lack lymph nodes and have disrupted splenic architecture
(Banks et al., 1995). LTA"/_ mice could clear productive MHV-68 infection with
delayed kinetics compared to wild type mice. LTAV" mice failed to develop
splenomegaly or lymphocytosis following MHV-68 infection (Lee et al., 2000).
1.3.8.1. B - LYMPHOCYTE
MHV-68 specific IgM antibodies are evident within first week of infection, which
is followed by class switched antibodies dominated by IgG2a and IgG2b isotypes
during the second week of infection (Sangster et al., 2000;Stevenson and Doherty,
1998). Transgenic pMT mice lack B-lymphocytes and hence the capacity to
produce antibody (Kitamura et al., 1991). Little difference was observed in the
acute lung infection in comparison with wild type mice following MHV-68
infection implying that antibody has little role to play in controlling acute
infection in the lung (Usherwood et al., 1996c).
1.3.8.2. CD4+ T- LYMPHOCYTES
CD4+ T-lymphocytes play a key role in the immune response by providing
support for protective antibody response and driving the Thl - mediated immune
responses. MHV-68 specific CD4+ T-lymphocytes remain activated and a stable
frequency during persistent infection (Christensen and Doherty, 1999). Control of
MHV-68 infections in B-lymphocyte deficient mice mediated by CD4+ T-
lymphocytes were shown to be through the action of IFNy (Christensen et al.,
1999). Infection of CD4+ T-cell deficient mice with MHV-68 follows the same
kinetics of virus clearance from the lung and spleen by 12-day p.i as that of
normal mice. It was also shown that, CD4+ T-cells contribute to the
lymphoproliferation seen in the spleen (Ehtisham et al., 1993). Depletion of CD4+
T-lymphocytes prevented the splenomegaly and greatly reduced the peak infective
centre level, while having no effect on the long-term level of latently infected
cells (Usherwood et al., 1996a).
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MHC class II deficient mice are another in vivo system available to study the role
of CD4+ T-lymphocytes in the pathogenesis of virus infections. Following MHV-
68 infection of MHC class II deficient mice, the clearance of infection from the
lung is comparable to that of normal mice. However, these knock out mice fail to
produce antiviral antibodies and induce splenomegaly. As a consequence, the
latent viral load also was low in these mice. A significant feature of MHV-68
infections in MHC class II deficient mice is the reactivation of virus infection in
the lung and development of a chronic unresolving lung disorder. This
progression of disease occurs inspite of an active CD8+ T cell response (Cardin et
al., 1996). The progression of chronic lung disorder in MHV-68 infected MHC
class II deficient mice is not preventable by vaccination with protective T cell
epitope p56 and p79 (Belz et al., 2000). However, stimulation of CD40 molecule
with an agonistic antibody substituted the CD4+ T-cell function in MHC class II
deficient infected mice in preventing the reactivation of infection in the lung
(Sarawar et al., 2001). The virus specific CD8+ T-lymphocytes from MHV-68
infected MHC class II deficient mice showed no sign of functional exhaustion,
even though these cells probably encounter viral antigens at fairly frequent
intervals (Belz et al., 2003).
1.3.8.3. CD8+ T- LYMPHOCYTES
CD8+T- lymphocytes recognising p56 and p79 were identified in high numbers in
the lung of MHV-68 infected mice up to 22 days post infection. p56
(AGPHNDMEI) is an epitope from ORF6, which encodes a single stranded DNA
binding protein, which is H-2Db restricted. p79 (TSINFVKI) from ORF61, which
encode the large ribonuclease reductase subunit is H-2Kb restricted epitope
(Stevenson et al., 1999). CD8+T-lymphocytes specific for these epitopes were
also observed in MHC class II deficient mice indicating that, these response are
induced and maintained in the absence of help from CD4+ T-lymphocytes
(Stevenson et al., 1998).
Pathogenesis of MHV-68 infection in mice depleted of CD8+ T-cells prior to
infection resulted in great exacerbation of infection of the lung and spleen. It also
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resulted in dissemination of infection to the liver and adrenal gland. This finding
indicates that, CD8+ T-lymphocytes have a major role in recovery of acute MHV-
68 infection (Ehtisham et al., 1993). The (32-microglobulin knock out (Pi"7") mice,
which are naturally deficient in CD8+ T-lymphocytes showed a defect in clearing
infectious virus from the spleen up to six weeks p.i., when mice were infected
with MHV-68 via intraperitoneal route (Week et al., 1996). Release of perforin
and granzymes are the known mechanisms by which the CD8+ T- cells exert their
cytotoxic effect. Surprisingly, absence of perforin did not significantly affect the
kinetics of either the lytic lung infection or latent spleen infection (Usherwood et
al., 1997). The mechanism by which the CD8+ T-cells achieve the control of
acute infection remains to be elucidated.
1.3.8.4. CO-STIMULATORY MOLECULES
CD28 is a molecule expressed on resting T-lymphocytes and its expression
increases following activation. CD40 ligation on an antigen presenting cell up-
regulates surface expression of B7.l (CD80) and B7.2 (CD86), which interact
with CD28 molecule on T-cells (Allison, 1994;Cella et al., 1996). The interaction
of CD28 with B7.1 or B7.2 leads to up-regulation of additional molecules and
thus initiates "cross talk" between CD8+ T-cells and antigen presenting cells
resulting in further activation of both cell types. The role of CD28 dependent co-
stimulatory interactions in the development and maintenance of antiviral immune
responses during MHV-68 infection was studied using CD28 knock out (CD28"/_)
mice (Lee et al., 2002). CD28_/" mice could clear a productive infection, although
the lung virus titre was significantly increased. Splenomegaly developed
normally in CD28~/~mice, whereas virus specific antibody responses were
significantly reduced and aberrant class switching was observed. It was concluded
that co-stimulatory interactions involving CD28 are not an absolute requirement
for the control of infection with MHV-68.
CD40 is constitutively expressed on macrophages, B Lymphocytes and dendritic
cells [Reviewed in (Mackey et al., 1998)]. CD40_/" mice infected with MHV-68
showed defective long term control of infection (Lee et al., 2002). A recent study
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showed that CD40" ~ mice efficiently established long term latency (three months)
in memory B cells of spleen. The mutant mice also showed significantly higher
levels of virus replication in the lungs at late times post infection (Wilier and
Speck, 2005). CD40 ligand (CD40L/CD154) is expressed in high quantities on
the surface of activated CD4+T-lymphocytes. CD40L~/~ mice infected with MHV-
68 do not show expansion of Vp4 T-lymphocytes indicative of its role in
developing IM like syndrome (Brooks et al., 1999).
1.4. INTERFERON (IFN)
IFNs are best known for their ability to induce cellular resistance to viral infection
and they were identified for the first time based on this property [Reviewed in
(Schroder et al., 2004). The known types of IFNs were grouped as either type I
IFN comprising IFNa, IFNp and IFN© or type II IFN with a single member
namely IFNy. Recently, a novel family of cytokines that are structurally related to
the type I IFNs and to the IF-10 family was reported (Kotenko et al.,
2003;Sheppard et al., 2003). Fike other IFNs, the newly described cytokines
protect cells from virus infection and induce MHC class I antigen expression
suggesting that, these previously unknown mediators contribute to the antiviral
defences and perhaps carry out other functions similar to those of the type I and
type II IFNs. The three member of this newly identified cytokine family termed
IFN-2H, IFN-a.2, and IFN- A.3 bind to a heterodimeric receptor, in which one
subunit is a novel member of class II cytokine receptor family and the other is
identical to the IF-10 receptor (Vilcek, 2003).
1.4.1. TYPE I INTERFERON
The genes encoding type I IFNs form a cluster and the genes and proteins of this
family are structurally related to each other. IFNP was earlier known as fibroblast
IFN as it is principally produced by fibroblasts. IFNp is the most divergent
member of this family and shows about 29% homology with members of IFN a
family at the amino acid level and about 45% homology in the coding sequence
level (Taniguchi et al., 1980). IFNp has a potential N-glycosylation site at
position 80 and the mature protein is known to be glycosylated, whereas the IFNa
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is not glycosylated (Knight E Jr, 1976a;Knight E Jr, 1976b). Both IFNa and IFNp
appear to be active in the monomeric form (Chelbi-Alix and Thang, 1986;Utsumi
et al., 1989). All type I IFNs bind with the same receptor and in most
experimental systems examined they generally exert similar biological activities
[Reviewed in (Smith et al., 2005)].
One of the mechanisms by which type I IFNs exert their action is by early
induction of inducible nitric oxide synthase (iNOS) (Diefenbach et al., 1998). One
study showed that infection with MHV-68 was lethal in iNOS deficient mice
when infected with 106PFU of MHV-68 (Kulkarni et al., 1997). In contrast, iNOS
deficient mice were resistant to infection with 4xl05 PFU of MHV-68
administered via intranasal route (Dutia et al., 1999). Thus it appears that
mortality observed in iNOS deficient mice following MHV-68 infection is
dependent on dose of administration. MHV-68 infection in mice with a targeted
disruption in an essential chain of the type I IFN receptor gene (IFNa/pR"") at
high dose of infection (4xl06 PFU) was lethal in 80 - 90 % of IFNa/pR"7" mice
and at low dose of infection (4X 103 PFU) mortality rate was 50%. Both high and
low doses of virus lead to 100 to 1000 fold higher lung virus titres in IFNa/pR7"
mice in comparison to wild type mice. Latently infected cells were detectable in
the spleens of IFNa/pR"" mice earlier than in wild type mice, and the numbers of
latently infected cells were 10 fold higher in the IFNa/pR_/" mice during the acute
phase of infection (Dutia et al., 1999). Interferon regulatory factor-1 knock out
mice (IRF1"") mice were also highly susceptible to MHV-68 infection and
behaved similar to IFNa/pR"A mice (70% of mice died in response to 4x105 PFU
ofvirus) (Dutia et al., 1999).
1.4.2. TYPE II INTERFERON / GAMMA INTERFERON (IFNy)
Type II IFNs are structurally different from type I IFNs, but they share functional
similarity. A single IFNy gene has been found in all mammalian species examined
so far. Human IFNy gene is located in the chromosome 12 (Naylor et al., 1983)
whereas in murine species, the gene is located at chromosome 10 (Naylor et al.,
1984). The human and murine genes are 6 kb in size and contain four exons and
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three introns. The coding part of the murine gene displays an overall nucleotide
homology with the human gene of about 40% and the protein homology is 65%.
As a result of this relative lack of conservation, IFNy tends to be strictly species
specific in its actions. The activation of human gene leads to generation of a 1.2
kb mRNA that encodes a 166 amino acid polypeptide (Gray et al., 1982;Derynck
et al., 1982;Gray and Goeddel, 1982). The amino terminal 23 residues of the
human protein constitute a typical hydrophobic signal sequence which when
proteolytically removed, gives rise to a mature 143 amino acid residue positively
charged polypeptide with a predicted molecular mass of 17 kilo Dalton (kDa).
The carboxy terminus of the molecule is susceptible to post - translational
enzymatic degradation. At least six different carboxy termini have been detected
on natural and recombinant forms of human IFNy. Two polypeptides self
associate to form a homodimer with an apparent molecular mass of 34 kDa. Only
the dimer can exert its biological activity. The murine gene gives rise to 1.2 kb
mRNA that encodes a mature 134 amino acid polypeptide with a predicted
molecular mass of 15.4 kDa (Gray and Goeddel, 1983).
1.4.2.1. BIOSYNTHESIS
In the normal host, the T-lymphocytes represent the major cellular source of IFNy.
All CD8+ T-cell population and certain subsets of CD4+ T-cells [Thl helper
subset, ThO (less differentiated CD4+ T-cell)] and NK cells can produce IFNy
(Vilcek et al., 1985). The primary physiologic stimulus is antigen in the context of
either MHC class II (for CD4+ T-cells) or MHC class I antigen (for CD8+ T-
cells). The T-cell dependent production of IFNy is enhanced by products of
activated T-cells and macrophages such as IL-2, hydrogen peroxide, and
leukotrienes (LT) such as LTB4, LTC4 and LTD4 (Kasahara et al., 1983;Vilcek
et al., 1985;Farrar et al., 1986;Munakata et al., 1985;Johnson and Torres,
1984;Johnson et al., 1986). NK cells require support from tumour necrosis factor
(TNF)a and macrophages for generation of IFNy. IL -12, which was formerly
called NK stimulatory factor is a product of B-cells and macrophages and induce
IFNy synthesis from T-cells and NK cells. IL-10 inhibits IFNy production by T-




The IFNy receptor contains two subunits namely a or R1 and p or R2. The
intracellular domain of this group of cytokine receptors is devoid of intrinsic
kinase or phosphatase activity. The human and murine IFNy receptors display
strict species specificity in their ability to interact with IFNy. The characterisation
of the structure of IFNy receptor was facilitated by the cloning of human cDNA
and murine homologue(Aguet et al., 1988;Gray et al., 1989;Kumar et al.,
1989;Munro and Maniatis, 1989). The human IFNy receptor a chain is encoded
by a 30 kb gene located on the long arm of chromosome 6 (Pfizenmaier et al.,
1988). The murine homologue is a 22 kb gene present in the chromosome 10.
Both murine and human genes consist of seven exons. Exons 1-5 encode the
extra cellular domain; exon 6 encodes a small portion of membrane proximal
region of the extra cellular domain and the transmembrane domain. The exon 7
encodes the entire intracellular domain. Transcription of both human and murine
genes give rise to 2.3 kb mRNA. The a receptor chain polypeptide is
posttranslationally modified as it moves from endoplasmic reticulum (ER) to the
Golgi by the addition of N-linked carbohydrates (Hershey and Schreiber,
1989;Mao et al., 1989). The human IFNy receptor p chain gene is located in
chromosome 21q22.1 (Soh et al., 1994;Cook et al., 1994) and the murine
homologue resides in chromosome 16 (Hibino et al., 1991). Transcriptional
activation of the IFNy receptor P chain results in the generation of an mRNA
transcript of 1.8 kb in human cells or 2 kb in mouse cells (Soh et al., 1994;Hemmi
et al., 1994). The murine IFNy receptor P gene consists of 7 exons.
1.4.2.3. THE SIGNAL TRANSDUCTION
The proposed model of signal transduction leading to the activation of IFNy
responsive genes is presented in figure. 1.3. [Reviewed in (Platanias,
2005;Schroder et al., 2004)]. In unstimulated cells, the IFN receptor a and P sub
unit are not pre-associated with each other but rather associate through their
intracellular domains with the inactive form of specific Janus kinases (JaK). JaKl
and JaK2 constitutively associate with the receptor a and P chains respectively
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(Sakatsume et al., 1995). JaKl binds to a subunit of the receptor through a four-
residue sequence (266 LPKS 269) in the membrane proximal region of the
intracellular domain. JaK2 binds to a 12 residue proline rich Box 1 - like
sequence (263 PPSIPLQIEEYL 274) in the membrane proximal region of the p
subunit of the receptor intracellular domain. Addition of IFNy induces the rapid
dimerisation of the a receptor chain. This dimerisation of the a receptor chain
leads to formation of a site recognised by the |3 receptor chain. The ligand induced
assembly of the complete receptor complex containing two a receptor chains and
two P receptor chains brings into close juxtaposition, the intracellular domains of
these proteins together with the inactive JaKs that they carry. In this complex,
JaK2 undergoes autophosphorylation, which in turn allows JaKl
transphosphorylation and then phosphorylate the functionally critical tyrosine on
440 residues in the a receptor chain, thereby forming a paired set of docking sites
for STAT-1. Two STAT-1 molecules then associate with the paired docking site.
The activated STAT-1 complex is phosphorylated near the C terminus at Y701.
Phosphorylation on a single serine (residue 727) is also required for maximal
transcriptional activity (Wen et al., 1995). This phosphorylation induces
dissociation of STAT -1 homodimer from receptor.
The active STAT-1 homodimers also known as IFNy activation factor (GAF)
translocate to the nucleus and bind to specific IFNy activated sequence (GAS)
elements of IFNy inducible genes and stimulates or suppresses their transcription
(Decker et al., 1997).
1.4.2.4. ANTIVIRAL EFFECTS
Inhibition of viral growth by IFNs has been described at various levels of virus
multiplication. At the same time viruses have also evolved different mechanisms
to circumvent the antiviral effects of interferons [Reviewed in (Katze et al.,
2002;Schroder et al., 2004)]. The best-characterised IFN inducible components of
the antiviral response mechanisms are double stranded RNA (dsRNA) dependent
protein kinase (PKR), the 2' - 5' oligoadenylate synthetases (OAS) and the Mx
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Figure 1.3. Diagrammatic representation of signal transduction pathway of IFNy.
(1) Ligand binding of IFNy receptor causes rapid dimerisation of a chains and in
formation of receptor complex comprising two a chains and two p chains. The
JaK2 associated with P chain undergoes autophosphorylation and which in
turn causes transphosphorylation of JaKl
(2) The activated JaKl phosphorylates functionally critical tyrosines (Y) on
residue 440 of each a chains of the receptor.
(3) The phophorylated a chains forms a docking site for Src Homology (SH)2
domains of latent STAT1
(4) The STAT1 undergoes phosphorylation near C terminus at Y701. The
phosphorylation induces dissociation of STAT1 homodimer from receptor.
(5) The STAT1 homodimers translocate to the nucleus and bind to promoter
elements (IFNy activation site (GAS) elements) to initiate transcription of
IFNy response genes
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Fig. 1.3. Please see the facing page for legend
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proteins. A more recent addition to the list of IFN inducible gene with antiviral
effect is the RNA-specific adenosine deaminases (ADAR) (Patterson et al., 1995).
1.4.2.4.1. PROTEIN KINASE (PKR)
PKR is a serine - threonine kinase with multiple functions in the control of
transcription and translation (Meurs et al., 1990). PKR is normally inactive, but
on binding to dsRNA or other polyanions it undergoes autophosphorylation and
subsequent dsRNA - independent phosphorylation of substrates (Meurs et al.,
1990;Katze et al., 1991;George et al., 1996). The antiviral effect of PKR is due to
its phosphorylation of the initiation factor eIF2a (Meurs et al., 1992). In the
initial step of translation, the initiator Met-tRNA is recruited to the 40S ribosomal
subunit via an interaction with guanosine triphosphate (GTP) bound eIF2. This
complex then interacts with mRNA, other initiation factors and the large
ribosomal subunit to form a pre - initiation complex, with subsequent hydrolysis
of the GTP molecule bound to eIF2 and release of GDP bound eIF2. In order to
participate in another round of translational initiation, the GDP bound to eIF2
must be exchanged for GTP, a reaction that is catalysed by the guanine exchange
factor, eIF2B. The phosphorylated eIF2a interacts strongly with eIF2B and traps
it such that it cannot mediate the recycling of eIF2 (Ramaiah et al., 1994). Since
eIF2B is present in limiting amounts, translation is inhibited. Apoptosis may also
play a role in the antiviral effect of PKR [Reviewed in (Tan and Katze, 1999)].
Although there is abundant evidence that PKR plays a major role in regulating
virus infection, PKR alone is not sufficient to mediate the full antiviral response.
Mice with homozygous disruptions of the PKR gene show resistance to virus
infection (Yang et al., 1995;Abraham et al., 1999).
1.4.2.4.2. 2'-5' OLIGOADENYLATE SYNTHETASE (OAS)
The oligoadenylate synthetase system is a multienzyme pathway in which IFN
inducible OAS is stimulated by dsRNAs, often of viral origin to produce a series
of short 2' - 5' oligoadenylates that activate the T - 5' adenylate dependent
endoribonuclease L (Rnase L) (Kerr and Brown, 1978). Activation of this
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pathway leads to extensive cleavage of single stranded RNA, including mRNA
and 28S ribosomal RNA (Wreschner et al., 1981;Floyd-Smith et al., 1981).
1.4.2.4.3. THE MYXOVIRUS RESISTANCE (Mx) PROTEINS
The IFN - inducible Mx proteins are highly conserved large GTPases with
homology to dynamin and have been found in all vertebrate species examined so
far [Reviewed in (Arnheiter et al., 1996;Staeheli and Haller, 1987)]. Mx proteins
interfere with virus replication, probably by causing redistribution of
nucleocapsids as shown recently in the case of bunyaviruses (Kochs et al., 2002).
1.4.2.5. GAMMA INTERFERON RECEPTOR KNOCK OUT MICE
Gene knock out mice for IFNy and either chain of IFNy receptors have been
generated (Huang et al., 1993;Dalton et al., 1993;Lu et al., 1998). All three types
of knockout mice showed normal development without any overt anomalies.
Among the three different types of knockout mice available, the IFNyR" ~ mice
with disruption of a chain were used to study the effect of IFNy in different virus
infection models. A few examples of such studies on virus infections and their
outcome are presented in table 1.3 [Reviewed in (Tau and Rothman, 1999)].
Surprisingly, such studies on different virus infection models have shown that the
antiviral function of IFNy is partially redundant, may be because they duplicate
with that of type I interferons.
1.4.2.6. GAMMA INTERFERON AND MHV-68
The cytokine profile during MHV-68 infection of C57BF/6J strain of mice was
evaluated (Sarawar et al., 1996). The cells obtained from spleen, mediastinal and
cervical lymph node produced high levels of IF-6, IFNy and lower levels of IF-2
and IL-10 in an in vitro restimulation assay. Production of IL-4 and IF-5 was
negligible. The IF-6 and IFNy levels peaked in correlation with viral clearance
from lung at day 10 p.i., although significant amount of cytokine was found from
day 3 p.i. Surprisingly, mice that were congenitally deficient in the IFNy gene
(IFNy~/_) cleared MHV-68 with similar kinetics with that in wild type mice which
suggested that IFNy is not essential for regulating infection (Sarawar et al., 1997).
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Table 1.3. Summary of phenotype of IFNyR''" mice in comparison to











Sendai virus Clear infection Clear infection
MHV-68 Resistant to splenic fibrosis
and large vessel arteritis
Develop splenic fibrosis and
large vessel arteritis








No transient immune deficiency
Theiler's virus Resistant on 129/SV
background
Develop chronic disease




Clear infection develops chronic arteritis
Persistent infection
Infection of IFNyR"7" mice with MHV-68 via intranasal route also showed similar
kinetics of viral clearance from lung (Dutia et al., 1997). The IFNyR"7" mice
showed no difference from wild type mice in the titres of infectious virus in the
lungs or in the rate of clearance of the lung infection. However, clear differences
were observed in the spleen. By 14 days p.i. spleens from IFNyR"7" mice were
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pale, shrunken and fibrous. Histological examination showed that there was an
early infiltration of granulocytes followed by widespread destruction of splenic
architecture. A marked decrease in the number of splenic B-cells and CD4+ and
CD8+ T-cells also occurred. These changes were accompanied by a 10 -100 fold
greater load of latently infected cells in the IFNyRmice than in wild type mice at
14 to 17 days p.i, but this was reduced to the levels found in wild type mice by 21
days p.i. Treatment of the mice with the antiviral drug 2 -deoxyl - 5 - ethyl - beta
- 4 - thiouridine from 6 days p.i did not prevent the occurrence of these changes.
The changes were completely reversed by depletion of CD8+ T-cells prior to and
during the primary infection. Depletion of CD4+ T-cells also reversed the major
pathological and virological changes, although in this case there was evidence of
some histological changes (Dutia et al., 1997).
Infection of IFNyR_/~ mice with MHV-68 also resulted in fibrosis and atrophy of
the mediastinal lymph nodes, interstitial pulmonary fibrosis and fibrotic changes
in the liver in addition to the pathological changes in spleen (Ebrahimi et al.,
2001). It was also concluded that atrophy and cellular depletion of the spleen in
IFNyR7" mice was not the result of increased cell death. The loss of splenocytes in
IFNyR_/" mice, which was most evident on day 23-p.i. correlated with an increase
in the number of leukocytes in peripheral blood. At the peak of leukocytosis,
peripheral blood cells from infected IFNyR"'" mice were unable to traffic through
the fibrosed spleens of IFNyR'" mice, but were able to enter the spleens of wild
type mice. It was also found that cytokines like IFNy, TNFa, TNFp, IL-ip,
transforming growth factor - pi (TGFpi), lymphotactin and MIP-ip were
elevated on day 14 after infection whereas the chemokines IP -10 and monokine
induced by IFNy (MIG) were significantly reduced.
1.4.2.6.1. ROLE OF VIRAL GENES IN MHV-68 INDUCED SPLENIC
FIBROSIS
In order to explore the role of viral genes in the pathogenesis of splenic fibrosis,
mutant virus with specific defects in individual genes were used to infect IFNyR "
mice. Disruption in the Ml gene with LacZ gene failed to produce splenic
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pathology in IFNyR"7" mice even though it produced comparable levels of blood
vessel pathology (Clambey et al., 2000) . A mutant virus with deletion of four of
the tRNA like sequences along with Ml from the virus genome and a mutant virus
with an insertion of green fluorescent protein (gfp) with effective deletion of
nucleotides 1-3223 in the left hand end of the genome failed to induce splenic
pathology in IFNyR"7" mice (Dutia et al., 2004). The same study also showed that
MHV-76 and another mutant virus with specific insertion at vtRNA3 also failed
to produce splenic pathology in IFNyR"7" mice.
1.4.2.7. VASCULAR PATHOLOGY AND MHV-68
Tropism of MHV-68 towards blood vessels was highlighted during infection of
knock out mice deficient in different components of interferon system (Week et
al., 1997). IFNyR"7" mice intraperitoneally infected with MHV-68 at a dose in the
range of 1- 3 x 106 PFU was monitored for viral clearance and establishment of
latency. Some IFNyR"7" mice survived for several months, but eventually most of
them died. Mice, which were 6 weeks of age at the time of infection died more
rapidly than those greater than 8 weeks of age at the time of infection. Despite
their ability to clear the virus from lung and spleen, the IFNyR"" mice died 1.5 to
14 weeks after infection. Post-mortem diagnosis was severe large vessel arteritis,
with narrowing of aortic lumen by inflammation and thrombus formation.
The arteritis lesions involved all three layers of the great vessels. The
inflammatory cells were mainly lymphocytic, although neutrophils were seen in
some areas. The lesions were most common and most extensive in the base of the
aorta. Lesions were also seen in 75% of pulmonary arteries. Immunostaining with
polyclonal rabbit serum against MHV-68 showed viral antigen in association with
lesions of arteritis. The antigen deposition was mainly noted in the tunica media
of blood vessels. The morphology of infected cells, together with the localisation




The IFNy_/" mice, B-cell deficient mice (p.MT), MHC class II deficient mice and
CD8+ T-lymphocyte deficient mice also developed arteritis of varying degrees
and intensity following MHV-68 infection. It was shown later that persistent
MHV-68 replication in the walls of large elastic arteries is required for the
maintenance of arteritis (Dal Canto et al., 2000). The suggested reasons for the
persistence of disease in arteries include: a) inefficient clearance of viral infection
from the site compared with other organs or other blood vessels and b) failure of
T cells and macrophages to enter the virus infected elastic media (Dal Canto et al.,
2001).
Tropism of MHV-68 towards blood vessels were also shown in Apolipoprotein E
deficient (ApoE"/_) mice. ApoE_/" mice on normal diet have high cholesterol levels
and spontaneously develop atheroma resembling human disease (Plump et al.,
1997). When ApoE_/" mice were infected with MHV- 68, atheroma formation was
accelerated over a 24-week period (Alber et al., 2000). Acceleration of
atherosclerosis was reduced by antiviral drug administration. Histological analysis
of the atheromatous plaques showed no difference between lesions of infected and
control mice. Viral mRNA was present in the aortas of infected mice before lesion
development on day 5 p.i. This suggests that the virus may initiate endothelial
injury, which is believed to be an early event in the development of
atherosclerosis. In a further study, the question of whether any virally induced
systemic immune response is sufficient to trigger enhanced atheroma formation
was addressed. To clarify this hypothesis, ApoE_/" mice were infected with either
MHV-68 or HSV-1. Viral message was not detected in the aortas of HSV-1
infected mouse. It was concluded that the systemic immune response to any
particular infectious agent is insufficient to induce enhanced atherosclerosis in the
ApoE"/_ mice and pointed to a specific infection or immune mechanisms mediated
by MHV-68 is essential for virally enhanced atherogenesis (Alber et al., 2002).
1.5. FIBROSIS
Forty five percent of human mortality in United States of America is associated
with a fibrotic disorder (Wynn, 2004). The major known fibrotic disorders
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affecting humans is cirrhosis, interstitial lung disease (ILD) including interstitial
pulmonary fibrosis (IPF), systemic sclerosis (SS), atherosclerosis, pancreatic
fibrosis, rheumatoid arthritis and glomerulonephritis. Fibrotic diseases represent a
large group of heterogeneous disorders without effective remedy at present.
The regenerating capacity of the injured tissue dictates whether repair with
regeneration of normal parenchymal cells or fibrosis should follow after excessive
tissue loss. Fibrosis is a highly co-ordinated complex tissue response characterised
by the deposition of extra cellular matrix (ECM). ECM consists of fibrous protein
like collagen, elastin and fibrillin, proteoglycans like decorin and fibromodulin,
adhesion molecules like fibronectin, laminin and integrins [Reviewed in (Prockop
and Kivirikko, 1995) (Aumailley and Krieg, 1996;Faull, 1995)]. Accumulation of
inflammatory cells is a hallmark event in the pathogenesis of fibrosis. The
infiltrating cells include platelets, macrophages, eosinophils, plasma cells and T-
lymphocytes. The pro-fibrotic cytokines secreted by these infiltrating cells include
TGFa, TGFp, platelet-derived growth factor (PDGF), IL-la, IL-ip, IL-4 and IL-
13. Evidence is emerging to confirm that the polarisation of the immune response
towards T-helper-2 (Th2) type involving IL-4 and IL-13 is crucial in this setting
[Reviewed in (Wynn, 2004)]. The type of Th cell response controls the magnitude
of fibrosis: if it is progressing towards Thl type response, the fibrotic response is
minimal and in the case of Th2 type response, enhanced fibrosis occurs. Such a
pattern was observed in various models of fibrosis such as schistosome egg
induced liver fibrosis (Wynn et al., 1995), pulmonary fibrosis (Keane et al.,
2001) and kidney fibrosis (Oldroyd et al., 1999). Microarray studies on the
transcription profile during Thl or Th2 type immune response confirmed that, at
the time of Th2 response the genes involved in fibrosis were up-regulated
(Sandler et al., 2003;Hoffmann et al., 2001).
1.5.1. TRANSFORMING GROWTH FACTOR - p (TGFp)
TGFp is the key cytokine responsible for the pathogenesis of fibrosis (Branton
and Kopp, 1999;Sato et al., 2003). It is the prototype member of the TGFp super
family of about 30 proteins, which include other TGFs, bone morphogenic protein
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(BMP), inhibins, myostatin and activin families. Activated lymphocytes,
macrophages, dendritic cells, neutrophils and immature haematopoietic cells
produce TGFp. There are three mammalian isoforms of TGFp (TGFpl-p3),
which are structurally identical (Gorelik and Flavell, 2002). TGFp is
chemoattractive for macrophages and induces the production of other growth
factors (Wahl et al., 1987;Chantry et al., 1989).
TGFP is secreted as a latent form, which needs to be cleaved prior to exerting its
action. Two latent forms of TGFp include a 75 kDa glycoprotein latency
associated form and a 135 kDa latent TGFp binding protein form. Cleavage ofN -
terminal fragment of TGFp to liberate the active C-terminal fragment is required
after its secretion into extra cellular environment. The cleavage happens through
several agents like macrophage derived plasminogen activator, matrix
metalloproteinase (MMP), cathepsins, calpain, thrombospondin and integrins or
acidification of the local environment by the lysosymal leakage [Reviewed in
(Fetterio and Roberts, 1998;Massague, 1990)]. The active TGFp is a 25-kDa-
homodimeric polypeptide. TGFp suppresses T-cell mediated cellular immunity
through multiple mechanisms (Gorelik and Flavell, 2002). The inhibitory effect
on T-cell proliferation is largely attributed to its ability to suppress IF-2
production (Brabletz et al., 1993). TGFp is chemoattractive for fibroblasts and it
can induce synthesis of collagens (type I, III, VI and XI), fibronectins, matrix
glycoproteins including osteopontin, osteonectin, thrombospondin, proteoglycans
such as biglycan and decorin (Massague, 1990). TGFP is a mitogen for fibroblasts
and its mitogenic potential is lower than platelet derived growth factor (PDGF)
and fibroblast growth factor (FGF). The mitogenic potential of TGFp is mediated
by the autocrine action of PDGF-AA (Yamakage et al., 1992;Battegay et al.,
1990) as well as PDGF independent pathways (Seifert et al., 1994).
1.5.1.1. SIGNAL TRANSDUCTION
Signal transduction of TGFp involves two of its receptors namely TGFp receptor
I and II (TGFpRI and TGFpRII). The receptor complexes are heterotetrameric
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consisting of two type II receptors and two type I receptors. The receptors have an
N-glycosylated extra cellular domain that is rich in cysteine residues, a
transmembrane domain and an intracellular serine/threonine kinase domain.
Although both receptors are required for signal transduction, TGFpRII only is
enough for binding of ligand (Laiho et al., 1991). TGFpRII is constitutively
phosphorylated by its own kinase activity and binding of TGFp to TGFpRII
results in recruitment of type I receptor to the complex and phosphorylation of
type I receptor by type II receptor kinase occurs (Wrana et al., 1994). The signal
transduction pathway after receptor ligand binding involves SMAD proteins. The
SMAD family of proteins originated from Drosophila. The founding member is
called MAD [mothers against decapentaplegic (dpp) gene] (Sekelsky et al., 1995).
The homologues of MAD proteins in Caenorhabditis elegans are called SMA,
because their mutation caused small body size (Savage et al., 1996). The
homologues in vertebrates were named SMADs as they are related to SMA and
MADs (Graff et al., 1996;Hahn et al., 1996).
There are eight different SMAD proteins identified and they fall into three distinct
functional groups. The SMAD 1, 2, 3, 5 and 8 fall in the group of receptor
activated SMADs (R-SMADs). SMAD-4 is the common mediator SMAD.
SMAD 6 and 7 are grouped as inhibitory SMADs (I-SMADs). The R - SMADs
are kept in the cytoplasm in the basal state bound to the protein called SMAD
anchor for receptor activation (SARA) (Tsukazaki et al., 1998). The type I
receptor kinase of the receptor ligand complex will phosphorylate the receptor
activated SMADs (SMAD-2 and 3). Upon phosphorylation, R-SMADs are
released from SARA and this pathway specific phoshorylated SMADs will
hetero-oligomerize with SMAD-4 in the cytoplasm. This complex will translocate
into the nucleus by a mechanism involving the cytoplasmic protein called
importin where it mediates transcriptional activation of the target genes (Kurisaki
et al., 2001;Xiao et al., 2000;Nakao et al., 1997). The binding of this complex
with DNA can occur directly or with the help of other co-factors, like cyclic
adenosine monophosphate (cAMP) response element binding protein (CREB) -
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Binding Protein (CBP)/p300 (Shen et al., 1998). The up-regulated genes include
the genes responsible for laying out the ECM including collagen.
Connective tissue growth factor (CTGF) is a molecule released from fibroblasts
activated by TGFfh CTGF is a member of CCN family of proteins [Reviewed in
(Perbal, 2004)]. CCN stands for the first three members of this family: cysteine -
rich 61 (CYR61/CCN1), connective tissue growth factor (CTGF/CCN2) and
nephroblastoma overexpressed (NOV/CCN3). The function of CTGF is to
promote fibroblast proliferation, matrix production and granulation tissue
formation (Bradham et al., 1991;Shi-wen et al., 2000;Moussad and Brigstock,
2000). The receptor and signal transduction process through which it mediates this
function remain to be elucidated.
1.5.2. PLATELET DERIVED GROWTH FACTOR (PDGF)
PDGF is a major mitogen and chemoattractant for connective tissue cells (Yi et
al., 1996;Yoshida et al., 1995). a-Granules of the platelets are the major source of
PDGF and many other cell type including macrophages can produce PDGF
(Shimokado et al., 1985;Martinet et al., 1986). Role of PDGF in fibrotic disorders
like atherosclerosis, lung fibrosis, cirrhosis and kidney fibrosis has been reported
and in most of these conditions the source of PDGF is from activated
macrophages [Reviewed in (Heldin and Westermark, 1999)]. It is a dimeric
molecule consisting of structurally similar A and B polypeptides linked by
disulfide bonds. It appears as homodimeric or heterodimeric isoforms of A and B
(AA, AB, and BB) polypeptide chains. In addition to the mitogenic activity, it has
a chemotactic activity as well due to its ability to induce reorganisation of the
actin system of the cell. Recently two other forms of PDGF (PDGF-C and PDGF
-D) have been identified (Li et al., 2000;Bergsten et al., 2001).
Fibroblasts have around 200000 receptors for PDGF and smooth muscle cells
carry 50000 receptors. Activation of receptor by ligand binding causes
autophosphorylation of the receptors leading to increased catalytic activity of the
kinases and formation of docking sites for signal transduction molecules.
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Different signal transduction molecules that contain Src homology -2 (SH2)
domains are involved (e.g. Phosphotidyl inositol -3 (PI3) -kinase). PDGF induces
the expression of ECM proteins such as collagen type I, III, IV and V as well as
collagenase (Chua et al., 1985;Bauer et al., 1985).
1.5.3. Th2 TYPE CYTOKINES
Th2 cytokines include IL-4, IL-5 and IL-13. Receptors for IL-4 were reported
from both mouse and human fibroblasts (Sempowski et al., 1994;Doucet et al.,
1998). IL-4 can induce collagen synthesis from human fibroblasts (Fertin et al.,
1991). Increased level of IL-4 was reported in the broncho alveolar lavage (BAL)
fluid obtained from IPF patients. Interstitium of patients suffering from
cryptogenic fibrosing alveolitis also showed evidence of IL-4 (Emura et al.,
1990;Wallace et al., 1995). Macrophage derived IL-4 was found in higher
quantities in pulmonary fibrosis induced in rats by radiation (Buttner et al., 1997).
IL-13 uses the IL-4Ra for inducing signal transduction and shares the biological
properties of IL-4 (Zurawski et al., 1993). Although IL-4 and IL-13 share similar
biological properties, IL-13 is the dominant cytokine mediating liver fibrosis
(Chiaramonte et al., 1999;Chiaramonte et al., 2001). Role of IL-13 in modulating
the development of fibrosis was also shown in several models of chronic
pulmonary disease (Blease et al., 2001;Zhu et al., 1999;Belperio et al., 2002). In
addition to directly stimulating fibroblasts to produce collagen (Oriente et al.,
2000), IL-13 also acts in the way of stimulating macrophages to produce TGFp
and MMP-9 (Lee et al., 2001). A recent study showed that IL-13 driven
fibrogenesis is completely independent of TGFp and MMP-9 (Kaviratne et al.,
2004).
IL-5 is the third member of the Th2 cytokine family and it is involved in the
differentiation, activation and recruitment of eosinophils. Studies on the role of
IL-5 in the pathogenesis of fibrosis yielded conflicting results in various models
of fibrosis (Sher et al., 1990;Cho et al., 2004;Hao et al., 2000). The role of IL-5 in
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the pathogenesis of fibrosis is currently believed to be indirect: by way of
promoting the pro- fibrotic cytokines like IL-13 and TGFp.
1.5.4. ANTI - FIBROTIC CYTOKINES
IFNy and TNFa are important cytokines with anti-fibrotic activity (Varga et al.,
1990;Kahari et al., 1990;Yufit et ah, 1995;Higashi et al., 1998). The anti-fibrotic
activity of IFNy is shown to be mediated by the up-regulation of SMAD-7
molecule in fibrosarcoma cells which is an inhibitory SMAD protein able to
inhibit the phosphorylation of SMAD-3 and consequent downstream signalling
events (Ulloa et al., 1999). However, it has been shown that this inhibitory
mechanism is not functional in human skin fibroblasts. It was shown that over
expression of transcriptional co-activator p300/CBP suppresses the IFNy mediated
inhibition of TGFp signalling suggesting that IFNy activated STAT1 sequestrates
endogenous p300/CBP and reduces the interaction with SMAD-3 and suppressing
collagen gene transcription (Ghosh et al., 2001). Several transcriptional factors,
which will suppress TGFP signalling, have been described [Reviewed (Ghosh,
2002)]. Another route through which IFNy exert its anti-fibrotic property is by up-
regulating the expression of MMPs. IFNy can also act as an inhibitor of IL-13
mediated fibrosis by way of up-regulating the production of IL-13Ra2 (Daines
and Hershey, 2002). IL-13 binds IL-13Ra2 with high affinity, but does not signal
and is considered as a decoy receptor. IFNy is able to downregulate the
phosphorylation of STAT6, the key molecule involved in the signal transduction
of IL-4 and IL-13 (Heller et al., 2004). The proposed interaction between TGFp,
IL-13/IL-4 and IFNy in regulating the collagen gene expression is presented in
figure. 1.4.
TNFa is a cytokine with a specific receptor present on a wide population of cells
(Schall et al., 1990). Lipopolysacharides (LPS), microbial agents, IL-1, IL-2, and
granulocyte macrophage colony stimulating factor (GM-CSF) are able to
stimulate macrophages to secrete TNFa. The signal transduction machinery starts
with TNF receptor I (TNFRI) and TNFRII. The signalling cascades involve
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activation of NF-kB and mitogen activated protein kinase (MAPK) pathways.
Adaptor molecules like TNFR associated factor - 1 (TRAF-1) and TRAF-2 also
play a key role in mediating the TNFR-I induced activation of NF-kB (Wajant
and Scheurich, 2001;Chen and Goeddel, 2002). The anti-fibrotic activity of
TNFa is mediated through differential induction of C-Jun and JunB. C-Jun and
JunB are transcription factors of the activator protein - 1 (AP-1) family, which
have antagonistic transcriptional activities. Induction of C-Jun by cytokines has
been shown to directly interfere with SMAD pathway by preventing binding of
SMAD-3 to DNA or to sequestrate the transcriptional co-activator p300
(Verrecchia et al., 2003).
1.5.5. BIOSYNTHESIS OF COLLAGEN
Fibroblasts are the main cell responsible for the synthesis of collagen.
Heterogeneity in the phenotype of fibroblast in many fibrotic disorders is reported
[Reviewed in (Fries et al., 1994)]. a smooth muscle actin (aSMA) expressing
myofibroblast is another cell type capable of producing collagen, which has been
reported from human patients with IPF and bleomycin model of the disease in
mice (Zhang et al., 1994). The cell of similar phenotype seen the case of liver
fibrosis is called hepatic stellate cell (HSC) and in the pancreatic fibrosis as
pancreatic stellate cell (PSC) (Madro et al., 2004;Ramadori and Saile, 2004).
Transformation of fibroblast to myofibroblast with the expression of aSMA was
shown in in vitro studies using profibrotic cytokines like TGF[3, IL-4 and IL-13
(Desmouliere et al., 1993;Hashimoto et al., 2001).The origin of these fibroblasts
and myofibroblasts at the site of fibrosis was thought to be by proliferation and
differentiation of cells in the local site. However, recent evidence shows that there
is a population of non-resident circulating cells called fibrocytes as the source of
myofibroblasts at the site of fibrosis. These cells express collagen I, CDllb,
CD 13, CD34, CD45RO, MHC class II and CD86. They constitute 0.1 to 0.5% of
the nonerythrocytic cells in the peripheral circulation (Abe et al., 2001).
Epithelial mesenchymal transition (EMT) is another possibility for generation of
myofibroblasts at the site of fibrosis [Reviewed in (Zeisberg and Kalluri, 2004)].
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Figure 1.4. Diagrammatic representation of anti - fibrotic activity of IFNy.
(1) The signal transduction machinery of TGFp involves phoshorylation
and activation of SMAD2 and 3 and its association with SMAD4
before translocating to the nucleus. SMAD7 is an inhibitory
molecule which can prevent the phosphorylation of SMAD2 and 3
and consequent events. IFNy upregulates the expression of SMAD7
and it is suggested as one of the mechanism by which IFNy exerts
the anti - fibrotic activity (Ullao et al., 1999).
(2) The binding of SMAD complex with DNA can occur directly or
with the help of other co - factors, like cyclic adenosine
monophosphate (cAMP) response element binding protein (CREB) -
Binding Protein (CBP)/p300. It is suggested that, activated STAT1
following IFNy signal transduction can sequestrate CBP/p300 and
can inhibit the pro-fibrotic activity of TGFp (Ghosh et al., 2001).
(3) IL-13 is another pro- fibrotic cytokine. IL-13 receptor a2 is a decoy
receptor for IL-13. IFNy can upregulate the release of IL-13 R a2
from its cytoplasmic stores. This action is suggested as the
mechanism by which IFNy mediates its anti-fibrotic activity (Daines
and Hershey, 2002).
(4) Another mechanism through which IFNy inhibits IL-13 mediated
fibrogenesis is by suppressing the activity of STAT6, the key
molecule involved in IL-13 signal transduction (Heller et al., 2004).
















Figure 1.4. Please see the legend on the facing page
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The collagen super family of proteins now contains 19 proteins formally defined
as collagens and another ten proteins that have collagen like domains. The
distinguishing feature of collagen family of proteins is their large domains
composed of repeating -Glycine-X-Y- sequence and their unique triple helical
structure. Proline is frequently found in the X and hydroxy - proline in the Y
position and it makes glycine and proline as the two main amino acids required
for the synthesis of collagen. The triple helix structure of collagen is formed from
three polypeptide chains that are each coiled into a left - handed helix. Three
chains are then coiled around each other into a right-handed helix so that the final
structure is like a rope - like rod [Reviewed in (Engel and Prockop, 1991)].The
different types of collagen are the product of different genes and some type of
collagen are the product of a combination of genes. Different combinations of
polypeptide chains determine the type of collagen. A list of known types of
collagen, their responsible genes and primary locations are presented in table 1. 4
(Prockop and Kivirikko, 1995). The fibril forming collagens contain large triple -
helical domains with about 1000 amino acids or 330 -Gly-X-Y- repeats per
chain. These proteins are first synthesised as precursors known as procollagens
that need to be cleaved into N-propeptides and C-propeptides by specific
proteinases. Type I is the most abundant collagen and it is found in variety of
tissues. The type I collagen is composed of two - al(I) and one-a 2(1) chains. The
al(I) chain is encoded by COL1A1 gene and a 2(1) by COL1A2 gene(de Wet et
al., 1983).
1.5.6. RESOLUTION OF FIBROSIS
Resolution of fibrosis is a promising concept. It was believed that fibrosis is non¬
reversible and it may be true that in reality, complete resolution of fibrosis is not
possible. However, evidence is emerging to confirm the ability of effective
therapeutic interventions to reverse the phenotype of fibrosis (Arthur, 2002).
Removal of etiological agent is the most effective remedial measure to treat many
forms of fibrosis. This approach is possible in the case of fibrotic disorders with
known etiological factor like alcohol abuse. In reality, there are many fibrotic
disorders with unknown etiology. In such instances, intervention of the
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Table 1.4. Different types of collagen, their genes and primary




Most connective tissues, major component of ECM in skin, bone
and ligaments
II COL2A1 Cartilage, vitreous humour
















VII COL7A1 Anchoring fibrils
VIII COL8A1
COL8A2




Tissues containing collagen II




Tissues containing collagen II
XII COL12A1 Tissues containing collagen I
XIII COL13A1 Many tissues
XIV COL14A1 Tissues containing collagen I
XV COL15A1 Many tissues
XVI COL16A1 Many tissues
XVII COL17A1 Skin hemidesmosomes
XVIII COL18A1 Many tissues, especially liver and kidney
XIX COL19A1 Rabdomyosarcoma cells
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the molecular events leading to the fibrogenesis is the most feasible therapeutic
approach. Fibrillar collagens (I and III) are degraded by interstitial MMPs.
Increase in the activity of MMPs supplemented by decreased activity of tissue
inhibitors of MMPs (TIMPs) favours resolution of fibrosis. Apoptosis of collagen
secreting cells is another mechanism, which favours resolution of fibrosis.
1.5.7. CIRRHOSIS
Chronic injury to liver from a variety of causes leads to fibrosis of liver. The main
causes of liver fibrosis include alcohol abuse, chronic hepatitis C virus (HCV)
infection, hepatitis B virus (HBV) infection and non-alcoholic steatohepatitis
(NASH). Apoptosis of hepatocytes is being recognised as a major contributory
factor in triggering the fibrotic response [Reviewed in (Canbay et al., 2004)]. The
distribution of fibrous tissue in the liver parenchyma depends on the type of
injury. In the case of chronic viral infection, fibrogenesis begins around the portal
tract. In cirrhosis due to chronic alcohol abuse, the deposition of fibrous tissue is
seen in the peri-central and peri-sinusoidal areas. However, the fibrosis progresses
and bridging fibrosis occurs leading to complete destruction of hepatic
architecture. Hepatic stellate cells (HSCs), formerly known as lipocytes, Ito cells
or peri-sinusoidal cells were identified as the main collagen producing cells in the
liver (Friedman et al., 1985). Other than HSCs, portal myofibroblasts and cells of
bone marrow origin also contribute to liver fibrosis (Ramadori and Saile,
2004;Forbes et al., 2004).
1.5.7.1. VIRAL AETIOLOGY OF CIRRHOSIS
Pathogenesis of HCV-induced liver fibrosis is poorly understood. The current
hypothesis is that infection of hepatocytes with HCV leads to the release of
profibrotic mediators that will activate the neighbouring HSCs to initiate fibrosis.
HCV infects a number of cell types, including hepatocytes, monocytes,
lymphocytes and salivary glandular cells (Shimizu et al., 1996;Caussin-
Schwemling et al., 2001;Arrieta et al., 2001). Recently, it has been shown that
recombinant core and NS3 proteins of HCV can directly stimulate the
inflammatory and fibrogenic actions of HSCs (Bataller et al., 2004).
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HBV, a member of Hepadnaviridae family is another virus associated with
pathogenesis of liver fibrosis. Recent estimate shows that this virus throughout the
world affects 350 million people. Chronic HBV infection is mainly seen in
children infected vertically from their mother. Infection during adulthood
normally results in lifelong immunity [Reviewed in (Fattovich, 2003). A
successful vaccine is available against HBV infection.
1.5.8. IDIOPATHIC PULMONARY FIBROSIS (IPF)
IPF is a poorly understood chronic human disease characterised by progressive
pulmonary fibrosis. Alveolar type II cell injury and apoptosis are thought to be
early events in the pathogenesis. Fung injury with bleomycin in laboratory rodents
is a popular model for studying this disease condition (Takahashi et al., 2001).
The role of myofibroblasts in the pathogenesis of IPF has been recognised in
human patients and animal models (Zhang et al., 1994;Kuhn and McDonald,
1991). Bone marrow derived fibrocytes also contribute to lung fibrosis in human
patients and bleomycin model of disease (Phillips et al., 2004;Moore et al., 2005).
Studies in human patients and animal models have established the protective
effect of IFNy on the development of IPF. Deficiency of IFNy has been proposed
as one of the aetiological factors (Ziesche et al., 1999;Giri et al., 1986).
Environmental exposure to dust and association with various viral agents have
been proposed as aetiological factors [Reviewed in (Egan et al., 1997) and (Tang
et al., 2003)]. Increased level of Th2 cytokines was reported in the lung of
patients suffering from IPF (Ando et al., 1999).
1.5.8.1. VIRAL ETIOLOGY OF IDIOPATHIC PULMONARY FIBROSIS
Association of EBV with IPF has been supported by serological, virological and
molecular biological data (Kelly et al., 2002;Vergnon et al., 1984;Egan et al.,
1995;Stewart et al., 1999;Tang et al., 2003). MHV-68 was demonstrated as a co -
factor in the development of pulmonary fibrosis in bleomycin resistant mice
(BALB/c) (Fok et al., 2002). Recently, it has been shown that chronic pulmonary
infection of IFNyR"'" mice with MHV-68 result in a progressive deposition of
interstitial collagen in lung. The infected mice also showed other features of IPF
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like increased TGFp expression, myofibroblast transformation, production of Th2
type cytokines, hyperplasia of type II alveolar epithelial cells and increased
expression of MMP-7 (Mora et al., 2005).Hepatitis C virus and adenovirus are the
two other suggested viral aetiological agents responsible for IPF (Ueda et al.,
1992;Kuwano et al., 1997).
1.5.9. SYSTEMIC SCLEROSIS (SS)
SS is a disease of unknown aetiology characterised by excessive deposition of
collagen in the skin and multiple internal organs [Reviewed in (Jimenez and Derk,
2004). Depending on the clinical severity, there are three recognised form of
disease: limited cutaneous SS, diffuse cutaneous SS and fulminant SS.
Involvement of gastrointestinal tract, kidney and lung leads to serious
complications and are often fatal. The histopathological changes in the skin
include marked thickening of the dermis with massive collagen deposition. Early
lesions are characterised by infiltration of mononuclear cells in the dermal -
adipose tissue interface. The pathogenesis of SS is not clearly defined.
Pathological alterations were noticed in fibroblasts, endothelial cells and T and B-
lymphocytes. Fibroblasts isolated from SS lesions show persistent activation of
collagen and other ECM proteins. Endothelial involvement leads to obliteration of
the lumen of small arteries and arterioles. The role of lymphocytes in the
pathogenesis of SS is suggested to be through the production of auto antibodies
and growth factors to promote the production of fibrous tissue. As the aetiology is
currently unknown, several factors including genetic, environmental and
infectious agents are suggested as etiological factors. Microchimerism is a novel
hypothesis suggested as the cause of SS. During pregnancy, allogenic foetal or
maternal cells cross the placenta in both directions and persist in the tissues of
mother and child and it is suggested that such foreign cells may become activated
by a second event and mount a graft-versus-host reaction which is manifested as
SS [Reviewed in (Artlett, 2003)].
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1.5.9.1. VIRAL AETIOLOGY OF SYSTEMIC SCLEROSIS
Retrovirus and HCMV are the main infectious agents attributed as the aetiological
factors of SS. Anti-Scl-70 antibodies seen in patients with SS is specific for
topoisomerase-I antigen. Sequence homology between topisomerase-I and certain
retrovirus proteins and the possibility of molecular mimicry is the evidence shown
in favour of retrovirus aetiology [Reviewed in (Jimenez et al., 1995)].
Furthermore, antibodies to retroviral proteins have been detected in SS patients
(Dang et al., 1991). Evidence in support of HCMV as an aetiological factor is the
presence of IgA antibodies specific for HCMV in SS patients and such antibodies
are capable of inducing apoptosis in human endothelial cells (Neidhart et al.,
1999).
1.6. THE ROLE OF MACROPHAGES IN FIBROSIS
Macrophages play key role in the pathogenesis of fibrosis (see Figure 1.5).
Macrophages contribute to the pathogenesis of fibrosis mainly through the
following mechanisms: 1) Release of pro - fibrotic cytokines like TGF[3 and
PDGF upon appropriate stimulation. Removal of apoptotic resident parenchymal
or stromal cells by macrophages leads to the release of pro - fibrotic cytokines. 2)
The up-regulation of arginase - I in alternatively activated macrophages favours
the production of proline, an important component of collagen. In addition to the
contribution from arginase - I up-regulation, the agents responsible for alternate
activation of macrophages like IL-4 and IL-13 itself can stimulate fibroblasts and
myofibroblasts to produce ECM. Macrophages isolated from fibrotic disorders in
humans like IPF have been shown to secrete the pro- fibrotic cytokines (Martinet
et al., 1987).
1.6.1. ACTIVATION OF MACROPHAGES
Considerable advances have been made on the understanding of activation of
macrophages in the past decade [Reviewed in (Mosser, 2003;Duffield,
2003;Mantovani et al., 2004;Gordon, 2003)]. Activated macrophages were
defined as cells that secreted inflammatory mediators and killed intracellular
pathogens. Advances in the biology of macrophages in the past decade have
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Figure 1.5. Role of macrophages in the pathogenesis of fibrosis
(1) Macrophages contribute to the pathogenesis of fibrosis by release of
pro-fibrotic cytokines upon appropriate mode of activation.
Activation by Th2 type cytokines constitutes the main mechanism by
which macrophages secrete pro-fibrotic cytokines. Removal of
apoptotic cells is another important mechanism which leads to
release of pro-fibrotic cytokines.
(2) Activation of macrophages by Th2 type cytokines is termed as
alternate activation of macrophages. The main feature of alternate
activation macrophages is selective metabolism of L- arginine by
Arginase -1 enzyme, which eventually leads to production of
proline, a main amino acid of collagen ( for details, please see figure
1.6).
(3) In addition to activating macrophages, the Th2 cytokines, especially
IL-13 can directly stimulate collagen producing cells to secrete extra
cellular matrix (ECM)
(4) Thl cytokine like IFNy antagonise the actions of Th2 cytokines.
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Figure .1.5. Please see the legend on the facing page
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revealed that such a definition would not cover all activated macrophages
encountered in different tissues during disease. Various endogenous and
exogenous stimuli activate macrophages in a different manner manifested by
release of cellular factors directed to perform different functions. Three main
modes of activation of macrophages have been recognised. They are grouped as:
classical activation (Ca), alternate activation (Aa) and type II activation. The Ca
macrophages and Aa macrophages are also referred as Ml and M2 macrophages
respectively (Mills et ah, 2000). The paradigm of polarisation of macrophages in
association with tumours was examined and it was concluded that the tumour-
associated macrophages (TAM) fall in the group of M2 macrophages (Mantovani
et al., 2002). Another proposal to classify activated macrophages on the basis of
the intracellular content of glutathione has emerged (Murata et al., 2002). Those
macrophages with high glutathione content are defined as reductive macrophages
(RM) and those with low glutathione content as oxidative macrophages (OM).
The cytokine secretion profile and other features show apparent analogy between
RM and Ca macrophage, and between OM and Aa macrophages.
It is suggested that the activation profile of macrophages change with time from
one predominated by Ca to the one predominated by Aa macrophages and it is
argued that engulfment of apoptotic cells by Ca macrophages contribute to this
transformation (Duffield, 2003;Gregory and Devitt, 2004). Recently, it has been
shown in a liver fibrosis model by a novel macrophage depletion strategy that
functionally distinct subsets of macrophages supporting development and
resolution of fibrosis occur during experimental induction and resolution of liver
fibrosis (Duffield et al., 2005).
1.6.1.1. CLASSICAL ACTIVATION (Ca)
Macrophages exposed to IFNy along with stimulation by a microbe or microbial
products such as LPS constitute classical activation. Other pro-inflammatory
cytokines like TNFa, IL-1, IL-12 and activated T-Lymphocytes through CD40
ligand can also cause Ca of macrophages. Classically activated macrophages
show up-regulation of MHC class II molecules, release pro-inflammatory
68
CHAPTER:! INTRODUCTION
cytokines like, IL-1, IL-6, IL-12, IL-23 and TNF along with nitric oxide (NO) and
reactive oxygen intermediates (ROI) (Ehrt et al., 2001;Hibbs, Jr.,
2002;MacMicking et al., 1997). These cells are capable of migrating towards sites
of inflammation to attack and degrade pathogens. Ca of macrophages is found in
granulomas in association with T-lymphocytes secreting pro-inflammatory
cytokines and in immunopathology associated with type I auto immune diseases.
1.6.1.2. ALTERNATE ACTIVATION (Aa)
IL-4 and IL-13 are the principal signals to orchestrate Aa of macrophages through
their common receptor chain IL-4Ra (Stein et al., 1992;Gordon, 2003). The role
of IL-10 and glucocorticosteroids as the stimulus for Aa of macrophages is
controversial (Goerdt and Orfanos, 1999;Gordon, 2003).These activated cells fail
to produce NO due to differential metabolism of L- arginine (See below) and
consequently are defective in killing intracellular microbes. They up-regulate
some MHC class II molecules and in many instances inhibit T-cell proliferation
(Schebesch et al., 1997). The signature cytokine produced by this cell is IL-10.
The Aa of macrophages also produce the key pro-fibrotic cytokines like TGFp
and PDGF (Mills et al., 2000;Song et al., 2000).Alternatively activated
macrophages produce fibronectin and matrix associated protein (Gratchev et al.,
2001). In addition to arginase -I expression, which is being recognised as the
principal marker molecule, these cells also produce a signature chemokine called
alternate macrophage activation associated CC chemokine-l(AMAC-l) (Kodelja
et al., 1998). First in Inflammatory Zone - 1 (FIZZ -1) and YM-1 are other two
novel molecules associated with Aa of macrophages. However, their functions are
not clearly defined (Raes et al., 2002). FIZZ -1 is involved in the transformation
of fibroblasts to myofibroblasts (Liu et al., 2004).
A key difference shown by Aa macrophage and Ca macrophage is with regard to
the metabolism of L-arginine (Munder et al., 1998;Hesse et al., 2001)
(Figure. 1.6). In a Ca macrophage, there is up-regulation of nitrous oxide synthase
-2 (NOS2) and it metabolises L- arginine into nitric oxide and citrulline. Whereas
in the case of Aa macrophages, arginase I is up-regulated and it leads to the
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production of L-ornithine and urea from L-Arginine. Arginase-I is the hepatic
isoform of arginase involved in the terminal stage of urea cycle. L-Ornithine can
be further converted to polyamines by ornithine aminodecarboxylase or proline by
ornithine aminotransferase. Proline is an important amino acid required for the
synthesis of collagen (see section 1.5.5). Arginase-I up-regulation and
enhancement of fibrosis by Aa of macrophages has been shown in the
Schistosoma mansoni induced liver fibrosis model (Hesse et al., 2001), bleomycin
induced IPF model (Endo et al., 2003), peritoneal nematode implantation model
of chronic type II inflammation (Nair et al., 2003) and different models of
parasitic diseases (Vincendeau et al., 2003). Dendritic cells and fibroblast also
show the difference in activation profile shown by macrophages when exposed to
either Thl or Th2 cytokines (Munder et al., 1999;Witte et al., 2002).
1.6.1.3. THE TYPE II ACTIVATION
Ligation of FcRs on macrophages with immune complexes and variety of stimuli
suppressed IL-12 production and produced large quantities of IL-10 (Sutterwala et
al., 1997;Gerber and Mosser, 2001). Such activated macrophages were called as
Type II activated macrophage (Anderson and Mosser, 2002). This mode of
activation required another stimulus after FcR ligation to express this phenotype.
The secondary stimuli included stimuli that signalled through toll like receptors
(TLRs), CD40 and CD44. Type II activated macrophages do not up-regulate
arginase -I expression. With the exception of IL-12 and IL-10 the cytokine
secretion profile mirrored that of Ca macrophage (Gerber and Mosser, 2001).
Type II activated macrophages stimulated T-lymphocytes to secrete IL-4




Murine gammaherpesvirus - 68 (MHV-68) infections in laboratory mice is a
small animal model for studying the pathogenesis of gammaherpesviruses in their
natural host.
A defect in the a chain of gamma interferon receptor (IFNyR7") renders the host
unresponsive to IFNy, although the mice can produce IFNy in response to virus
infection. Intranasal infection of IFNyR7" mice with MHV-68 results in fibrosis of
spleen. The core objective of this project was to further characterise the
pathological changes in the spleen of IFNyR7" mice infected with MHV-68. To
achieve this objective, the study was focussed around the following core areas.
• Sequential gross and histopathological changes
• Characterisation of the cellular events
• Identification of host response genes
• Role of IFNy responsiveness in pathogenesis
• Assessment of the level of productive and latent infection
In addition to the pathological changes in the spleen, intraperitoneal infection of
IFNyR7" mice with MHV-68 was shown to cause chronic arteritis affecting the
major blood vessels. The effect of IFNy unresponsiveness on the pathology of
lung and liver following MHV-68 infections is currently unknown. Therefore, the
study was also extended to explore the pathological changes in lung, liver and
aorta following intranasal infection of IFNyR7" mice with MHV-68.
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2.1. MAINTENANCE OF CELL CULTURES
Baby hamster kidney (BHK-21) cells are a continuous fibroblastoid cell line
derived from a Syrian golden hamster. BHK-21 cells were cultured in Glasgow
modified eagle's medium (GMEM, Invitrogen, UK) supplemented with 10% (v/v)
tryptose phosphate broth (TPB. Invitrogen, UK) and 10% (v/v) new born calf
serum (NBCS, Invitrogen, UK), lOOU/ml penicillin, lOOU/ml streptomycin and
2mM L-glutamine. Cell lines were cultured in sterile plastic-ware (Nunc) and
incubated at 37°C in equilibrium with humidified 5% CO2. For further passaging,
adherent cells were maintained in sub-confluent growth. The medium was poured
off and the monolayer washed in 0.02% versene. The monolayer was then
incubated with 0.25% trypsin (Invitrogen, UK) until the cells could be removed
from the surface of the flask by gentle tapping. The trypsin was then diluted in an
equal volume of medium and cells with diluted medium were collected in plastic
universals pre - rinsed with medium and centrifuged (450g, 5mins). The cell pellet
was resuspended in appropriate growth medium. For quantification, small aliquot
(50pl) was mixed with 50pl 0.1% trypan blue (w/v) and the number of un-stained
viable cells was counted using a haemocytometer. Approximately 5 x 106 - 1 x
107 cells were re-seeded into fresh tissue culture flasks in about 50 ml of medium.
2.2. PREPARATION OF VIRUS STOCKS AND MOCK INOCULUM
Stocks of MHV-68 were generated in BHK-21 cells. Cells were grown in
9 7
TC175cm" flasks (-1x10 cells/flask).The cells were harvested and counted as
described in section 2.1, resuspended in medium (lxl07/ml) and infected with
MHV-68 at a multiplicity of infection (MOI) of 0.001. The cells were incubated
for 1.5 hours at 37°C with shaking to enhance infection and seeded (2x106
cells/flask) in TCI75cm2 flasks. The infected cells were incubated at 37°C for 5-7
days or until gross cytopathic effect (CPE) were observed. Once complete CPE
was observed, the cells were dislodged from the monolayer by scraping or gentle
tapping of the flask and collected in a universal tube pre-rinsed with medium and
centrifuged (2000g, 20mins, 4°C). The pellet was resuspended in a small volume
of sterile phosphate buffered saline (PBS) (5-10ml) and homogenised with 20 - 30
strokes of a chilled Wheaton-Dounce homogeniser. The homogenate was
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transferred to a glass universal tube and sonicated in a water-bath for 15 minutes
at 4°C. Following centrifugation (2000g, 20mins, 4°C) of the homogenate, the
supernatant was transferred to a clean universal tube and kept on ice. The pellet
was resuspended in 1ml sterile PBS, re-homogenised and centrifuged (2000g,
20mins, 4°C). The supernatants were pooled, aliquoted and stored at -70°C. The
mock inoculum was prepared from the uninfected BHK- 21 cells by following the
same procedure as described above for preparing virus stocks.
2.3. TITRATION OF MHV- 68
Titres of virus stocks were determined using a plaque assay as described
previously (Sunil-Chandra et al., 1992a). Duplicate serial dilutions of the virus
1 o z:
sample were prepared (10" to 10" ) in 1.8ml medium. BHK-21 cells (1x10 ) were
added to each virus dilution and incubated for one hour at 37°C with shaking.
The infected cells were transferred to 60mm culture plates and incubated at 37°C
for four days. Uninfected BHK-21 cells were also seeded in duplicate plates at
the same density as a negative control. Cells were fixed in 4% buffered formal
saline (v/v) (BFS) (Surgipath) and stained with 0.1% toluidine blue. Virus
plaques were counted using a light microscope and virus titre was calculated as
plaque forming units (PFU/ml).
2.4. INFECTION AND SAMPLING OF MICE
Wild type 129/Sv/Ev mice and IFNyR"'" mice on the 129/Sv/Ev background were
purchased from Bantin and Kingman, Hull, United Kingdom and bred in house.
Age and sex matched mice were anaesthetised with halothane (Merial Animal
Health Ltd.) and inoculated intranasally with 4xl05 PFU of MHV-68 in 40pl of
sterile PBS. Three experiments were conducted to study the sequential
pathological changes following intranasal inoculation of virus. The first
experiment was to look at the sequential pathological changes on day 8, 10, 12,
14, 16, 18 and 20. The second experiment was conducted to study the pathological
changes at later time points. The time points in this experiment were day 12, 20,
30, 35, 40, 45, 50, 60, 80 and 120 p.i. The time point at day 12 and 20 was taken
to overlap the first experiment. The third experiment was conducted to clarify the
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effect of mock infection on IFNyR_/" mice. Two sets of IFNyR~~ age and sex-
matched mice were used for this experiment. One set of mice was infected with
4xl05 PFU of MHV-68 in 40 pi of sterile PBS. The other set of mice was
instilled with mock inoculum (prepared as described in section 2.2) in 40 pi
volume intranasally. The time points taken in this experiment were day 12, 16, 20
and 50.
At various time intervals as indicated above, 3-5 mice were sacrificed by CO2
asphyxiation. At very few time points, two mice were sacrificed. A detailed post¬
mortem examination of the mice was carried out. The lung was inflated BFS
(Surgipath) in situ through trachea and collected in BFS. The spleen and liver was
also collected in BFS in separate tubes. The organs collected were processed and
used for histopathology, immunohistochemistry (IHC) and in situ hybridisation
(ISH) studies.
2.5. HISTOPATHOLOGY
The histopathological analysis involves processing of tissue, blocking of tissue
into paraffin wax, sectioning of tissue and adhering 5 — 7 pm thick sections on to
appropriate glass slides and staining them with haematoxylin and eosin stain or
special stains as required. These procedures were carried out at the Veterinary
Pathology Unit of the Easter Bush Veterinary Centre, Edinburgh.
2.5.1. TISSUE PROCESSING
The organs fixed in BFS were processed routinely and paraffin blocks were made.
Automatic tissue processor was used for processing of tissues. The tissues for
processing were placed in a plastic cassette before starting the schedule. The
processing schedule involved dehydrating the tissues by passing through
ascending grades of alcohol (80% alcohol, 95% alcohol and isopropanol) for 45
minutes at each concentration of solvents. Before moving to xylene for clearing,
the tissues were passed through a mixture of isopropanol and xylene (50% each)
for 90 minutes. Clearing of tissues was carried out by passing through xylene
(Two changes of xylene for 75 and 90 minutes duration). Before embedding in
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wax, the cleared tissue was passed through two change of pre - melted wax
(60°C) for 90 minutes and 120 minutes. The wax used for embedding processed
tissue was pre-melted overnight (60 ± 5°C). The processed tissue was placed in a
mould tray with melting wax and the tissue was pressed to the base of the mould.
The plastic cassette carrying tissue was placed on top of the mould and placed in a
cold plate to allow solidification. The block was moved to cold water for
complete solidification of the block.
2.5.2. SECTIONING
The paraffin blocks were cut to obtain 5-7 pm sections. Sectioning was carried out
in a Rotary microtome. Cut sections were floated out on a water bath set at 48 -
50°C to facilitate proper spread of section before lifting on to appropriate glass
slides. The sections used for routine haematoxylin and eosin stain and special
stains were adhered on to normal glass slides. The sections required for IHC and
ISH studies were adhered on to snowcoat extra (Surgipath) glass slides to allow
firm adhesion of sections to slides. The glass slides with adhered sections were
dried by keeping them in an oven set at 55°C for 30 minutes.
2.5.3. HAEMATOXYLIN AND EOSIN STAINING
The sections mounted on to the glass slides were stained with haematoxylin and
eosin in an automatic stainer. The staining procedure involved dewaxing,
hydration, staining, dehydration, clearing and mounting. Dewaxing of slides was
achieved by passing through two changes of xylene for three minutes each. Then
sections were passed through descending grades of alcohol and taken to water.
The hydrated sections were stained with Haematoxylin solution for five minutes.
The stained sections were washed in water and taken through 1% acid alcohol and
Scott's tap water substitute with washing steps in water in between. The
cytoplasmic staining was done using eosin solution for two minutes. The stained
sections were washed and dehydrated through ascending grades of alcohol.
Passing through two changes of xylene for two minutes each cleared the
dehydrated sections. The cleared sections were mounted with glass cover slip and
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permanent mountant. The mounted slides were allowed to dry for 30 minutes
before viewing under microscope.
2.5.4. SPECIAL STAINS
The special staining techniques employed to demonstrate fibrous tissue in the
spleen sections were Masson's trichrome (MT), Martius yellow-brilliant crystal
scarlet-soluble Blue (MSB), and Picrosirius red. Von Kossa method for
demonstration of calcium in the bony metaplasia lesions in the spleen and Perls
technique for demonstration of hemosiderin pigment in the spleen were also used
in this study.
2.5.4.1. MASSON'S TRICHROME (MT)
The tissue sections were taken to water by passing through two changes of xylene
and descending grades of alcohol. Nuclear staining was done in iron haematoxylin
solution for five minutes. The washed sections were differentiated in acid alcohol
and washed in tap water before staining in acid fuchsin solution for five minutes.
The sections were washed in water and differentiated in phosphomolybdic acid
solution for five to ten minutes. The sections are washed well in water and
counterstained with light green solution for one minute. After counter staining, the
sections were washed well in water and dehydrated by passing through ascending
grades of alcohol and cleared in xylene and mounted using glass cover slip and
vectamount (Vector laboratories).
2.5.4.2. MARTIUS YELLOW-BRILLIANT CRYSTAL SCARLET-
SOLUBLE BLUE (MSB)
The dewaxed sections were taken to water and nuclei was stained with iron
haematoxylin solution and rinsed in 95% alcohol. The sections were then taken to
martius yellow solution for two minutes. The sections were washed briefly in
water and stained in brilliant scarlet solution for 10 minutes. After washing in
water, the sections were treated with phosphotungstic acid solution for 5-10
minutes. Then the sections were washed in water and stained with aniline blue
solution for 10 minutes. The stained sections were dehydrated by passing through
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ascending grades of alcohol and cleared in xylene before mounting in Vectamount
(Vector laboratories).
2.5.4.3. PICROSIRIUS RED
The sections were dewaxed and hydrated by passing through descending grades of
alcohol and taken to water. Nuclear staining was done using Elaematoxylin QS
(Vector laboratories) for one minute. The washed sections were treated with 0.2%
phosphomolybdic acid for two minutes and stained in picrosirius red solution for
90 minutes. The stained sections were dehydrated by passing through ascending
grades of alcohol, cleared and mounted in Vectamount (Vector Laboratories).
2.5.4.4. VON KOSSA
The dewaxed sections were taken to water through descending grades of alcohol.
The sections were covered with 2% aqueous silver nitrate solution and exposed to
bright light for 60 minutes. The sections were then washed in several changes of
deionised water and later in tap water and counter stained with 1% aqueous
neutral red. The sections were dehydrated, cleared and mounted using
Vectamount (Vector laboratories).
2.5.4.5. PERLS STAINING
The dewaxed sections were taken to water through descending grades of alcohol.
Equal parts of hydrochloric acid and potassium ferrocyanide solutions were mixed
and filtered on to the section. The staining was allowed for 30 minutes with a
change of solution after 15 minutes. The sections were washed several times in
water. Nuclear staining was done with neutral red solution for five minutes. The
sections are dehydrated, cleared and mounted with Vectamount (Vector
Laboratories).
2.6. IMMUNOHISTOCHEMISTRY (IHC)
IHC techniques were employed to demonstrate viral antigen and various marker
antigens on tissue sections. Indirect double immunoperoxidase technique was
used with all primary antibodies.
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2.6.1. PRIMARY ANTIBODY
The list of primary antibodies used in this study and their source is presented in
table 2.1. A rabbit polyclonal antibody against MHV-68 was used to characterise
the presence of viral antigen positive cells in various organs. The cell types
studied include B-lymphocytes, T- lymphocytes (CD3) and T-lymphocyte subsets
(CD4 and CD8), red pulp macrophages (RPM), marginal zone macrophages
(MZM) and marginal metallophils (MM) in spleen. Arginase - I, a key marker of
alternatively activated macrophages was investigated with a polyclonal antibody
raised in rabbit against human recombinant arginase - I (A gift from Dr.Gotoh,
Kumamoto University, Japan). This antibody was shown previously to cross react
with mouse arginase -I (Endo et al., 2003). The characterisation of bony
metaplasia in the spleen of IFNyR7" mice was done using an antibody against bone
morphogenic protein^- (BMP-4). BMP-4 is a cytokine involved in the
morphogenesis of bone (Chen et al., 2004). Myofibroblasts positive for a- smooth
muscle actin (a-SMA) has been shown to contribute to fibrogenesis in many
fibrotic disorders and animal models of fibrotic disorders (Grotendorst et al.,
2004). The role of myofibroblasts in the model of splenic fibrosis was
investigated by IHC with antibody against a-SMA. The negative control included
polyclonal serum from the species of animals from which primary antibodies was
made.
2.6.2. BLOCKING
BFS fixed and paraffin embedded tissue sections adhered on to snowcoat extra
glass slides (Surgipath) were deparaffinised in xylene and taken through
descending grades of alcohol. The endogenous peroxidase was quenched by 0.6%
H2O2 in methanol for 30 minutes. Immersing in deionised water for five minutes
hydrated the sections. The antigen unmasking was done using 0.1% protease IV in
tris buffered saline (TBS) [PH 7.6]. Blocking of endogenous immunoglobulins
was carried out by incubating the sections with 10% normal serum in TBS
(Normal serum from the species of animals from which secondary antibodies
were made - Blocking serum). In the case of primary antibody of mouse
immunoglobulin isotype, mouse immunoglobulin blocking reagent supplied in the
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Table 2.1. Primary antibodies used for immunohistochemistry
SI. Primary Clone and Dilution Source Reference
No. antibody [in square brackets]
1 Anti- MHV-68 Polyclonal antibody Laboratory (Sunil-Chandra





2 F4/80 Clone A3: 1 Serotec, (Austyn and
(Rat IgG2b) United Gordon, 1981)
[1:20] Kingdom.
3 ER-TR9 Polyclonal antibody BMA (Dijkstra et al.,
raised in rat Biomedicals, 1985)
[1:1000 (l|ig/ml)] Switzerland
4 MOMA-1 MOMA -1 clone Serotec, (Kraal et al.,
(Rat IgG2a) United 1988)
[1:10] Kingdom
5 CD3 Clone CD3-12 Serotec, (Jones et al.,
(Rat IgGl) United 1993)
[1:200] Kingdom
6 CD4 Clone YTS -191.1 Laboratory (Cobbold et al.,





7 CD8 Clone YTS -169.4 Laboratory (Cobbold et al.,
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SI. Primary Clone and Dilution Source Reference
No. antibody [in square brackets]






9 Arginase -I Polyclonal antibody Dr. Tomomi (Sonoki et al.,
raised in rabbit Gotoh, 1997)
(Anti-recombinant Kumomoto
human arginase -1) University,
[1:250] Japan
10 BMP-4 Clone 3H2 Novocastra (Jones et al.,
(Mouse IgG2b) Laboratories, 1991)
[1:20] United
Kingdom
11 a Smooth Clone asm-1 Novocastra (Skalli et al.,
muscle actin (Mouse IgG2a)







Mouse on Mouse (MOM) kit (Vector laboratories) was used. The incubation time
was 30 minutes. After treating the sections with blocking serum/reagent, the
primary antibody was applied at the concentrations mentioned in the table 2.1.
The primary antibody was diluted in 2% of the blocking serum in TBS and
incubated at room temperature for two hours.
2.6.3. SECONDARY ANTIBODY
The sections incubated with primary antibody were thoroughly washed in TBS
and treated with biotinylated secondary antibodies. For primary antibodies
originating from rabbit the biotinylated secondary antibodies raised in goat against
rabbit immunoglobulins were used. When, the primary antibodies were of rat
immunoglobulin, the secondary antibodies raised in rabbit against rat
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immunoglobulins were used. In the case of mouse monoclonal primary antibody,
the biotinylated Anti-mouse IgG reagent supplied in the Mouse on Mouse kit
(Vector laboratories) was used. The concentration of biotinylated secondary
antibody used was 10p,g/ml. The secondary antibody was diluted in 1.5% of the
blocking serum in TBS. The incubation time for secondary antibody was 30
minutes.
2.6.4. ENZYME CONJUGATE AND SUBSTRATE
The conjugated complex of antigen, primary antibody and biotinylated secondary
antibody was detected by adding ABC reagent (Vector laboratories), streptavidin
peroxidase conjugate ready to use solution (Zymed laboratories) or Steptavidin -
peroxidase (POD) conjugate (500mU/ml) (Roche molecular biochemicals). The
ABC reagent was prepared and kept for thirty minutes as per manufacture's
instructions before applying to the sections. The streptavidin - POD conjugate
(Roche molecular biochemicals) was prepared in TBS. The incubation time for
enzyme conjugate was 30 minutes at room temperature. The substrate solution
was applied after washing the sections in TBS. 3, 3'-diaminobenzidine (DAB) or
Vector Nova Red (Vector Laboratories) was used as the substrate for detection of
peroxidase conjugate. The substrate solution was prepared in deionised water as
per the manufactures instruction. The development of colour was monitored under
microscope and the incubation time varied between five to ten minutes.
Haematoxylin QS (Vector laboratories) was used as the counter stain to
demonstrate the nucleus. The counter stain was applied for 45 seconds after
thorough washing in water. The counterstained sections were washed in deionised
water with two changes of deionised water. The sections were dehydrated by
passing through ascending grades of alcohol and cleared in xylene. The stained
sections were mounted with glass cover slip using Vectamount (Vector
laboratories).
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2.7. IN SITU HYBRIDISATION (ISH)
The ISH protocol involves generation of riboprobe with a digoxigenin label,
hybridisation of probe into RNA in tissue sections and detection of the
digoxigenin label by immunoenzymatic techniques.
2.7.1. GENERATION OF RIBOPROBE
Riboprobe was generated from a recombinant plasmid, pEH1.4 (Figure.2.1).
pEH1.4 was prepared by inserting 1,4kb EcoRI-Hindlll sub fragment of Hindlll -
E fragment of MHV-68 genome encoding tRNAl-4 into pBS (Stratagene)
(Bowden et al., 1997).
2.7.1.1. QUANTIFICATION OF PLASMID DNA
Plasmid DNA was quantified using a spectrophotometer (Cecil). In a quartz
cuvette 99 pi of water and one pi of plasmid DNA was added and optical
absorbance measured at 260 nm and 280 nm. The absorbance value obtained at
260 nm was multiplied by 100 to account for the dilution of the DNA and by 50
again to obtain the concentration (pg/ml). This quantification was based on the
fact that one absorbance unit at 260 nm is equivalent to approximately 50 pg/ml
of double-stranded DNA. The ratio of absorbance values at 260 nm to 280 nm
indicated the purity of the DNA. A ratio between 1.7 and 1.9 indicate good purity
of DNA (Sambrook et al., 2001).
2.7.1.2. RESTRICTION DIGESTION OF PLASMID
Restriction enzymes were obtained from New England Biolabs and used with the
supplied buffers according to the manufacturer's instructions. 25 pg of plasmid
DNA was used for restriction digestion reaction. Restriction digestion reactions
were carried out in a volume of 100 pi with one unit of enzyme per one pg of







EcoR1 <T4l <T3l <T2l <Ti
CD
CT4]<T3] <T2l<rn Hind III T3
Figure. 2.1. Restriction digestion of pEH1.4. A recombinant plasmid pEH1.4
containing MHV- 68 tRNA 1-4 (As shown in the top panel) is used for making
the riboprobe (Bowden et al. 1997). The plasmid linearised by restriction digestion
with Hind III (Panel 2) is used for generating antisense probe by in vitro
transcription with T7 RNA polymerase. The sense probe was made by linearising
the plasmid with Eco R1 (Panel 3) and in vitro transcription with T3 RNA
polymerase. Tl, vtRNAl. T2, vtRNA2. T3, vtRNA3. T4, vtRNA4.
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2.7.1.3. PURIFICATION OF THE LINEARISED PLASMID
Phenol - chloroform extraction procedure was used for purification of linearised
plasmid. A mixture of phenol [pH 7.9], chloroform and iso-amyl alcohol in a
ratio of 25:24:1 (v/v) was added to 0.2 volume of DNA (digested with restriction
enzymes in lOOpl) in a 1.5ml eppendorf tube. The contents of the tube were
thoroughly mixed using a vortex for 30s then centrifuged (9000g) for 2mins. The
upper aqueous phase containing the DNA was transferred to a clean tube and the
procedure was repeated until the interface between the aqueous and non-aqueous
solutions became clear. A single chloroform extraction was performed to ensure
removal of phenol from the DNA. DNA was precipitated in 2.5 volume of
ethanol (96%) and 0.15 volume of 3M sodium acetate [pH 5.5] at" 80°C for one
hour. The precipitated DNA was centrifuged (9000g, lOmins), washed in 70%
ethanol and resuspended in 20pl of TE.
2.7.1.4. AGAROSE GEL ELECTROPHORESIS
DNA (typically < 1 pg) was mixed with 3 pi gel loading buffer and lOpl of milli-
Q water and loaded onto agarose gels containing 1% agarose (SeaKem®,
Flowgen) and 0.5 pg/ml (w/v) ethidium bromide in TAE buffer. Electrophoresis
was carried out in a horizontal tank (BIO-RAD) containing TAE buffer at 80V.
The size of DNA bands was estimated by comparison with DNA molecular
weight markers (lkb Plus DNA ladder, Invitrogen). DNA bands were visualised
using a short wave UV transilluminator (UVP Inc.).
2.7.1.5. IN VITRO TRANSCRIPTION OF DNA
One microgram of linearised plasmid DNA was used for in vitro transcription.
The plasmid digested with Hindlll was used for making run off transcripts of
antisense probe with T7 RNA polymerase and the EcoRI cut plasmid for
generation of sense probe with T3 RNA polymerase. The in vitro transcription
procedure incorporates a digoxigenin labelled UTP in every 20 -25th position of
the transcript. The in vitro transcription reaction was carried out in a volume of
20pl. In addition to one microgram of linearised plasmid DNA, 2pl of lOx DIG
RNA labelling mix (Roche Molecular Biochemical), 2pi of lOx Transcription
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buffer (Roche Molecular Biochemicals), 2j.il of either T7 RNA polymerase or T3
RNA polymerase (Roche Molecular Biochemicals) and enough sterile filtered
water to the make up the volume to 20pl was used. The contents of the tube were
mixed well and centrifuged before incubation in a water bath at 37°C for three
hours. The template DNA was denatured using 2 U RNase free Dnase I (Roche
Molecular Biochemicals) and incubated at 37°C for 15 minutes. The transcription
reaction was stopped by adding 2pl of 0.2M Ethylene diamine tetra acetic acid
(EDTA) [pH: 8.0]. The labelled RNA probes in the mixture are precipitated by
adding one pi of yeast tRNA (lOpg /ml), 2pl of 3M sodium acetate [pH: 5.5] and
50 pi of ice cold absolute alcohol. Incubating the mixture at ~80°C for 30 minutes
facilitated the precipitation of RNA. The precipitated RNA was recovered by
centrifuging (13000 g) the mixture at 4°C for 20 minutes. The precipitated RNA
was washed in ice - cold 70% ethanol, air-dried and allowed to regain to room
temperature. The RNA pellet was resuspended in 45 pi sterile filtered water for
30 minutes. An aliquot of the RNA was run on an ethidium bromide stained
agarose gel for checking the presence of transcript.
2.7.1.6. ALKALINE HYDROLYSIS OF THE PROBE
The transcript generated by in vitro transcription was about 1.4 kb in size and
hence alkaline hydrolysis of the probe was done to regulate the length of the
probe. The following formula was used to arrive at the time of incubation during
alkaline hydrolysis to regulate the length of the probe.
Lo - Lf
t =
k x Lo x Lf
t = Time in minutes
Lo = Initial length of transcript in kb
Lf, Desired probe length in kb;
k = constant = 0.1 lkb/min
The desired probe length was set at 170 bp and the time required for alkaline
hydrolysis was estimated as 47 minutes. The alkaline hydrolysis was carried out
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by adding 5 pi of carbonate buffer to 45 pi of riboprobe diluted in sterile filtered
water. (The entire amount of riboprobe obtained by in vitro transcription as
described in section 2.7.1.5.) The incubation time was 47 minutes at 60° C. The
hydrolysis was stopped by adding 5 pi of hydrolysis - neutralisation buffer (1:10
volume). The hydrolysed riboprobes were precipitated by adding 2.5 volume of
chilled ethanol. The samples were mixed well and incubated at -80°C for 30
minutes. To precipitate the RNA, the sample was centrifuged at 13000g for 20
minutes at 4°C. After centrifugation, the absolute alcohol was decanted and the
pellet washed with 70% alcohol and centrifuged again at 13000 g for 20 minutes
at 4°C. The pellet was air dried and diluted in 50 pi of sterile filtered water and the
aliquots are stored at -70° C.
2.7.1.7. ESTIMATING THE YIELD OF DIGOXIGENIN - LABELLED
PROBE
The yield of digoxigenin labelled probe was estimated by making serial dilutions
of the newly prepared probe and comparing it with dilutions of a standard
digoxigenin labelled RNA probe. Digoxigenin labelled "antisense"- Neo RNA,
transcribed with T7 RNA polymerase from one pg DNA (Roche Molecular
Biochemicals) was used as the standard. The concentration of the probe in the
standard solution was approximately 100 pg/ml DIG labelled RNA. The
following dilutions of the standard RNA probe were made in TE: lOng/pl, lng/pl,
lOOpg/pl, lOpg/pl and lpg/pl. The newly synthesised probe was also diluted with
the assumption that in vitro transcription of one pg of DNA would have yielded
10 pg of labelled RNA. Five pi each of diluted newly prepared probes and
standard solutions were applied on to a nylon membrane (Hybond - N+,
Amersham) in parallel. The spots were allowed to air dry and another five pi of
the diluted probes were applied to the corresponding original spots in the
membrane. The cross linking of nucleic acid to the membrane was achieved by
placing the air-dried membrane in a stratalinker at 120 mJ. The membrane was
transferred to a plastic container and washed with maleic acid buffer in a shaker.
The washing was done three times with change of buffer every five minutes. The
membrane was incubated with buffer no.2 for 30 minutes making sure that the
89
CHAPTER:2 MATERIALS AND METHODS
solution was covering the area with spots of probes. The anti-DIG antibody
conjugated with alkaline phosphatase (Roche Molecular Biochemicals) diluted in
buffer no.2 at a concentration of 1: 5000 was applied to the membrane and
incubated for one hour at room temperature. The membrane was washed with
washing buffer three times for ten minutes each time in a shaker. The membrane
was equilibrated in buffer no.3 for five minutes and substrate solution was
applied. The substrate solution was prepared by dissolving one tablet of Sigma
Fast substrate (Sigma) in 10 ml of deionised water. The colour development was
allowed to occur in dark for two hours and washing the membrane in deionised
water for five minutes stopped the colour development. The colour intensities in
the control and newly prepared probe were compared and approximate
quantification of the newly prepared probe was achieved.
2.7.2. HYBRIDISATION
ISH technique was performed on formalin fixed paraffin embedded tissue sections
(5-7 p thickness) adhered onto Snowcoat extra coated slides (Surgipath). Paraffin
wax was removed by passing through xylene for five minutes each with two
changes of xylene. The sections were taken to deionised water through descending
grades of alcohol. Sections were equilibrated in PBS for five minutes and then
treated with 0.1% solution of protease IV for five minutes. Protease treated
sections were washed in PBS and passed through two changes (five minutes each)
of 0.3M ammonium acetate in absolute alcohol and air dried before application of
the pre - hybridisation buffer. The sections covered with pre- hybridisation buffer
were incubated at 55°C for an hour in a hydrated chamber. The salmon sperm
DNA (SS DNA) solution was boiled for two minutes prior to adding into the pre-
hybridisation and hybridisation buffer. The probe was diluted in hybridisation
solution at a concentration of 200 ng/ml. After addition of the probe into the
hybridisation buffer, the solution was boiled for two minutes, vortexed,
centrifuged and chilled on ice. One-hundredth volume of IM Dithiothreitol (DTT)
was added to the probe mix before applying on to the tissue sections. The pre-
hybridisation solution was tipped off before applying the probe in the
hybridisation solution. 50pl of probe mix was applied to each section and
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covered with parafilm to prevent evaporation of the probe mix during over night
incubation in a hydrated chamber at 55°C.
2.7.3. DETECTION OF DIGOXIGENIN LABEL
Digoxigenin label on the hybridised probe was detected by anti-digoxigenin
antibody tagged with alkaline phosphatase enzyme. The hybridised sections were
immersed in 4x standard saline citrate (SSC) buffer and the adhered parafilm
carefully removed. The sections were washed in descending concentration of SSC
(2xSSC, lxSSC and 0.2x SSC with two changes in each dilution for 15 minutes)
on a shaking platform set at 37°C, except for the final wash in 0.2x SSC, which
was carried out at 55°C. The sections were rinsed in PBS before washing in
buffer No.l for three times (five minutes each time). The sections were then
incubated in buffer no.2 supplemented with 0.3% (v/v) Titron - X 100 for 30
minutes at room temperature. The Fab fragments anti-digoxigenin antibody
tagged with alkaline posphatase also is diluted in the above solution (Buffer no.2
supplemented with 0.3% (v/v) titron -x 100) at a concentration of 1:200 (3750
mU/ml). Incubation of antibody was carried out for two hours in room
temperature. After incubation with primary antibody, the sections were washed
in buffer no.l for three times (15 minutes each time) on a shaking platform. After
the washing steps, the sections are equilibrated in buffer no.3 for five minutes.
Substrate solution was prepared by dissolving Sigma Fast substrate tablet in 10 ml
deionised water. After two hours of incubation in the dark, washing the sections
thoroughly in deionised water for five minutes stopped the enzyme reaction. The
sections were then flooded with nuclear fast red solution (Vector laboratories) and
incubated in room temperature for five minutes. The stained sections were washed
thoroughly in deionised water and air dried. The air-dried sections were
dehydrated by passing through ascending grades of alcohol and cleared by passing
through two changes of fresh xylene. The dehydrated and cleared sections were
permanently mounted with Vectamount permanent mounting solution (Vector
Laboratories)
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2.8. EXTRACTION OF RNA FROM SPLEEN
Total RNA was isolated from spleen using the RNeasy® Mini Kit (QIAGEN).
Initially, the spleen was disrupted and homogenised in guanidine isothiocyanate
(GITC) containing buffer. Disruption of the spleen was achieved by grinding the
tissue in a sterile eppendorf tube with 600 pi lysis buffer (Buffer RLT) using a
sterile plastic pestle (Sigma). With the twisting action of the pestle, the spleen
tissue is made into a viscous lysate. Homogenisation of the lysate was done using
a QIAshredder homogeniser (Qiagen). The viscous lysate was loaded on to the
QIAshredder spin column sitting in a 2 ml collection tube. The spin column was
centrifuged for two minutes at 13000 rpm. The homogenised clear lysate in the
collection tube is saved for isolation of RNA. The clear lysate was transferred
into a fresh sterile eppendorf tube and centrifuge at 13000 rpm for three minutes.
The supernatant was carefully transferred into a new microcentrifuge tube. One
volume of 70% ethanol was added to the cleared lysate and mixed immediately by
pipetting. 700 pi of the sample was loaded on to the Rneasy mini column placed
in a 2 ml collection tube. The tube was closed gently and centrifuged at 10000
rpm for 15 seconds. The flow through was discarded. 700 pi of buffer RW1 was
applied to the RNeasy column and tube was closed gently and centrifuged at
10000 rpm for 15 seconds to wash the column and the flow through along with
the collection tube was discarded. The RNeasy column was transferred to another
2 ml collection tube and applied 500 pi of buffer RPE on to the column.
Centrifuged the samples for 15 seconds and the flow through was discarded.
Another 500 pi of buffer RPE was applied to the column and centrifuged again at
10000 rpm for two minutes to dry the silica gel membrane in the spin column.
After making sure that the column was dry and free of ethanol, RNA was eluted
with 50 pi of RNase free water.
2.8.1. QUANTIFICATION OF RNA
RNA concentration was calculated by measuring the absorbance at 260 nm
(A260) in a spectrophotometer (Cecil). An absorbance of 1.0 unit at 260 nm is
equivalent to 40pg/ml of RNA. The RNA sample was diluted in the ratio of 1:100
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and absorbance was measured at 260 nm and the concentration was calculated by
the following formula.
RNA concentration = Absorption at 260nm (A260) x 40 x dilution factor
The purity of the nucleic acid sample, with respect to protein contamination, was
assessed using the ratio A260/A280, where a value greater than 1.8 indicates that the
sample is free from protein contamination. The RNA was also analysed by gel
electrophoresis on a 1% agarose gel prepared in TAE. Representative samples of
RNA were also tested in an Agilent 2100 Bioanalyser to check the integrity of
RNA.
2.8.2. DNA DECONTAMINATION OF RNA SAMPLES
Decontamination of RNA samples from DNA is absolutely essential for
subsequent applications like Reverse Transcriptase - Polymerase Chain Reaction
(RT- PCR) and real time RT- PCR. DNA -free kit (Ambion) was used for
decontamination of RNA samples from DNA. Recombinant DNase - I (rDNase -
I) was the principal ingredient of the kit to denature contaminating DNA in the
sample. The kit also provides reagents to subsequently remove DNase and
divalent cations from sample. DNase treatment was carried out on 10 pi of RNA
sample. 0.1 volume of lOx buffer supplied in the kit (lpl) and lpl of rDNase I
(2U/pl) was added to the RNA sample. The solution was incubated at 37°C for 30
minutes. After 30-minute incubation another 1 pi of rDNase was added and
incubated at 37°C for 30 minutes. DNase inactivation was carried out by adding
2pl of the inactivation reagent. The solution with inactivation reagent was
incubated for two minutes at room temperature with occasional mixing. The
solution was centrifuged at 10000 g for 1.5 minutes and the supernatant was
carefully transferred into a new tube. The quantification of decontaminated RNA
was carried out as described above (section 2.8.1). The DNA decontamination of
the RNA sample was tested by PCR for murine P- actin gene on RNA samples.
Positive control for this PCR reaction was DNA sample extracted from the blood
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of a control wild type mouse. The procedure for extraction of DNA from blood of
mice will be described later (section 2.8.7).
2.8.3. COMPLIMENTARY DNA (cDNA) SYNTHESIS
cDNA synthesis from RNA was carried out by reverse transcription (RT)
reaction. DNase treated RNA was used for RT reaction. The DNA
decontamination of RNA was checked by PCR for P-actin. The RNA
quantification was carried out after DNase treatment and 1 pg of RNA was used
for RT reaction. To the RNA taken in a fresh tube, 200 ng of random primers
(Amersham Biosciences, UK) and 1 pi of lOmM dNTP mix were added and the
final volume was made up to 12 pi with Rnase free water. The mixture was
incubated at 65° C for five minutes and quickly transferred to ice for chilling.
After chilling, 4pl 5x first strand buffer (Invitrogen, UK) and 1 pi of 0.1 M DTT
were added and mixed gently and centrifuged briefly before incubating at 42° C
for two minutes. Following this incubation, 200 U (1 pi) Superscript II RNase H"
Reverse Transcriptase (Invitrogen, UK) was added and the cDNA synthesis
reaction was carried out at 42°C for 50 minutes. Incubating at 70°C for 15 min
inactivated the enzyme. The cDNA was stored at -20°C until further
manipulations such as PCR and Real Time PCR. The success of the RT reaction
was checked by PCR for P- actin gene. One tenth of the reverse transcribed
sample was used in a PCR reaction. Once the success of RT reaction was
confirmed by PCR for P- actin gene, PCR for the arginase - 1 gene was carried
out. The newly synthesised cDNA was used for down stream analysis by RT-PCR
and Quantitative -RT-PCR (Q-RTPCR).
2.8.4. POLYMERASE CHAIN REACTION (PCR)
PCR was typically performed in a volume of 50pl containing a final concentration
of lOOpM 2'-deoxyadenosine-5'-triphosphate (dATP), 2'-deoxyguanosine-5'-
triphosphate (dGTP), 2'-deoxycytidine-5'-triphosphate (dCTP), 2'-
deoxythymidine-5'-triphosphate (dTTP) (Ultrapure dNTP set, Amersham
Biosceinces, UK), reaction buffer (20mM Tris [pH 8.4], 50mM KC1, Invitrogen,
UK), 3 mM MgCh (Invitrogen, UK), 50pmol of each primer (MWG Biotech,
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Germany), 100 - 500 ng of template DNA and 5U of Taq DNA polymerase
(Invitrogen, UK). All PCR primers were purchased from MWG - biotech and are
shown in table no.2.2. PCR was carried out in thin-walled 0.5ml eppendorf tubes
(ThermoHybaid) on an Omnigene thermal cycler (ThermoHybaid). The reactions
without Taq DNA polymerase were overlaid with mineral oil (Sigma, UK). The
reactions were heated to 94°C for 5mins, then held at 80° C and Taq DNA
polymerase was added ("hot-start"), thus limiting non-specific amplification. The
block was programmed to repeat 35 cycles of 45s denaturation at 94°C, annealing
at 55°C for 45 sec, 30s extension at 72°C and ending with 5mins at 72°C. PCR
products were analysed by agarose gel electrophoresis.
2.8.5. PURIFICATION OF PCR PRODUCTS
Amplified DNA was purified using the QIA quick PCR purification kit (Qiagen)
according to the manufacturer's instructions. PCR products were pooled and
mixed with five volumes of buffer PB supplied in the kit. The mixture was
applied to the QIAquick spin column and centrifuged for one minute at 13000
rpm. The follow through was discarded and 750 pi of buffer PE applied to the
spin column assembly. The column assembly was centrifuged for one minute; the
follow through was discarded and centrifuged again at 13000 rpm for one minute.
The column was placed in a new sterile 1.5 ml eppendorf tube. The purified DNA
from the column was eluted with 50pl of buffer EB and stored at ~ 20° C until
further required.
2.8.6. QUANTITATIVE-RT PCR (Q- RTPCR)
Q-RTPCR was carried out on the cDNA synthesised as per the procedure
described above (section 2.8.3.). SYBR Green I dye (Biogene) chemistry method
was used for Q-RTPCR. The fluorescence intensity of SYBR Green I dye
(Excitation max. 497 nm and emission max. 520 nm) increases 1000 - fold in the
presence of dsDNA and does not interfere with DNA amplification during PCR.
This characteristic allows the detection of PCR products in real time when the dye
is added into the PCR reaction. A Rotor-Gene real time PCR machine (Corbett
Research) was used for the analysis.
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2.8.6.1. NORMALISATION OF GENE EXPRESSION
P-actin gene was used as the endogenous control to normalise the expression level
of the target gene. The transcription of the P-actin gene and target gene from the
cDNA samples was assessed by PCR and agarose gel electrophoresis as described
above. Two sets of primers were designed by Dr.B.M. Dutia and they were called
as 'outer' and 'inner' (Table No. 2.2) primers. The amplicons generated by PCR
with the 'outer' set of primers on cDNA obtained from pooled samples was
purified and used as the template for PCR with 'inner' set of primers to generate a
standard curve. The gene copy number in the sample was estimated in relation to
the assigned value of gene copy numbers in the standard. Standard curves were
prepared for both target and endogenous control. For each experimental sample,
the amount of target and endogenous control was determined from the appropriate
standard curve. Then, the target amount was divided by the endogenous control
amount to obtain a normalised target value. The normalised amount of target is a
unitless number that can be used to compare the relative amount of target in
different samples
2.8.6.2. PROTOCOL FOR Q-RTPCR
The 'inner' PCR primers were used for the Q-RTPCR. The target and
endogenous control gene amplifications were carried out in separate tubes. The
purified PCR product obtained from PCR with 'outer' primers for both
endogenous control and target gene were diluted tenfold in duplicate and used to
generate standard curve. The experimental samples also assayed concurrently in
duplicate and the relative concentration of endogenous control and target gene
was determined for each experimental sample. The Q-RTPCR was conducted in
20pl volume and consisted of lOx fast start taq polymerase buffer (Roche
Molecular Biochemicals) (2pl), lOmM of each dNTPs (0.4pl), 50pM of primers
(0.5pl) each, fast start taq polymerase (0.15pl), SYBR green dye I (0.7pl). The
volume was made up to 15pl with Rnase free water and 5pi of diluted template
cDNA was added. Two micro litres of cDNA samples were diluted to 10 pi and
5 pi each was added in duplicate reactions (cDNA was prepared from 1 pg of RNA
as described in section 2.9.3. and the final volume of cDNA reaction was 19pl).
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Table No. 2.2. Primer pair used in the experiments
Sense(S)
Antisense (A)





5' - TGT GAT GGT GGG AAT GGG TCA - 3'
5' - TTT GAT GTC ACG CAC GAT TTC - 3'
(Amplicon size: 513 bp)




P-Actin - (1) S
p-Actin -(1) A
('inner')
5'- CGT TGA CAT CCG TAA AGA CC - 3'
5' -CTG GAA GGT GGA CAG TGA - 3'
(Amplicon size : 201 bp)







5'- GTG GCA TCC ATG AAA CTA CA-3'
5'- GTA CTC CTG CTT GCT GAT CC -3'





Arginase -I (I) S
Arginase -I (I) A
('inner')
5'- CAG AAG AAT GGA AGA GTC AG -3'
5'- CAG ATA TGC AGG GAG TCA CC - 3'
(Amplicon size : 249 bp)
Nt 341 - 360
Nt 590 - 571
(Accession No.
NM.007482)
Arginase -I (2) S
Arginase -I (2) A
('outer')
5'- GAG TAT GAC GTG AGA GAC CAC -3'
5'- GAA GGT CTC TTC CAT CAC CTT - 3'
(Amplicon size : 518 bp)






5'-GAG TGT AAT GAG AGT CTG TG -3'
5'- CTG TCA TCA TGG AAA GGA GGG - 3'
(Amplicon size: 148 bp)
Nt 705 - 724
Nt 853 - 833
(Accession No.
NM: 010511.1
The amplification cycle was as follows: a melting step of 95°C for 10 minutes was
followed by 45 cycles of 94°C for 30 seconds, 62°C for 20 seconds and 72°C for
20 seconds, followed by a melting analysis step from 65 to 94° C at 0.3°c/20
seconds at first step and 0.3°c / every second for each step afterwards. The
amplification cycle for target gene (Arginase -I) was as follows; a melting step of
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95° C for 10 minutes was followed by 45 cycles of 94° C for 20 seconds, 60° C for
20 seconds and 72° C for 20 seconds, followed by a melting analysis step from 65
to 99° C at 0.5° C / second.
2.8.7. EXTRACTION OF DNA FROM BLOOD
Blood was collected from two mice (one IFNyR"'" and one wild type) to extract
DNA to use as positive control for PCR to check the DNA contamination of RNA
samples extracted from spleen of mice. Blood was also collected from the bone
marrow chimera mice made as described in section 2.9.1. to confirm the success
of chimera formation. QIAamp DNA Blood Mini kit (Qiagen, UK) was used to
extract DNA from blood. 20 pi of proteinase - K (20pg/ml) (Sigma, UK) was
taken in a 1.5 ml eppendorf tube and 200 pi of blood sample was added to the
enzyme and ensured that the enzyme mixed well with blood. 200 pi of buffer AL
was added to the sample and mixed by pulse — vortexing for 15 seconds to make a
homogenous solution. The sample was centrifuged briefly and incubated at 56° C
for 10 minutes. The eppendorf tube was centrifuged briefly after incubation to
collect drops of solution from the inside of the lid. 600 pi of 96% ethanol was
added to the sample and mixed by pulse vortexing for 15 seconds. The mixture
was carefully applied on to a spin column assembly sitting in a 2 ml collection
tube and the tube containing filtrate was discarded. The spin column assembly
was centrifuged at 8000 rpm for one minute. The collection tube containing the
filtrate was discarded and spin column assembly was placed in a new collection
tube. 500 pi of buffer AW1 was applied to the spin column assembly without
wetting the rim. The spin column assembly was centrifuged at 8000 rpm for one
minute. 500 pi of buffer AW2 was applied to the column and centrifuged at
13000 rpm for three minutes. The collection tube containing filtrate was discarded
and the spin column assembly was placed in a sterile 1.5 ml eppendorf tube. 200
pi of buffer AE was applied to the membrane in the spin column and incubated at
room temperature for five minutes. The DNA adhered to the membrane of the
spin column assembly was eluted by centrifugation at 8000 rpm for one minute.
The concentration of DNA was estimated as per the same procedure used for
quantification of plasmid DNA as described in section 2.7.1.1.
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2.9. BONE MARROW CHIMERA EXPERIMENT
In order to study the contribution of bone marrow derived cells in the
pathogenesis of splenic fibrosis in IFNyR"7" mice infected with MHV-68, bone
marrow chimera mice were generated and pathological changes were investigated
in comparison with normal mice following intranasal infection with MHV-68.
2.9.1. GENERATION OF BONE MARROW CHIMERA MICE
Two sets of bone marrow chimera mice were made. The first set of chimeras was
made on wild type (129 Sv/Ev) background and the second set on IFNyR""
background.
To generate bone marrow chimeras in the wild type background, two sets of
twelve each wild type 129 Sv/Ev female mice were selected and grouped as
recipient. Another two set of nine female mice each in the IFNyR" " background
and wild type 129 Sv/Ev mice was also selected and designated as donor. The
donor groups of mice were sacrificed by asphyxiation with CO2 and the femurs
collected aseptically in Roswell park memorial institute - 1640 (RPMI -1640)
medium supplemented with foetal calf serum (FCS) and stored separately. The
bone marrow cells from the femur were squeezed out and collected in fresh batch
of RPMI-1640 with FCS. The harvested bone marrow cells from each group were
pooled in 40 ml of RPMI-1640. The cells were centrifuged at 1500 rpm for five
minutes and resuspended in 40ml of fresh RPMI-1640. 1 X 107 cells were
injected in to the recipient mice via tail vein in a volume of 100 pi. The recipient
mice were subjected to irradiation (920 rad for 47 minutes) before injecting with
the bone marrow cells from donor mice. The wild type mice, which received bone
marrow cells from IFNyR"7" mice were designated as 'WG' and the other group,
which received wild type cells, were designated as 'WW'. To generate bone
marrow chimera mice in the IFNyR"7" (129 Sv/Ev) background, the same
procedure as above was followed with IFNyR"7" mice as the recipient group. The
IFNyR"7" mice, which received bone marrow cells from IFNyR"7" were designated
as 'GG' and the IFNyR"7" mice which received cells from wild type 129 Sv/Ev
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as 'GG' and the IFNyR7" mice which received cells from wild type 129 Sv/Ev
mice were designated as 'GW'. The recipient mice were maintained on a normal
diet for two months before infecting with virus.
2.9.2. INFECTION OF BONE MARROW CHIMERA MICE
The repopulation of peripheral circulation with cells originating from newly
received bone marrow cells were confirmed by PCR for IFNyR gene on DNA
isolated from blood. The blood was collected from the tail tip and DNA was
extracted as per the procedure described in section 2.8.7. The PCR was carried out
as per the procedure described in section 2.8.4. by using the primer set as
described in table 2.2. After confirming the repopulation of cells in the peripheral
circulation with cells originating from newly injected bone marrow cells the mice
were infected with 4x 105 PFU of MHV -68 in 40pl volume as described in
section 2.4. Along with two groups of chimera mice, another group of 12 wild
type mice designated as 'WO' was also infected in the similar way as described
above in the experiment involving bone marrow chimera mice in the wild type
(129 Sv/Ev) background (In total three groups designated as WG, WW and WO).
In the experiment involving bone marrow chimera mice in the IFNyR7"
backgrounds, 12 each age matched IFNyR7" mice and wild type mice were also
used and they were designated as G and W respectively (In total four groups
designated as GW, GG, W and G). Three mice from each group were sacrificed
on day 12, 16, 20 and 35 post infections. Detailed post-mortem examination was
carried out. Weight of dead mouse and spleen was estimated and the weight of
spleen was expressed as percentage of body weight. The spleen was collected in
BFS and processed as described in section 2.5 for histopathological evaluation.
2.10. STATISTICAL ANALYSIS
Mann - Whitney test and 2 sample t- test in the MINITAB Release 14 software
was used for statistical analysis of the data.
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APPENDIX 1 - CHEMICALS AND SOLUTIONS
All chemicals were obtained from Sigma (Sigma-Aldrich Company Ltd., Fancy
Road, Poole, Dorset, BH12 40H, England) or MERCK BDH (VWR international
Ltd, Merck House, Poole, Dorset BH15 1TD, England). The chemicals obtained
from other manufactures are specifically mentioned as and when they appear in
the text.
Water:
Deionised water (Millipore) was used for making solutions and rinsing glassware
used for immunohistochemistry. Sterile filtered water acquired from Sigma was
used for preparations of nucleic acid, PCR and RT- PCR. The solutions for in situ
hybridisation studies were made in Diethyl-pyrocarbonate (DEPC) treated
deionised water. The deionised water was treated with DEPC at a level of 0.1%
(v/v) and incubated at 37° C overnight and autoclaved before use.
TE buffer:
lOmM Tris - HC1, ImM EDTA [pH 8.0].
TAE buffer:
0.04M Tris - acetate, ImM EDTA [pH 8.0].
TBS:
50mM Tris, 150mM NaCl [pH 7.6],
PBS:
137mM NaCl, 2.7mM KC1, 10 mM Na2HP04,1.0 mM KH2P04 [pH 7.4]
6x loading buffer:
10% (w/v) Ficoll, 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanole,
0.4% (w/v) orange G, 10 mM Tris-HCl [pH 7.5], 50 mM EDTA.
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SOLUTIONS FOR HAEMATOXYLIN AND EOSIN STAINING
a. Elarris's haematoxylin solution
Haematoxylin 5g, Ethyl alcohol 50ml, Potassium alum lOOg,
Deionised water 950 ml, Mercuric oxide 2.5g, Glacial acetic acid 40ml.
b. Eosin solution: 1% aqueous solution
c. Acid alcohol: 1% hydrochloric acid in 70% alcohol
SOLUTIONS FOR MASSON'S TRICHROME (MT) STAINING
a. Weigert's Iron Haematoxylin solution
Stock solution A:
Haematoxylin lg in Alcohol 100ml (95%).
Stock solution B:
30% ferric chloride in water 4ml, Deionised water 95ml, Con. HC1 1ml.
Working solution:
Mix equal parts of solution A and B
b. Acid fuchsin 0.5g, Glacial acetic acid 0.5ml and deionised water 100 ml
c. Phoshomolybdic acid l.Og and deionised water 100ml
d. Light green 2.0g, Glacial acetic acid 2.0ml and deionised waterlOOml
(Diluted 1:10 with deionised water prior to use)
SOLUTIONS FOR MARTIUS YELLOW-BRILLIANT CRYSTAL
SCARLET-SOLUBLE BLUE (MSB) STAINING
a. 0.5% Martius Yellow in 2% phosphotungstic acid in 95% alcohol
b. 1% brilliant crystal scarlet 6R in 2.6% acetic acid
c. 1% aqueous phosphotungstic acid
d. 0.5% aniline blue in 1% acetic acid
SOLUTIONS FOR PICRO SIRIUS RED STAINING
a. 1% Sirius red FSB (Raymond A Lamb Ltd.) in saturated aqueous picric acid
b. 0.2% Aqueous phosphomolybdic acid
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SOLUTIONS FOR VON KOSSA STAINING
a. 2% aqueous silver nitrate
b. 1 % aqueous neutral red
SOLUTIONS FOR PERLS STAINING
a. 2% aqueous potassium Ferrocyanide
b. 2% hydrochloric acid
c. 1 % aqueous neutral red
SOLUTIONS FOR IN SITU HYBRIDISATION
lOx DIG RNA labelling Mix [pH: 7.5]:
lOmM ATP, lOmM CTP, lOmM GTP, 6.5mM UTP, 3.5mM DIG UTP
lOx Transcription buffer: [pH: 8.0]
400mM Tris-HCl, 60mM MgCl2. lOOmM DTT, 20mM Spermidine
Carbonate Buffer [pH10.2]:
0.4M NaHC03, 0.6M Na2 C03
Hydrolysis Neutralisation Buffer [pH: 4.6]
3M Sodium Acetate [pH adjusted to 4.6 with glacial acetic acid]
Maleic Acid Buffer [pH: 7.5]:
0.1 M Maleie acid, 0.15 M NaCl
Buffer No.l: [pH 7.5]
O.lMTris, 0.15 M NaCl
Buffer No.2 (Blocking solution)
0.1% (v/v) Normal Sheep Serum in Buffer No.l.
Buffer No.3: [pH 9.5]
0.1M Tris, 0.1M NaCl, 0.05M MgCE
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Washing Buffer
0.5% (v/v) Tween-20 in Buffer No. 1.
20x SSC [pH 7.0]:
3 M NaCl, 0.3 M sodium citrate
20x Salts ]pH6.8)
0.1M EDTA, 0.1M Piperazine N, N - bis (2-ethane sulfonic acid) (PIPES),
3M NaCl
50x Denhardt's solution:
1% (w/v) Ficoll, 1% (w/v) polyvinylpyrrolidone, 1% (w/v) Bovine Serum
Albumin (BSA)
Pre hybridisation Solution:
50% (v/v) Formamide, 25% (v/v) 20x Salt solution, 10% (v/v) 50x Denhardt's
solution, 2.5% (v/v) Salmon Sperm DNA (llmg/ml), 2.5% (v/v) Yeast tRNA
(lOmg/ml), 1.0% (v/v) Fleparin (2000U/ml), 1.0% (v/v) Sodium Dodecyl sulphate
(SDS) - 10% (w/v)
Hybridisation Solution:
50% (v/v) Formamide, 25% (v/v) 20x Salt solution, 10% (v/v) 50x Denhardt's
solution, 2.5% (v/v) Salmon Sperm DNA (llmg/ml), 2.5% (v/v) Yeast tRNA
(lOmg/ml), 1.0% (v/v) Heparin (2000U/ml), 1.0% (v/v) Sodium Dodecyl sulphate
(SDS) - 10% (w/v), 10% (v/v) Dextran sulphate (0.5g/ml)
Buffer for Anti-Digoxigenin - AP, Fab fragments: [pH 7.6]
50 mM Triethanolamine, 03 mM NaCl, 01 mM MgCh, 0.1 mM ZnCh,
1% BSA (w/v)
Sigma Fast Alkaline Phosphatase Substrate Solution: [pH 9.5]
5-Bromo-4-Choloro-3-Indolyl phosphate (BCIP): 0.15mg/ml,
Nitro Blue Tetrasolium (NBT): 0.30mg/ml, Tris: lOmM, MgCh: 05mM
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APPENDIX 2 - COMMERCIAL SUPPLIERS
Ambion Inc, Ambion (Europe) Ltd, Ermine Business Park, Spitfire Close,
Huntingdon, Cambridgeshire PE29 6XY
www.ambion.com
Amersham Biosciences UK Ltd, Amersham Place, Little Chalfont,
Buckinghamshire HP7 9NA HP7 9NA
www.amershambiosciences.com




Bio-Rad Laboratories Ltd, Bio-Rad
Hempstead, Hertfordshire HP2 7TD
www.bio-rad.com
House, Maylands Avenue, Hemel
Biologo, Br. Hartmut Schultheiss e.K. Steindamm 1G-H, 24119 Kronshagen,
Germany
www.biologo.de
BMA Biomedicals AG, Rheinstrasse 28-32, 4302 Augst, Switzerland
Email: info@bma.ch
Cecil Instruments Ltd, Milton Technical Centre, Cambridge CB4 6AZ
www.cecilinstruments.com
DakoCytomaton Ltd, Denmark House, Angel Drove, Ely, Cambridgeshire CB7
4ET
www.dakocvtomation.com
Flowgen, Findel House, Excelsior Road, Ashby Park, Ashby de la Zouch,
Leicestershire LE65 1NG
www.flowgen.co.uk
Invitrogen Ltd, 3 Fountain Dr, Inchinnan Business Park, Paisley PA4 9RF
www, invitro gen, com
Merial Animal Health Ltd, Sandringham House, Harlow Business Park, Harlow,
Essex, CM19 5TG http://uk.merial.com
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Millipore, 80 Ashby Road, Bedford, Massachusetts, USA
www.millipore.com
MWG Biotech (UK) Ltd, Mill Court, Featherstone Road, Wolverton Mill South,
Milton Keynes MK12 5RD
www.mwg-biotech.com
Nalgenunc International, 75 Panorama Creek Drive, Rochester, NY 14625
www.nalgenunc.com
New England Biolabs (UK) Ltd, 73 Knowl Piece, Wilbury Way, Hitchin,
Elertfordshire, SG4 OTY
www.neb.com
Novocastra Laboratories Ltd. Balliol Business Park, WestBenton Lane,
Newcastle upon TyneNE12 8EW
www.novocastra.co.uk
Pharmingen - BD biosciences Pharmingen, 21 In Between Towns Road,
Cowley, Oxford 0X4 3LY
www.bdbiosciences.com/pharmingen/
QIAGEN Ltd, Boundary Court, Gatwick Rd, Crawley, West Sussex RH10 9AX
www.QIAGEN.com
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3. CHARACTERISATION OF SPLENIC FIBROSIS
The spleen is the major organ which shows distinct pathological changes in
IFNyR" " mice infected with MHV-68. The main features of splenic pathology are
development and resolution of fibrosis (Dutia et al, 1997, Ebrahimi et al 2001).
Characterisation of the virological, cellular and molecular events associated with
these pathological processes was the main objective of this study.
The study was structured under the following sub-headings:
3.1. Survey of pathological changes in the spleen
3.2. Characterisation of cellular events
3.3. Alternate activation of macrophages
3.4. Bone marrow chimera experiments
3.5. Role of productive and latent virus infection in the pathogenesis of splenic
fibrosis
Each sub-chapter detailing the study under each sub-heading is presented with an
introduction, followed by description of the results and a brief summary. Finally,
a comprehensive discussion of results is presented with suggestions for future
work.
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3.1. SURVEY OF PATHOLOGICAL CHANGES IN THE SPLEEN
The sequential pathological changes during the development and resolution of
fibrosis in the spleen of IFNyR"7" mice infected with MHV-68 are not known. In
this study, a detailed pathological survey was undertaken to delineate these
events. As described in the Materials and Methods (section 2.4), three different
experiments were carried out with close time intervals between day 8 and 120 and
gross and histopathological observations were made.
Fibrosis is a host response to injury of a chronic nature characterised by
deposition of extra cellular matrix (ECM). The ECM consists of proteoglycans
(e.g. decorin and fibromodulin), adhesion molecules (e.g. fibronectin and laminin)
and different types of fibrous proteins (e.g. collagen, elastin and fibrillin).
Collagens are the major fibrous protein in the ECM. To date 19 different types of
collagens have been described (Ghosh. 2002). Type I collagen, which is a product
of two genes (COL1A1 and COL1A2) is the main type of collagen found in many
tissues like skin, bone and ligaments. A diverse group of cells (fibroblasts and
myofibroblasts) is responsible for the production of ECM proteins including
collagen. The cell type responsible for the synthesis of ECM in splenic fibrosis
caused by MHV-68 has not been investigated before. The current study
investigated whether myofibroblast - type cells characterised by the expression of
a smooth muscle actin (aSMA) are involved in the pathogenesis of splenic
fibrosis. The expression of aSMA was investigated by immunohistochemical
techniques as described in the Materials and Methods section 2.6.
3.1.1. GROSS PATHOLOGY
Splenomegaly was observed as the initial response of the spleen towards virus
infection in both IFNyR"" and 129 Sv/Ev mice. The size and colour of the spleen
showed distinct changes during the course of infection, especially in the IFNyR7"
mice (Figure.3.1.1). In IFNyR"7" mice, at the time of splenomegaly during day 10 -
12 p.i., the spleen appeared dark red or brownish black in colour with a glistening
smooth surface. During day 14-18 p.i., the colour changed to yellowish brown,
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Figure 3.1.1 Gross pathological changes in the spleen of mice
infected with MHV-68. A representative image of spleen at
each time point is presented. Note the difference in size and
colour of spleen from IFNyR"7" and 129 Sv/Ev mice at later time
points.
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though the spleen appeared enlarged with a smooth glistening capsule. At day 20
p.i. the spleen was shrunken and pale in colour. At day 30 p.i. the colour changed
towards reddish brown, although the size of the spleen appeared small. The colour
and appearance of the spleen remained the same during the rest of the time points
up to day 120 p.i. The spleen of 129 Sv/Ev group of mice appeared dark red or
brownish black in colour and enlarged with glistening smooth capsule during the
phase of splenomegaly (Day 14-18 p.i.). Thereafter the spleen regained its normal
size and remained in that state until day 120 p.i.
The weight of spleen expressed as a percentage of body weight from two different
experiments is presented in Figure. 3.1.2. The spleen showed a progressive
increase in weight during the initial time points of the experiment. The weight of
the spleen peaked at day 12 p.i. in IFNyR_/" mice and then showed a steep decline.
The difference in the weight of the spleen expressed as percentage of body weight
at this time point was statistically significant (p value = 0.0131). In 129 Sv/Ev
mice, the peak of splenomegaly was observed at day 16 p.i. and then showed a
gradual decline. The contrast in the weight of the spleen was marked at day 20 p.i.
between two groups with a drastic drop in the weight of the spleens from IFNyR"7"
mice compared to 129 Sv/Ev mice. The difference in the weight of the spleen
expressed as percentage of body weight at day 20 p.i was statistically significant
(p value = 0.0367). The weight of the spleen remained at apparently the same
levels in both groups of mice from day 30 up to day 120 p.i. However, the
difference in splenic weight expressed as percentage of body weight is not
statistically significant at day 30 p.i. (p value = 0.0518) whereas, statistically
significant at day 120 p.i. (p value = 0.02). Data for day 12 and day 20 p.i. from
experiment No.l and 2 was pooled for statistical analysis.
In the third experiment conducted to assess the effect of mock infection in
IFNyR'^mice, the spleens of mock infected mice did not show any obvious
pathological change. Whereas, the MHV-68 infected IFNyR_/" mice showed a
similar pattern of pathological changes as observed in experiment no.l and 2.
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Figure. 3.1.2. Weight of spleen expressed as percentage of body
weight:
Experiment 1 (A) (n= 2 each at day 8, 3 each at day 10, 3 each at day
12, 2 each at day 14, 16,18 and 20) Experiment 2 (B) (n= 3 each at
day 12 and 20, 4 IFNyR -/- and 3 129 Sv/Ev at day 30, 5 IFNyR -/- and
3 129 Sv/Ev at day 35, 4 IFNyR -/- and 3 129 Sv/Ev at day 40, 3 each
at day 45, 50, 60 and 80, 5 IFNyR -/- and 4 129 Sv/Ev at day 120 )
Each bar represent Mean± Standard Deviation
I I IFNyR -/- mice infected with MHV-68
J 129 SV/Ev mice infected with MHV-68
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3.1.2. HISTOPATHOLOGY
Histologically, the spleen showed no signs of infection at day 08 p.i in both
groups of mice (Figure. 3.1.3A and 3.1.3F). By day 10 p.i. both groups of mice
showed germinal centre (GC) formation in the white pulp. GCs develop in
response to an antigenic challenge characterised by proliferation of B-
lymphocytes. Hyperplasia of the white pulp was characterised by an increase in
the number of mitotic figures and tingible body macrophages (TBM) loaded with
apoptotic bodies. Transformation of B-lymphocytes towards plasma cells was also
evident. The red pulp was congested. In IFNyR"/_ mice, by day 12 p.i, there was
an expansion of the white pulp with GC and active TBM. TBM were large with
many apoptotic bodies. Focal expansion of small lymphocytes was visible in the
red pulp area. These changes were moderate in 129 Sv/Ev mice compared to
IFNyR~/_ mice (Figure. 3.1.3B and 3.1.3G). The appearance of micro-abscesses
with a focal collection of neutrophils in the splenic parenchyma was another
notable finding at this time point in IFNyR"7" mice. In IFNyR7" mice, by day 14
p.i., depletion of mature lymphocytes in the white pulp, which were occupied by a
heterogeneous mixture of larger mononuclear cells, was noticed. The infiltrating
cells showed the morphological features of macrophages. They appeared to be
round with slightly irregular cell outlines and slightly acidophilic cytoplasm. In
IFNyR"7" mice at day 16 p.i. a mild degree of fibroblast proliferation and collagen
deposition was noticed around the white pulp (Figure.3.1.3C). The peak level of
fibrosis along with collapsed red pulp and shrunken lymphoid follicles was
noticed at day 20 p.i. (Figure. 3.1.3D).
From day 30 p.i. onwards the spleens from IFNyR-/" mice showed signs of
recovery with appearance of red blood cells in the red pulp and more dark blue
stained small lymphocytes in the lymphoid follicles. The recovery state was more
evident at day 35 p.i. The expanding lymphoid follicles pushed the fibrous tissue
towards the periphery (Figure 3.1.3E). From day 35 p.i. onwards, the red pulp also
carried brown coloured hemosiderin pigments in between the fibrous tissue
strands. Some of the macrophages also were laden with hemosiderin pigments
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Figure.3.1.3. Histopathological changes in the spleen of MHV -68 infected
mice.
Haematoxylin and Eosin staining.
Note the tightly packed small lymphocytes in the lymphoid follicles in both
spleens at day 8 p.i. (A and F). At day 12 p.i. the GC formation in the
lymphoid follicles of both groups of mice is evident. A number of TBM
(arrows) with apoptotic bodies is evident in the IFNyR"'" mice (B). At day 16
p.i. in the IFNyR"7" spleen, the majority of the cells in the lymphoid follicles
are lightly stained large cells with increased cytoplasm (macrophage like)
compared to normal GC structure in 129 Sv/Ev spleens. Also note the
presence of a few spindle shaped cells in the periphery of lymphoid follicles
of IFNyR-/- spleen (Highlighted in a rectangle with arrow in C. Magnified
version of the area highlighted is presented in the inset). At day 20 p.i. the
shrunken lymphoid follicles contain few lymphocytes and TBM in the
IFNyR"7" and these are encircled by spindle shaped cells and extra cellular
matrix - 'fibrotic cage' formation (D). The dramatic re-appearance of
mature lymphocytes in the lymphoid follicles of IFNyR-/- spleen is noticed
at day 35 p.i. (E)










Figure. 3.1.3. Please see the legend on the facing page
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(Figure. 3.1.4). By day 45 p.i. the long stretches of fibrous bands appeared broken
and smaller bands of fibrous tissue was noticed.
In 129 Sv/Ev mice, from day 10 p.i. onwards, the spleen remained active with GC
and TBMs and by day 16 p.i. showed peak levels of antigen responsiveness with
features similar to the spleens of IFNyR"/_ mice at day 12 p.i. From day 18 p.i.
onwards, the spleens of the 129 Sv/Ev mice showed features of resolution with a
reduction in the size of lymphoid follicles in the white pulp, decreased cellularity
and reduced number of TBMs. The spleen, at later time points until day 120 p.i.,
did not show any significant changes from the descriptions given above.
No significant pathological changes were observed in the spleen of mock infected
IFNyR_/~ mice from the third experiment. Whereas, the spleens of MHV-68
infected IFNyR"/_ mice showed a similar pattern of pathological changes as
observed in experiment no.l and 2
3.1.3 IDENTIFICATION OF MYOFIBROBLAST-TYPE CELLS IN THE
SPLEEN OF IFNyR"'" MICE INFECTED WITH MHV-68
The distribution of collagen in the spleen was initially investigated by various
histochemical techniques including Masson's trichrome (MT), Martius yellow -
brilliant crystal scarlet - soluble Blue (MSB) and picrosirius red (PSR). The
histochemical staining of spleen sections showed the accumulation of collagen
and their secreting cells predominantly around the shrinking white pulp lymphoid
follicles ('fibrotic cage') and in the capsular area. Strands of collagen were also
noticed in the red pulp parenchyma (Figure 3.1.5). Among the cell population,
which showed positive staining, the majority of them were spindle shaped with a
central elongated nucleus. The positive cells also included round to stellate
shaped cells with central round nucleus. The staining for aSMA showed mainly
stellate shaped cells with positive staining reaction among the fibrous tissue
around the shrunken white pulp lymphoid follicles (Figure 3.1.6).
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Figure.3.1.4. Hemosiderosis in the spleen of IFNyR-/- mice at day
40 p.i.
A, Haematoxylin & Eosin staining : Note the presence of brown
pigments in the red pulp (arrows). B, Perl's staining : Note the
presence of blue pigments in the red pulp (Arrow).
Magnification 200X.
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Figure. 3.1.5. Characterisation of fibrosis in the spleen by
histochemical techniques.
Formalin fixed paraffin embedded tissue sections of spleen from
IFNyR-/- mice infected with MHV-68 and harvested at day 20 p.i.
were stained with Masson's trichrome (light green counter stain)
(A), Martius yellow - Brilliant crystal scarlet - soluble blue (Blue
colour for collagen) (B) and Picrosirius red (Red colour for
collagen) (C). Note the predominance of collagen deposition
around the shrinking white pulp lymphoid follicles and capsular
locations. An area is highlighted in a rectangle to demonstrate
spindle shaped cells. The highlighted area is magnified and
presented in the inset. LF, lymphoid follicle. Ca, Capsule.
Magnification 200X 1 19
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Figure. 3.1.6. Identification of myofibroblast-type cells in the spleen
of IFNyR-/- mice infected with MHV-68 and harvested at day 20 p.i.
Alpha smooth muscle actin staining . Red colour indicate positive
staining (arrows). LF, lymphoid follicle. A magnified view of the
cells in highlighted rectangle is presented below the original image
Magnification 200X
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3.1.4. SUMMARY
The survey of pathological changes in the spleen identified key time points, which
are relevant to the development and resolution of fibrotic changes in the spleen.
Interestingly, the spleen did not show any obvious sign of antigen responsiveness
in the form of a GC reaction at day 8 p.i. in either group of mice. The induction
period required for development of the GC in lymphoid organs after exposure to
an antigen is around three days (Heinen, 2002). Earlier studies on detecting latent
viral load in the spleen following MHV-68 infection in immunocompetent mice
have recovered latent virus from spleen as early as day 3 p.i.(Sunil-Chandra et al.,
1992a). The current observation of lack of antigen responsiveness in the spleen at
day 8 p.i. suggests that the virus may be reaching the spleen in a latent form as
early as day 3. p.i. and exposure of viral antigen to the splenic immune system
takes place only a few days earlier than day 10 p.i.
In IFNyR"7" mice, the spleens follow a different pattern of events from day 14 p.i.,
which is characterised by invasion of lymphoid follicles with a heterogeneous
mixture of large mononuclear cells morphologically similar to macrophages. This
pattern reaches its peak at day 16 p.i. and the majority of the cells in most of the
lymphoid follicles at this point are occupied by macrophages. At the same time,
fibroblasts also start to appear in the periphery of these lymphoid follicles. From
this point onwards the spleens from IFNyR"" mice showed a drastic change
characterised by the collapse of the red pulp occupied by plump fibroblasts and
collagen fibres. The lymphoid follicles in the white pulp shrinks and the
macrophage - like cells, except for few TBM disappeared from the centre of the
lymphoid follicles. Day 20 p.i. is the peak time point where the highest level of
fibrotic changes were seen and appeared like a 'fibrotic cage' around the shrunken
white pulp nodule mainly carrying tightly packed small lymphocytes. From day
30 p.i. onwards the spleen gradually regained its normal structure, which became
clear as early as day 35 p.i. and the spleens maintain this 'recovery' state until the
last time point of the experiment.
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This part of the study indicated that, gradual depletion in the number of
lymphocytes in the lymphoid follicles of the spleen is the primary event
associated with the pathogenesis of fibrosis. The recovery phase was
characterised by re-population of shrunken lymphoid follicles. The preliminary
characterisation of the fibrotic changes in the spleen showed a contribution from
myofibroblast-type cells characterised by aSMA expression in the pathogenesis
of fibrosis. This is the first description of the aSMA positive myofibroblast type
cell in the spleen which we would like to name it as splenic stellate cells (SSc) in
line with hepatic stellate cells and pancreatic stellate cells.
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3.2. CHARACTERISATION OF CELLULAR EVENTS
Survey of the pathological changes in the spleen at close time intervals following
MHV-68 infection of IFNyR"7" mice compared to 129 Sv/Ev mice revealed the
nature of sequential pathological changes taking place in the spleen during the
development and resolution of fibrosis. To delineate these sequential
histopathological changes, cellular characterisation was undertaken with reference
to different cell populations in the spleen. The different cell types present in the
spleen include B-lymphocytes, T-lymphocyte, follicular dendritic cells and
different subsets of macrophages. B-lymphocytes are the primary cells harbouring
latent MHV-68 in spleen (Sunil-Chandra et al., 1992b). T-lymphocytes constitute
between 5 - 25% of the cells present in the GC (Heinen, 2002) and they have an
important role in the regulation of MHV-68 infections (Ehtisham et al.,
1993;Doherty et al., 2001). Both CD4+ and CD8+ T-lymphocyte are important in
the pathogenesis of splenic fibrosis caused by MHV-68 in IFNyR" mice as their
depletion prior to and during the course of infection abrogates the pathogenesis
(Dutia et al., 1997). Macrophages play a central role in the pathogenesis of
fibrosis mainly through the alternate activation pathway (Wynn, 2004). The role
of macrophages in the pathogenesis of splenic fibrosis induced by MHV-68
infection of IFNyR"7" mice is not known. The current investigation was undertaken
to assess the contribution of these different cell populations to the pathogenesis.
Thus the profile and distribution pattern of B-lymphocytes, T-lymphocyte and
different subsets of macrophages in the spleen during the course of infection was
investigated using immunohistochemical techniques.
3.2.1. B-LYMPHOCYTES
CD45R/B220 staining was used to identify distribution patterns of B-lymphocytes
during the course of infection. Sections of spleen from experiments no. 1 and 2
were used in this study. As expected, B-lymphocytes were mainly seen in the
lymphoid follicles and marginal zone of the spleen (Figure 3.2.1). No difference
in the distribution pattern was observed between two groups of mice up to day 10
p.i. At day 12 p.i., in IFNyR_/" mice, in line with peak hyperplasia of the lymphoid
follicles and GC formation, a relative increase in the number of B-lymphocytes
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Figure.3.2.1. B-lymphocytes in the spleen of MHV-68 infected mice.
CD45R/B220 staining (See Materials and Methods).
Note the tightly packed CD45R/B220 positive B-lymphocytes (Reddish
brown colour) in the lymphoid follicles in both spleens at day 8 p.i. (A and
F). Expansion of B - lymphocytes with TBM (Arrows) are evident in both
groups of mice at day 12 p.i. (B and G), but is more intense in IFNyR"7"
mice. At day 16 p.i, in the IFNyR-/- spleen, the numbers of B lymphocytes
are reduced in number compared to 129 Sv/Ev spleens (C and H). Note the
shrunken lymphoid follicles with few B-lymphocytes in the spleen of
IFNyR"7" mice at day 20 p.i. (D and I). The re-appearance of B -
lymphocytes in large numbers in to the lymphoid follicles of IFNyR"7" spleen
was noticed at day 35 p.i. (E and J)











Figure. 3.2.1. Please see the legend on the facing page
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was noticed (Figure. 3.2.IB). From day 12 to day 20 p.i. the number of B-
lymphocytes showed a gradual decrease in the lymphoid follicles of IFNyR"'"
mice. At day 20 p.i. very few B-lymphocytes were present in the contracted
spleen (Figure. 3.2.ID). At day 30 p.i., the spleens of IFNyR"7" mice showed a
dramatic increase in the number of B-lymphocytes indicating the resolution phase
of the fibrotic response. The recovery state was pronounced at day 35 p.i. (Figure
3.2.IE). There was no difference in the distribution pattern in the spleen from day
30 to day 120 p.i. in IFNyR"7" mice. In 129 Sv/Ev mice, the spleens from day 12
to day 16 p.i. showed a gradual increase in the size of the lymphoid follicles with
more B-lymphocytes, as well as other features of the GC. From day 16 p.i.
onwards the spleens of 129 Sv/Ev mice showed a normal pattern of distribution of
B-lymphocytes up to day 120 p.i.
3.2.2. T- LYMPHOCYTES
Serial sections of the spleens from experiment no.l and 2 were used in this study.
T-lymphocytes were identified by CD3 staining and subsets of T-lymphocyte
were further characterised by CD4 and CD8 staining. T-lymphocytes are
normally seen around the blood vessels in periarteriolar lymphoid sheath (PALS)
(Figure. 3.2.2A and 3.2.2F). CD3+T-lymphocyte were detected in the GC
throughout the course of the experiment with their notable absence in the
lymphoid follicle area of the spleen from IFNyR"7" mice between day 16 and day
20 p.i. (Figure 3 -2.2C and 3.2.2D). From day 35 p.i. onwards T-lymphocyte were
mainly seen in the PALS area. Analysis of the sub- population of T-lymphocytes
among the infiltrating cells in the GC showed that they included both CD4+ and
CD8+ T-lymphocytes with increased numbers present in the spleens of IFNyR""
mice (Figure. 3.2.3).
3.2.3. SPLENIC MACROPHAGES
There are at least four different sub-populations of macrophages in the spleen
(Mebius and Kraal, 2005;Taylor et al., 2005): Red pulp macrophages (RPM),
Marginal zone macrophages (MZM), Marginal metallophils (MM) and TBM.
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Figure.3.2.2. T- lymphocytes in the spleen of MHV -68 infected mice.
CD3 staining (See Materials and Methods).
Note the presence of CD3+ T lymphocytes (Reddish brown colour) in the
PALS in both spleens at day 8 p.i. (A and F). At day 12 p.i presence of T
lymphocytes in the germinal centre area of the spleen is observed in both
groups of spleen (B and G). CD3 positive T lymphocytes were not seen in
the IFNyR"'" spleen at day 16 and 20 p.i. (C and D), whereas T lymphocytes
are seen in the 129 Sv/Ev spleen in the PALS and GC (H and I). At day 35
p.i. re-appearance of CD3 positive T lymphocytes in the IFNyR_/~ spleen in
the PALS (E) and in 129 Sv/Ev spleen T lymphocytes are seen in the PALS
and GC.
GC, Germinal Centre. LF, lymphoid follicles. PALS, Peri arteriolar













Figure. 3.2.2. Please see the legend on the facing page
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Figure. 3.2.3. T-lymphocyte subsets in the spleen of mice infected
with MHV -68 at day 12 post infection. A and B IFNyR -/-. C and
D 129 Sv/Ev. A and C CD4 positive lymphocytes. B and D CD8
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A schematic representation of the subsets of macrophages in the spleen is
presented in Figure.3.2.4.
3.2.3.1. RED PULP MACROPHAGES (RPM)
One of the major activities taking place in the splenic red pulp is the filtering and
removal of senescent red blood cells. This function is carried out by the RPM
lining the red pulp cords. RPM are strongly positive for macrophage specific
plasma membrane differentiation antigen F4/80 (Austyn and Gordon, 1981).
F4/80 antibody was used to study the profile of RPM in the spleen during the
course of MHV-68 infections. At day 8 p.i, the F4/80 positive cells were
distributed in the red pulp and in the sub-capsular locations. The morphological
features of the macrophages were not clearly visible at this stage in either group of
mice. They appeared as syncitium in the red pulp of the spleen (Figure.3.2.5A and
3.2.5F). The distribution pattern of RPM showed dramatic changes during day 12
- 16 p.i. in IFNyR"7" mice (Figure. 3.2.5B - 3.2.5C). On day 12 p.i., F4/80
positive cells were noticed in the white pulp lymphoid follicles. At this time point,
the morphological features of the macrophages were round and amoeboid in shape
suggesting an activation profile. At day 16 p.i an increased number of positive
cells in the white pulp area were observed. By day 18 and 20 p.i., there were only
a few positive cells in either red pulp or white pulp (Figure. 3.2.5D). By day 30
p.i. the F4/80 positive cells showed a dramatic return into the red pulp and sub¬
capsular locations, which were pronounced at day 35 p.i (Figure.3.2.5E). The
RPM remained in the red pulp with an activated phenotype throughout the course
of experiment until day 120 p.i. In 129 Sv/Ev mice, the RPM always remained in
the red pulp and never showed any activated phenotype (Figure 3.2.5F - 3.2.5J).
3.2.3.2. MARGINAL ZONE MACROPHAGES (MZM)
The area immediately surrounding lymphoid follicles and PALS, which demarcate
it from red pulp, is called the marginal zone (MZ) of the spleen. The MZ
structure is remarkably uniform with a fine reticular network supporting an evenly
distributed specific population of cells. MZM are large cells (15-20 pm) with
well-developed phagocytic activity and close contact between its cell processes
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Figure.3.2.4. Schematic representation of different resident
macrophage population in the spleen : RP: red pulp contain F4/80 +
red pulp macrophages (RPM), MZ: Marginal Zone contains ER-TR9
+ Marginal Zone Macrophages (MZM) in the outer zone of MZ and
MOMA -1+ Marginal Metallophils (MM) in the inner side of MZ.
The resident macrophages in the white pulp (WP) lymphoid follicles
are called Tingible Body macrophages (TBM)
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Figure.3.2.5. F4/80 positive red pulp macrophages in the spleen of MHV -
68 infected mice.
F4/80 staining (See Materials and Methods).
Note the presence of F4/80 positive macrophages (reddish brown colour) in
the red pulp of the spleen in both groups of spleen at day 8 p.i. (A and F).
Dramatic movement of activated macrophages are noticed into the germinal
centre area (GC) in IFNyR-/- mice at day 12 p.i. (B). At the same time,
macrophages were restricted to the red pulp in 129 Sv/Ev mice at all time
points (G, H, I and J). In IFNyR-/- mice, the number of F4/80 positive
macrophages increases at day 16 p.i (C) and then disappears at the time of
peak fibrosis at day 20 p.i. (D). The macrophages show a dramatic return to
the red pulp at day 35 p.i. (E)
GC, Germinal Centre. W, White pulp. R, Red pulp
For images A, E, F and J, magnification 10X. For images B, C, D, G, H and
I, magnification was 200X.
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Figure. 3.2.5. Please see the legend on the facing page
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and the surrounding marginal zone B (MZB) cells. MZM can selectively take up
neutral polysaccharides such as Ficoll (Humphrey and Grennan, 1981), which is
used as a distinguishing feature of these macrophages.
The ER-TR9 monoclonal antibody selectively identifies a specific group of
macrophages in the marginal zone of the spleen (Van et al., 1985). There has been
renewed interest in this sub-population of macrophages in recent years as it has
been shown that the antigen recognised by the ER-TR9 antibody is the same as
SIGNR1 which is the murine homologue of human dendritic cell specific ICAM -
3 grabbing non Integrin (DC - SIGN) (Geijtenbeek et al., 2002). DC - SIGN is a
C - type lectin that binds to an immunoglobulin super-family adhesion molecule,
ICAM -3/CD50 expressed specifically on a group of resting T cells (Geijtenbeek
et al., 2000b). DC - SIGN was found to bind HIV -1 envelope lipoprotein and
transmit the virus to T cells (Geijtenbeek et al., 2000a). This molecule is shown to
bind many pathogens including Ebola virus (Alvarez et al., 2002), human
cytomegalovirus (Halary et al., 2002), Leishmania major (Colmenares et al.,
2002) and Mycobacterium tuberculosis (Tailleux et al., 2003/
As detailed in the Materials and Methods section, ER-TR9 antibody was used to
assess the profile of MZM of spleen from experiment no.l and 2. MZM appeared
as clearly defined round active cells in the MZ. As with RPM, MZM also
appeared to increase in number and move into the GC area of the white pulp in
IFNyR" mice during day 12 and day 16 p.i. (Figure 3.2.6A and 3.2.6B). At day 20
p.i. there were only a few MZM in the spleen of IFNyR"" mice (Figure 3.2.6C). In
contrast, few ER-TR9 positive macrophages were found in the MZ of the spleen
of the 129 Sv/Ev mice at day 12 p.i. (Figure 3.2.6D). By day 16 p.i. and day 20
p.i. low numbers ofMZM were found in the lymphoid follicles in 129 Sv/Ev mice
(Figure 3.2.6E and 3.2.6F). At day 35 p.i. the MZM were mainly confined to the
marginal zone in both groups of mice.
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Figure. 3.2.6. Marginal zone macrophages in the spleen of mice
infected with MHV-68 at various time points - ER-TR9 staining.
Note the increase in the number and movement of ER-TR9 positive
marginal zone macropahges towards the germinal centre area in
IFNyR -/- ( A and B) wheareas, in wild type mice the MZM are
restricted to marginal zone.
Magnification 200X
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3.2.3.3. MARGINAL METALLOPHILS (MM)
MM are found in the inner side of the marginal zone with cell processes extending
into the white pulp. These macrophages are strongly positive for non-specific
esterase (Eikelenboom, 1978) and acid phosphatases, but negative for ER-TR9
and F4/80. These macrophages can take up latex particles and colloidal carbon
upon intravenous administration. The MOMA -1 monoclonal antibody (Kraal and
Janse, 1986) was used to detect MM in tissue sections in this study. The profile of
MM during the course of infection was similar to that of MZM. There was an
increase in the number of MM moving towards lymphoid follicles at day 12 and
day 16 p.i. infection in IFNyR"7" mice (Figure 3.2.7A and 3.2.7B). In contrast, in
129 Sv/Ev mice, the MM always remained in the marginal zone (Figure 3.2.7C
and 3.2.7D). At day 20 p.i, there were only a few MM seen around lymphoid
follicles in IFNyR"7" mice.
3.2.3.4. TINGIBLE BODY MACROPHAGES (TBM)
TBM are specialised phagocytic cells present in the GC of lymphoid organs. In
the GC, the B-lymphocytes that fail to recognise an antigen or only have low
affinity for the antigen are destined to undergo apoptosis and are swiftly removed
by TBM. TBM are positive for CD68 (Rabinowitz and Gordon, 1991) and milk
fat globule epidermal growth factor (EGF) factor 8 (MFG - E8) (Hanayama et al.,
2004). Absence of MFG-E8 on TBM renders them less efficient at engulfing
apoptotic B-cells in the GC.
The morphological features of TBM were used to asses the profile of TBM in this
study. TBM are large cells with vacuolated cytoplasm carrying numerous
apoptotic bodies which gives a 'starry sky' appearance to the secondary lymphoid
follicles (see the inset of figure 3.2.8). The number of TBM per 10 random GC
per section of spleen from experiment No. 1 was counted. The number of TBM
peaked at day 12 p.i in IFNyR"7" mice, whereas, the number peaked at day 16 p.i.
in 129 Sv/Ev mice in first experiment (Figure 3.2.8). However, the difference in
the number of TBM at both time points between IFNyRv" and 129 Sv/Ev mice was
not statistically significant (p=0.0809 at day 12 and 1.0 at day 16 p.i.).
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Figure. 3.2.7. Marginal metallophils in the spleen of mice infected
with MHV -68 at various time points - MOMA-1 staining.
Note the increase in the number and movement of marginal
metallophils towards the germinal centre area in sections A and B.
Magnification 200X.
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Figure.3.2.8. Tingible body macrophages in the spleen. Ten random
germinal centres from each spleen was chosen and the number of TBMs
were counted. Each bar represents the average number of TBM with
standard deviation for each group of mice at different time points. A
representative image of TBM is presented in the inset (arrow).
Magnification 400x
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3.2.4. SUMMARY
This study was concerned with the dynamics of cell populations in the spleen of
IFNyR_/" mice and 129 Sv/Ev mice following MHV-68 infection. The profile of B
- lymphocytes during the course of infection supported the observation made
during the histopathological examination. In the spleens from IFNyR_/" mice, the
B-lymphocyte showed a progressive reduction and only very few B-lymphocytes
were present in the lymphoid follicles at day 20 p.i, which was encircled by the
'fibrotic cage'. The recovery phase was characterised by re-population of
lymphoid follicles with increased numbers of B-lymphocytes.
The profile of T-lymphocytes identified by immunohistochemistry confirmed
their contribution to the development of the GC reaction in both groups of mice.
Both CD8 and CD4 positive T lymphocytes were present in the GC. The presence
of T-lymphocytes could be a response to latently infected B-lymphocytes. These
cells could act as a trigger for the development of fibrosis as seen by Dutia et al
(1997). In the absence of IFNy signalling, the immune response could be shifting
towards a Th2/Tc2 type of response. Further characterisation of infiltrating CD8
and CD4 positive T lymphocytes are required to identify the shift in the immune
response towards Th2/Tc2 type.
This part of the investigation revealed the activation profile of different subsets of
macrophages in the spleen during the course of infection in IFNyR" ~ mice prior to
the development of fibrosis. This is particularly important as this activation
profile is noticed in mice, which are not able to respond to IFNy, which is
considered as the most important classical activator of macrophages. It is possible
that the cytokines released by the infiltrating T-lymphocytes may be responsible
for the activation of macrophages and their movement towards the lymphoid
follicles carrying latently infected cells. This observation indicates the operation
of an alternate pathway of activation in this setting. This hypothesis was therefore
investigated in the next part of the study (section 3.3).
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The quantification of TBM showed no obvious difference between two groups of
mice. It is possible that the process of removal of apoptotic cells by phagocytic
cells contributes to the pathogenesis of fibrosis by releasing pro-fibrotic
cytokines like TGFp (Savill and Fadok, 2000). In this model, the TGFp released
during this process may be enough to drive the development of fibrosis in the
absence of anti-fibrotic effect of IFNy. In support of this hypothesis, an earlier
investigation on the cytokine profile in the spleen of IFNyR"7" mice infected with
MHV-68 has shown up-regulation of TGFp (Ebrahimi et al., 2001).
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3.3. ALTERNATE ACTIVATION OF MACROPHAGES
The observation of an activated phenotype and change in the distribution pattern
of different subsets of macrophages towards GC in the spleen following MHV-68
infection in IFNyR~/_ mice compared to 129Sv/Ev mice suggested a contributory
role of these cells in the pathogenesis of fibrosis. This was particularly important,
as the mice in which we see these changes are not able to respond to IFNy, the
classical macrophage activator, due to their inherent deficiency of the receptor.
This prompted an investigation into the alternate activation of macrophages. The
well characterised marker molecule for alternatively activated macrophage is
arginase-I (Gordon, 2003). L - arginine can be metabolised by three different
enzymes namely, inducible nitric oxide synthase (iNOS), arginase-I and arginase-
II. In macrophages, L - arginine is metabolised by iNOS to produce citrulline and
nitric oxide, which is one of the principal cytotoxic mechanisms of these cells
(Hibbs, Jr. et al., 1987). Alternatively, arginase-I and arginase-II metabolise L -
arginine to L - ornithine and urea. L - ornithine can be further metabolised to
proline or polyamines. Polyamines aid cellular proliferation and proline is an
important amino acid required for collagen synthesis. We investigated the role of
arginase-I in this scenario by three different methodologies namely, reverse
transcriptase - polymerase chain reaction (RT - PCR), Quantitative RT - PCR
(QRT-PCR) and immunohistochemistry.
3.3.1. REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
(RT-PCR)
RT- PCR studies showed the up-regulation of arginase-1 in IFNyR_/" mice infected
with MHV-68 in a time dependent manner (Figure 3.3.1). In IFNyR"" mice,
arginase-I transcripts were detected reproducibly from day 12, 16 and 20. The
bands became faint from day 35 p.i onwards. Faint bands were visible in few mice
of the 129 Sv/Ev group at different time points indicating that arginase -1 may be
expressed at a reduced level in 129 Sv/Ev mice infected with MHV-68.
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Figure.3.3.1. Reverse Transcriptase - Polymerase chain reaction (RT-
PCR) for Arginase - 1 from RNA samples extracted from spleens of
mice infected with MHV-68. RNA was extracted from spleens of three
mice each at day 0 (lane 1,2,3), day 8 (Lane 4,5,6), day 12 (Lane
7,8,9), day 16 (lane 10, 11, 12), day 20 (Lane 13, 14, 15) and day 35
(Lane 16, 17, 18). Top panel , PCR for p actin gene to confirm
removal of DNA from the RNA samples after DNase treatment.
Middle panel, RT - PCR for p actin gene after cDNA synthesis to
confirm transcription efficiency of RNA. Bottom panel, RT-PCR for
arginase - I gene. L, DNA ladder. PC, positive control. NC, Negative
control
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3.3.2. QUANTITATIVE RT- PCR (QRT-PCR)
To quantify the level of expression of arginase-I in IFNyR"7" mice in comparison to
129 Sv/Ev mice following MHV-68 infection at different time points, QRT-PCR
analysis was carried out on RNA samples isolated from the spleen of mice
infected with MHV-68. The relative copy number of gene for arginase-I was
negligible or below the level of detection in 129 Sv/Ev mice at all time points
whereas the copy number of arginase-I in IFNyR_/" mice showed a progressive
increase in copy number from day 8 p.i. to day 16 p.i and then it declined at
subsequent time points. The fold change in the level of arginase-I is presented in
Figure. 3.3.2.
3.3.3. IMMUNOHISTOCHEMISTRY
The antibody against arginase-I used in this study was raised in a rabbit against
recombinant human arginase- I. This antibody cross-reacts with rat and mouse
arginase-I (Endo et al., 2003) and was a kind gift from Dr. Tomomi Gotoh of
Kumamoto University, Japan. Staining of sections of spleen for arginase-I
showed cells expressing arginase-I in the spleen at day 12, 16 and 20 p.i from
IFNyR~~ mice. A representative image of the sections of spleen taken at day 12 p.i
and stained with arginase-I antibody is presented in Figure. 3.3.3. Arginase-I
positive cells were noticed in the light area of GC. None of the sections of the
spleen from MHV-68 infected 129 Sv/Ev mice or IFNyR"7* mice harvested at day
8 and day 35 p.i showed arginase-I positive cells.
3.3.4. SUMMARY
This study indicated a positive contribution of macrophages in the pathogenesis of
fibrosis through their alternate activation pathway characterised by arginase-I
expression. The concept of an alternative pathway of macrophage activation by
the Th2 type cytokines such as IL-4 and IL-13 has gained credence in the past
decade to account for a distinctive macrophage phenotype that is consistent with
their role in tissue repair. It is reasonable to assume that in the absence of
signalling towards a Thl response, the immune response following MHV-68
infections may skew towards Th2 type characterised by IL- 4 and IL-13
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Figure.3.3.2. Quantitative Reverse Transcriptase - Polymerase chain
reaction (Q-RTPCR) for arginase - I gene from RNA samples
extracted from spleens of mice infected with MHV -68.
RNA was extracted from spleens of three mice each at day 0, day 8,
day 12, day 16 , day 20 and day 35 from IFNyR-/- and 129 Sv/Ev mice
infected with MHV-68. p actin gene expression was used to normalise
the data. Purified PCR product generated with the outer set of primers
for arginase-I and p actin gene was used to generate the standard curve.
The level of arginase -I gene expression normalised with p actin gene
is expressed as fold change (average three values at each time point) in
relation to level of gene expression at day 0 post infection.
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Figure.3.3.3. Arginase - I positive cells in the spleen of MHV-68
infected mice at day 12 p.i. Arginase -1 antibody staining
Arginase -1 staining. A= IFNyR-/-; B= 129/Sv/Ev.
Note the presence of Arginase -1 positive cells in the germinal centre
of IFNyR-/- mice. Arginase -1 positive cells are absent in the spleen of
129 Sv/Ev mice. GC, germinal centre
Magnification 200X
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expression. Interestingly, earlier studies on infection of IFNyR"/_ mice and IFNy""
mice with MHV-68 infections have not shown such a switch towards Th2
response (Sarawar et al., 1997;Ebrahimi et al., 2001). In view of the expanding
knowledge on the cytokine, chemokine and chemokine receptor homologues
encoded by herpesviruses, (Alcami, 2003) it is possible that, a hitherto
uncharacterised gene of MHV - 68, as proposed recently (Dutia et al., 2004) may
be selectively secreting a molecule to directly activate macrophages. However, a
recent study reported that following intranasal infection of IFNyR" " mice with
MHV-68 produced high levels of IL-4, IL-5 and IL-10 in the lung (Mora et al.,
2005). It will be useful to assess the cytokine profile in the IFNyR"" mice
following MHV-68 infections with more sensitive techniques to establish the role
of Th2 cytokines in pathogenesis.
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3.4. BONE MARROW CHIMERA EXPERIMENTS
The role of IFNy responsiveness of bone marrow derived cells (BMDC) in the
pathogenesis of splenic fibrosis was investigated. The approach taken to address
this hypothesis was through generation of bone marrow chimera mice (in 129
Sv/Ev background and IFNyR"7" background) and their infection with MHV-68.
The procedure adopted for generation of chimera mice is presented in Materials
and Methods (section 2.9.1.)
3.4.1. ASSESSMENT OF BONE MARROW CHIMERA FORMATION
The success of bone marrow chimera formation was assessed by PCR on DNA
extracted from blood of chimera mice. The IFNy receptor knock out mouse was
generated by inserting a blunted Xhol-Sall fragment of pMClneopA (Stratagene)
(1146bp) into blunted Aat II site on exon V of IFNy receptor gene (Huang et al.,
1993). The primers used for PCR for assessing the success of chimera formation
were designed (Table 2.2) to span the insertion site of the neomycin cassette so
that the normal gene will provide a small product of 148 bp and the disrupted
gene would provide a large product (148 + 1146 = 1294bp).
The PCR for IFNy receptor gene from IFNyR"7" mice replaced with BMDC from
129 Sv/Ev mice (129Sv/EV=> IFNyR"7") showed that almost all of the BMDC
were from 129 Sv/Ev mice (Panel A of figure 3.4.1). Lane number 3, 4. 5 and 6
had few faint bands of 1294bp suggesting that few BMDC from IFNyR"7"
background are still present in the blood. Those bands may be due to epithelial
cell contamination at the time of blood collection. The gel picture of PCR
products for IFNyR gene from control gamma chimera (IFNyR"7" => IFNyR"7")
mice shows few non specific bands other than the bands for smaller products
(148bp) (Panel B of figure 3.4.1). Lane 2 had no PCR product. This may be
because of poor quality of template DNA or inhibitors of PCR in the DNA
sample.
The generation of bone marrow chimera mice on the 129 Sv/Ev background
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Figure.3.4.1. Polymerase chain reaction (PCR) for IFNyR gene from
DNA samples extracted from blood of bone marrow chimera mice in
the IFNyR -/- background .
Panel A, IFNyR -/- mice with replaced bone marrow cells from 129
Sv/Ev mice. Panel B, IFNyR -/- mice with replaced bone marrow
cells from IFNyR -/- mice as control
L, DNA ladder. NC, Negative control , Each lane represent
individual mice
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Figure.3.4.2. Polymerase chain reaction (PCR) for IFNyR gene from DNA
samples extracted from blood of bone marrow chimera mice in the 129
Sv/Ev background .
Panel A, 129 Sv/Ev mice with replaced bone marrow cells from IFNyR -/-
mice. Panel B, 129 Sv/Ev mice with replaced bone marrow cells from 129
Sv/Ev mice as control
L, DNA ladder. NC, Negative control , Each lane represent individual
mice
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detected for the small PCR products in the blood of 129 Sv/Ev mice with BMDC
from IFNyR"7" mice (IFNyR"7" => 129 Sv/EV). However, the dominant genotype
detected was BMDC in the IFNyR"7" background (Panel A of Figure.3.4.2). The
control wild type chimera mice (129 Sv/Ev => 129 Sv/Ev mice) showed PCR
products of expected size (148bp) from all animals (Panel B of Figure 3.4.2).
3.4.2. PATHOLOGICAL CHANGES IN CHIMERA MICE IN 129 Sv/Ev
BACKGROUND (IFNyR"7" => 129 Sv/Ev)
At the time of infection, another set of age and sex matched 129 Sv/Ev mice were
recruited into the study. All three groups of mice (129 Sv/Ev, 129Sv/Ev => 129
Sv/Ev and IFNyR"7" => 129 Sv/Ev) were infected intranasally with 4X105 PFU of
MHV-68 in 40pl of sterile saline as described in Materials and Methods section
2.4.
Three mice each from three groups were sacrificed on day 12, 16, 20 and 35.
There was no difference in the gross and histopathological features of spleen
between three groups of mice at all four time points. The weight of spleen
expressed as percentage of body weight is presented in Figure 3.4.3. The
difference in weight of spleen expressed as a percentage of body weight between
three groups of mice [129 Sv/Ev mice, IFNyR"7" =>129 Sv/Ev, and 129 Sv/Ev
=>129 Sv/Ev] at all four time points was not statistically significant.
Histopathological examination also confirmed the absence of any differences in
the structure of spleen between three groups of mice infected with MHV-68. All
the spleen showed immune responsiveness in the form of GC reaction with TBM
and behaved like the spleens from experiment no.l and 2.
3.4.3. PATHOLOGICAL CHANGES IN CHIMERA MICE IN IFNyR"7"
BACKGROUND (129 Sv/Ev => IFNyR"7")
As with chimera mice in the 129 Sv/Ev background, control chimera mice were

















































Figure. 3.4.3. Weight of spleen expressed as percentage of body
weight from bone marrow chimera experiment in the 129 Sv/Ev
background. Mice were intranasally infected with 4x 105 PFU of
MHV -68. Panel A, Day 12 P.I. Panel B, Day 16 P.I. Panel C, Day 20
P.I. Panel D, Day 35 P.I. WG, 129 Sv/Ev mice replaced with bone
marrow cells from IFNyR -/- mice. WW, 129 Sv/Ev mice with bone
marrow cells from 129 Sv/Ev mice (Control). WO, 129 Sv/Ev mice
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infection, a group of age and sex matched IFNyR"" and 129 Sv/Ev mice were
recruited in to the study. There were four groups of mice in this experiment [129
Sv/Ev mice, IFNyR"7" mice, 129Sv/Ev => IFNyR"7" and IFNyR"7" => IFNyR"7"]. The
mice were infected intranasally with 4X 103 PFU of MHV - 68 in 40pl of sterile
saline as described in Materials and Methods section 2.4. The time points in this
experiment were day 12, 16, 20 and 35 and three mice each were sacrificed on the
stipulated time points and pathological changes in the spleen was investigated.
The weights of spleen expressed as percentage of body weight was not
statistically significantly between four groups of mice at all time points (Figure
3.4.4). However, the size, colour and appearance of the spleen from gamma
chimera mice (129Sv/Ev => IFNyR"7") appeared similar to the spleens of 129
Sv/Ev groups of mice rather than the spleen of IFNyR"7" mice at day 12, 16 and
more specifically at day 20 p.i. (Figure 3.4.5). At day 35 p.i. the spleens from
gamma chimera mice (129Sv/Ev => IFNyR"7") appeared smaller in size like the
spleens of control gamma chimera (IFNyR"7" => IFNyR"7") and IFNyR"7" mice.
Histopathologically, the spleen from gamma chimera mice (129Sv/Ev => IFNyR"7"
) at day 12 p.i and day 16 p.i. appeared similar to the spleens of 129 Sv/Ev mice.
The features included early GC reaction at day 12 p.i. which progressed to
expansion of white pulp lymphoid follicles with extensive GC reaction at day 16
p.i. (Figure 3.4.6C, D, G and H). The histopathological features of spleens from
control chimera mice (IFNyR"7" => IFNyR"7" mice) and IFNyR"7" mice appeared
similar. The GC reaction was more intense at day 12 p.i and invasion of white
pulp lymphoid follicles with macrophages were evident at day 16 p.i. (Figure
3.4.6A, B, E, and F).
Even though the gross appearance of the spleen from gamma chimera mice
(129Sv/Ev => IFNyR"7") at day 20 p.i. looked similar to the spleen of 129 Sv/Ev
mice, a distinct histopathological feature was noticed in the spleen of gamma
chimera mice. The red pulp of the spleen was intact with erythrocytes and splenic
cords. However, depletion of small lymphocytes in the lymphoid follicles was









Figure. 3.4.4. Weight of spleen expressed as percentage of body
weight from bone marrow chimera experiment in the IFNyR-/-
background. Mice were intranasally infected with 4X 105 PFU of
MHV -68. Panel A, Day 12 P.I. Panel B, Day 16 P.I. Panel C, Day 20
P.I. Panel D, Day 35 P.I. G, IFNyR -/- mice. GG, IFNyR -/- mice
replaced with bone marrow cells from IFNyR -/- mice (Control) GW,







Figure. 3.4.5. Gross pathology of spleen from bone marrow chimera
experiment in the IFNyR-/- background at day 20 p.i,. G, IFNyR -/-
mice. GG, IFNyR -/- mice replaced with bone marrow cells from
IFNyR -/- mice (Control) GW, IFNyR -/- mice with bone marrow
cells from 129 Sv/Ev mice W, 129 Sv/Ev mice. Note the difference in
the colour and size of the spleen primarily between the group 'G'
and'GW'. Bar = lcm
W
'..ijj l .i ; i : i.-
154
Figure.3.4.6. Histopathological changes in the spleen of MHV-68 infected
mice in the bone marrow chimera experiment (129 Sv/Ev => IFNyR-/-) -
Day 12 and Day 16 p.i.
Haematoxylin and Eosin staining.
The spleens of control chimera (IFNyR-/- => IFNyR-/-) (B) showed features
of active TBM reaction like that of IFNyR-/- mice (A) at day 12 p.i. The
TBM reaction was less intense in gamma chimera (129 Sv/Ev => IFNyR-/-)
and 129 Sv/Ev mice at this time point (C and D). At day 16 p.i. the
lymphoid follicle area was occupied by macrophage like cells in control
chimera (IFNyR-/- => IFNyR-/-) and IFNyR-/- mice (E and F). In 129 Sv/Ev
mice and gamma chimera mice (129 Sv/Ev => IFNyR-/-) the TBM reaction
was more intense than seen at day 12 p.i (G and H). In summary, control
chimera (IFNyR-/- => IFNyR-/-) and IFNyR-/- mice behaved similar and
gamma chimera (129 Sv/Ev => IFNyR-/-) and 129 Sv/Ev mice behaved
similar at both time points (day 12 and day 16 p.i.).
Magnification 200X.
155
IFNyR-/- DAY 12 129 Sv/Ev
a i*HHF c
GC
IFNyR -/- -> I FNyR -/- 129 Sv/Ev -> IFNyR -/-
IFNyR-/- DAY 16 129 Sv/Ev
hhhhhl g
GC
IFNyR -/- IFNyR -/- 129 Sv/Ev —»• IFNyR -/
GC
Figure. 3.4.6. Please see the facing page for legend
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fibroblastic morphology. A pinkish red amorphous material encircled such
disfigured lymphoid follicles (Figure 3.4.7D). At day 20 p.i, the spleens of
IFNyR"7" mice and control chimera mice (IFNyR"7" => IFNyR"7") showed features of
splenic fibrosis as described in earlier experiments. At day 35 p.i., the spleens of
gamma chimera mice (129Sv/Ev => IFNyR"7") showed features of recovery with
more mature lymphocytes in the lymphoid follicles. Hemosiderin laden
macrophages were noticed in the red pulp. Similar changes were noticed in
IFNyR"7" mice as well as control chimera mice (IFNyR"7" => IFNyR"7"). The spleen
from 129 Sv/Ev mice showed mild GC reaction with very few TBM.
Further characterisation of the histopathological change observed in the spleen of
gamma chimera mice (129Sv/Ev => IFNyR"7") was investigated by histochemical
techniques including Masson's trichrome (MT) and Martius yellow-brilliant
crystal scarlet-soluble blue (MSB). The MT technique showed that the dark
pinkish amorphous material seen around the lymphoid follicles was not collagen
(Figure 3.4.8D). The MSB technique confirmed the observation and showed that
the pinkish amorphous material was fibrin (Figure 3.4.8E). This shows that
replacing the BMDC in IFNyR"7" mice with BMDC from 129 Sv/Ev mice
prevented the development of splenic fibrosis following MHV-68 infection.
However, it appears that the mechanism by which gamma chimera mice
(129Sv/Ev => IFNyR"7") control the development of fibrosis is not exactly similar
to the mechanisms operating in wild type mice. Detailed cellular and virological
characterisation of sequential events is required to delineate the underlying
mechanism.
3.4.4. SUMMARY
The bone marrow chimera mice experiments further confirmed the contributory
role of IFNy responsiveness of bone marrow derived cells in the pathogenesis of
splenic fibrosis. It was more evident in bone marrow chimera mice in the IFNyR"7"
background (129Sv/Ev => IFNyR"7"). Replacing the BMDC in IFNyR"7" mice with
BMDC from wild type mice prevented the development of fibrosis in the spleen.
The histopathological features of the spleen at day 20 p.i. from gamma chimera
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Figure.3.4.7. Histopathological changes in the spleen of MHV-68 infected
mice in the bone marrow chimera experiment (129 Sv/Ev => IFNyR-/-) -
Day 20 and Day 35 p.i.
Haematoxylin and Eosin staining.
The spleens of IFNyR-/- mice (A) and control chimera mice (IFNyR-/- =>
IFNyR-/-) (B) showed features of splenic fibrosis and shrunken lymphoid
follicles at day 20 p.i. The gamma chimera mice (129 Sv/Ev => IFNyR-/-)
showed normal red pulp as like 129 Sv/Ev mice at day 20 p.i (C and D).
However, the white pulp lymphoid follicles differed significantly with 129
Sv/Ev mice. The lymphoid follicles of gamma chimera mice showed
depleted number of lymphocytes which were replaced by macrophage like/
fibroblast like cells. Such disfigured lymphoid follicles were encircled by
dense dark pink amorphous material (arrow in 3.5.7D). At day 35 p.i. the
spleens from IFNyR-/- mice, control chimera (IFNyR-/- => IFNyR-/-) and
gamma chimera (129 Sv/Ev => IFNyR-/-) (E, F, and H) showed features of
recovery with mature lymphocytes in the lymphoid follicles. Hemosiderin
laden macrophages are also present in the red pulp (Brown pigmented
cells).The spleen from 129 Sv/Ev mice showed minimal TBM activity (G).
GC, Germinal Centre. R, Red pulp
Magnification 200X.
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Figure.3.4.8. Flistochemical characterisation of pathological changes in the
spleen of MHV-68 infected mice in the bone marrow chimera experiment
(129 Sv/Ev => IFNyR-/-) - Day 20.
Masson's Trichrome stain (Analine blue as the counter stain). A, IFNyR-/-
mice, B, control chimera (IFNyR-/- => IFNyR-/-) C, 129 Sv/Ev mice. D,
Gamma chimera - (129 Sv/Ev => IFNyR-/-).
The spleens of IFNyR-/- mice (A) and control chimera mice (B) showed
features of splenic fibrosis in the subcapsular and perifollicular locations.
The gamma chimera (129 Sv/Ev => IFNyR-/-) and 129 Sv.Ev mice did not
show positive for collagen except on few strands of trabeculae (C and D).
More interestingly, the amorphous pink substance noticed around
perifollicular area in H& E sections were not positive for collagen (arrow in
D).
The MSB technique confirmed that the amorphous pinkish material was
fibrin in nature (Arrow) (E)
Magnification 100X in images A, B C and D. In image E, magnification
200X
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IFNyR -/- 129 Sv/Ev
IFNyR -/- —> IFNyR -/- 129 Sv/Ev -»• IFNyR-/-
Figure. 3.4.8. Please see the facing page for legend
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mice (129Sv/Ev => IFNyR"7") indicated distinct mechanisms involving the
generation of a fibrin meshwork around the lymphoid follicles. Further sequential
cellular and virological characterisation is required to understand the exact
mechanism involved in this process. It is reasonable to argue that, if the
replacement of BMDC from wild type mice into IFNyR"7" mice could prevent the
development of splenic fibrosis, replacing the BMDC of wild type mice with bone
marrow from IFNyR"'" mice should make the wild type chimera mice (IFNyR"7"
=>129Sv/Ev) susceptible to the development of splenic fibrosis. However, the
wild type chimera mice (IFNyR"7"=>129Sv/Ev) behaved similar to any other wild
type mice irrespective of replacement of bone marrow. One of the reasons for
such a phenotype in wild type chimera mice (IFNyR" "=> 129Sv/Ev) would be the
partial success in the formation of chimera state as noticed in the PCR of DNA
from peripheral blood. In other words, it suggests that, inspite of replacing the
majority of BMDC in the 129 Sv/Ev mice with cells un-responsive to IFNy, the
remaining few cells with ability to respond to IFNy could prevent the
development of fibrosis in the spleen of wild type chimera mice (IFNyR"7"
=>129Sv/Ev). It will be interesting to pursue the mechanisms by which the limited
number IFNy responsive cells in the spleen of wild type chimera (IFNyR"7"
=>129Sv/Ev) mice manage to prevent the development of fibrosis in the spleen.
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3.5. ROLE OF PRODUCTIVE AND LATENT VIRUS INFECTION IN THE
PATHOGENESIS OF SPLENIC FIBROSIS
The biology of gammaherpesvirus infection in their natural host is not completely
understood. From the pathogenesis studies using MHV-68 infections in different
strains of mice, it has become apparent that, there are four distinct components of
gammaherpesvirus infection in their natural host: (a) acute infection (b) latent
infection (c) reactivation from latency and (d) persistent replication. The
relationship between these components of infection is not well defined, especially
the factors involved in the maintenance of latency and triggers responsible for
reactivation of virus.
The role of IFNy in the control of MHV-68 infection has been extensively studied
and it is generally accepted that IFNy has little role in the control of acute
infection in lung, even though the infected mice produce large quantities of IFNy
(Sarawar et al., 1996;Sarawar et al., 1997;Dutia et al., 1997). However, one study
reported that infection of IFNy"7" mice resulted in mortality of one third of infected
mice (Kulkarni et al., 1997). The CD4+ T- lymphocyte mediated control of
MHV-68 infection in B -lymphocyte deficient mice was shown to be mediated by
IFNy (Christensen et al., 1999). It has been shown that IFNy controls persistent
replication in peritoneal exudate cells (PEC) but not in splenocytes. In this
experiment involving intraperitoneal infection of IFNy"'" mice, ex-vivo
reactivation from latency was strikingly low in splenocytes compared to PEC
(Tibbetts et al., 2002). Recently, it has been shown that, control of acute and
latent MHV-68 infection mediated by CD4+ T lymphocytes require IFNy (Sparks-
Thissen et al., 2005).
The traditional techniques (Plaque assay) used for detection of acute lytic viral
infection involved mechanical disruption of cells most commonly by freezing and
thawing of organ homogenate, mixing it with a permissive monolayer of cells and
observing the development of plaques. Plaques are counted after four to five days
of incubation (Sunil-Chandra et al., 1992a). This technique could not detect low
level of preformed infectious virus during long term latent infection (Flano et al.,
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2000;Flano et al., 2002a; Week et al., 1996;Week et al., 1999b) except in the case
of an immunocompromised host where there is enhanced reactivation from
latency or persistent lytic virus replication (Cardin et al., 1996;Dal Canto et al.,
2001). Considerable improvement to this technique has been carried out recently
to enhance the sensitivity of the assay in the form of mechanical and enzymatic
digestion of tissue and mechanical disruption of isolated cells using beads. The
virus was then assayed in a one week plaque assay in 12 well plates. The
improved assay for lytic virus was able to detect low levels of infectious virus
(<100 PFU/tissue) in both spleen and lung during long term latent infection (Flano
et al., 1999).
Latency is usually assessed by an 'infectious centre' assay, which measures the
ability of viable latently infected cells to reactivate in vitro and form plaques on a
permissive monolayer (Sunil-Chandra et al., 1992b). Theoretically this technique
would detect preformed lytic virus as well. More sensitive limiting dilution assays
coupled with PCR for viral DNA in paired samples have shown that non
reactivatable latently infected cells are present in higher concentration in latently
infected tissues (Week et al., 1999a).
Immunohistochemical and in situ hybridisation techniques have the ability to
implicate the cell types harbouring the infection based on their distribution pattern
and morphology of the infected cell. In addition, the in situ hybridisation
technique will identify the actual number of latently infected cells rather than the
latently infected cells reactivating ex vivo in an in vitro system. In the present
study, immunohistochemistry and in situ hybridisation technique as detailed in the
Materials and Methods section 2.6 and 2.7 were carried out to assess the profile of
virus infection in spleen at close time intervals ranging from day 8 p.i. to day 120
p.i. Sections of spleen from experiment no.l and 2 were used for this purpose.
3.5.1. PRODUCTIVE INFECTION AND PATHOGENESIS OF FIBROSIS
The viral antigen positive cells detected by immunohistochemistry with a
polyclonal antibody raised against MHV-68 in rabbit were quantified from all
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mice from experiment no.l and 2. The distribution pattern of viral antigen
positive cells was predominant in the marginal zone of the spleen in both groups
of mice (Figure 3.5.1). The productively infected cells appeared to be large cells
with fairly large cytoplasm and centrally placed large nucleus. The staining was in
both nucleus and cytoplasm with intense colour reaction in the nucleus. There
were no viral antigen positive cells in both groups of mice at day 8 p.i. Viral
antigen positive cells were present at day 10 p.i in both groups of mice and from
then onwards the number of viral antigen positive cells showed the same trend
in both 129 Sv/Ev mice and IFNyR" " group of mice with peak of viral antigen
positive cells detected at day 14 p.i. However, the number of viral antigen positive
cells was higher in IFNyR"7" mice compared with 129 Sv/Ev groups of mice
(Figure 3.5.1). In addition, the IFNyR"7" mice never showed any viral antigen
positive cells in the spleen after day 20 post infection, whereas in 129 Sv/Ev mice
there were viral antigen positive cells at late time points (Day 30, 35, 40 and 45)
indicating reactivation of productive infection or low level of persistent infection
in the spleen. Interestingly the viral antigen positive cells were seen in the
marginal zone of the spleen during this phase of infection as well (Figure. 3.5.2).
3.5.2. LATENT INFECTION AND PATHOGENESIS OF FIBROSIS
A representative sample of spleen from both groups of mice at every time point
used in the first and second experiment was assessed for latent infection by in situ
hybridisation technique with a riboprobe specific for viral tRNA 1-4 of MHV-68.
All the latently infected cells were mainly found with in the centre of the
lymphoid follicles and the cells were small in size with limited cytoplasm
suggestive of lymphocytes. This preliminary analysis suggested significant
difference in the biology of latent infection in the spleens of IFNyR"7" mice and
129 Sv/Ev mice. There were no latently infected cells in the spleens of both
groups of mice at day 8 p.i. Latently infected cells were detected in both groups
of mice from day 10 p.i. In 129 Sv/Ev mice the latently infected cells were found
at relatively low levels at later time points. In contrast, in IFNyR"7" mice, higher
number of latently infected cells were observed from day 10 p.i. to day 20 p.i.
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Figure.3.5.1. Number of productively infected cells in the spleen
detected by immunohistochemistry using anti-rabbit MHV-68
polyclonal antibody. All the antigen positive cells were counted from
all the spleen sections (2-3 mice at each time point) and the average
count with standard deviation is presented in the bar diagram. On an
average two adjacent spleen sections were stained for viral antigen. A
representative section of spleen with viral antigen positive cells
(Brown colour) is presented in the top of the page. Objective
magnification - 400X
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Figure. 3.5.2. Virus antigen positive cells in the spleen of 129 Sv/Ev
mice detected by immunohistochemistry using anti - rabbit MHV -68
polyclonal antibody. Panel A, Day 30 P.I. Panel B, Day 35 P.I. Panel
C, Day 40 P.I. Panel D, Day 45 P.I. Positive cells are brown in





Figure. 3.5.3. In Situ Hybridisation with a riboprobe specific for MHV-68 vtRNA
1 -4 to detect latently virus infected cells in the spleen . Note the relative increase in
the number of latently infected cells in the spleen of IFNyR-/- mice at day 10 and
day 20 p.i. A significant reduction in the number of latently infected cells is noticed
at day 35 p.i. in IFNyR-/- mice
Magnification 100X
168
CHAPTERS CHARACTERISATION OF SPLENIC FIBROSIS
At day 20 p.i. there was marked fibrosis in the spleen along with shrinkage of
white pulp lymphoid follicles. Interestingly, there were few or no latently
infected cells in the spleen at later time points in IFNyR~/" mice. (Figure 3.5.3.)
These observations suggested that fibrosis, as a process was able to contain the
expansion of latently infected cells in the spleen. To confirm this hypothesis, an
additional experiment was conducted. A set of age and sex matched IFNyR_/~ mice
and 129 Sv/Ev mice were infected with MHV-68 as described in Materials and
Methods section 2.4. This experiment had close time intervals between day 18 p.i
and day 30 p.i. and at each time point three mice were used. For 129 Sv/Ev group
of mice time point 20 and 30 day p.i. was taken. All the sections of spleen from
this experiment were subjected to in situ hybridisation with riboprobe against
vtRNA 1-4. As shown in Figure 3.5.4. there was a progressive reduction in the
number of latently infected cells in the spleen of IFNyRv" mice from day 18 p.i. to
day 30 p.i. At day 18 p.i. all three mice carried latently infected cells in their
tightly packed lymphoid follicles and then showed a gradual reduction in the
number of lymphoid follicles infected with latent virus, as well as the total
number of latently infected cells. As seen in the preliminary experiment the
spleens collected at day 30. p.i. had no latently infected cells suggesting that there
was a absence of latently infected cells in the spleen by day 30 p.i. All the spleens
of 129 Sv/Ev mice at day 20 and 30 p.i. carried moderate numbers of latently
infected cells (figure 3.5.5). At least two adjacent sections of the spleen were
stained by the in situ hybridisation technique. The percentage of lymphoid
follicles carrying latently infected cells and total number of latently infected cells
from all the spleen sections were estimated by examination of stained sections
under a light microscope and the data is presented in table 3.5.1.
3.5.3. SUMMARY
The study for assessing the productive and latent infection in the spleen showed a
difference in the level of both forms of infection in the spleen between IFNyR"/"
mice and 129 Sv/Ev mice. The levels of productive infection in the lymphoid
organs are beyond the level of detection of conventional techniques and hence
data on the level of productive infection in the spleen in normal mice is scant.
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Table 3.5.1. Latent virus infection in the spleen determined by in situ
hybridisation technique
Day Animal Percentage of follicles Total number of latently infected cells
No latently infected with in the spleen section
MH V-68
IFNyR'
18 G1 100 864
G2 100 280
G3 100 637
22 G1 72.72 526
G2 42.85 20
G3 73.3 122
24 G1 50 9
G2 66.7 53
G3 76.47 229
26 G1 7.69 1
G2 0 0
G3 0 0
28 G1 0 0
G2 9.1 30
G3 0 0




20 W1 11.76 32
W2 68.96 120
W3 15 6
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Figure. 3.5.4. In Situ Hybridisation with a riboprobe specific for
MHV-68 vtRNA 1-4 to detect latently infected cells in the spleen of
IFNyR-/- mice infected with MHV-68. (day 18 p.i. to day 30 p.i.).
Three mice each in all time points. Note the gradual disappearance of






Figure. 3.5.5. In Situ Hybridisation with a riboprobe specific for
MHV-68 vtRNA 1-4 to detect latently infected cells in the spleen of
129 Sv/Ev mice infected with MH V-68. (day 20 p.i. and day 30
p.i.). Three mice each at both time points. Note the presence of
uniform number of latently infected cells in the spleen at day 20 p.i.
and day 30 p.i.
Magnification 200X
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Dutia et al (1997) investigated the level of productive infection in the spleen of
IFNyR"7" mice in comparison to 129 Sv/Ev mice following MHV-68 infection by
plaque assay and found no evidence of productive infection in 129 Sv/Ev mice at
any time point, whereas a low level of infectious virus (< 50 PFU/107 cells) was
noticed in IFNyR"7" mice. The present study employing immunohistochemistry
with a polyclonal antiserum showed productive infection in the spleen from day
10 p.i. The number of productively infected cells showed a similar pattern in both
groups of mice with a peak at day 14 p.i. A negligible number of productively
infected cells were detected at day 20 p.i. in both groups of mice. However, the
number of productively infected cells was invariably higher in IFNyR"7" mice.
The interesting feature of the profile of productive infection is the absence of any
productively infected cells in the spleen of IFNyR"7" mice after day 20 p.i. In
contrast, in 129 Sv/Ev mice there were a limited number of productively infected
cells at day 30, 35, 40 and 45 p.i. suggestive of low grade persistence of
productive infection or reactivation from a latent infection. The most interesting
feature of the productively infected cells during early times or later in infection is
their location within the spleen. At all times, the productively infected cells were
seen in the marginal zone of spleen and not in the GC. The earlier description of
the location of productively infected cells in the spleen of mice depleted of CD8+
T-lymphocyte prior to infection with MHV-68 was also at the marginal zone of
the spleen (Ehtisham et al., 1993).
The profile of latently infected cells showed dramatic differences between the two
groups of mice over the course of infection. There were no latently infected cells
detectable by the expression of viral tRNA like molecules in the spleen of both
groups of mice at day 8 p.i. From day 10 onwards, the number of latently infected
cells increased in number in both groups of mice, however the rate of expansion
was higher in IFNyR"7" mice compared to 129 Sv/Ev mice. The number of latently
infected cells reached a peak around day 18 - day 22 p.i, which is mirrored, by the
peak of fibrotic changes in the spleen. The exponential increase in the number of
latently infected cells showed a dramatic decline to negligible numbers at day 30
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p.i and subsequent time points. Interestingly, this decline in latently infected cells
is mirrored by the re-population of the spleen with new cell populations in their
respective locations. These observations suggest the following: 1) Fibrosis as a
host response mechanism is able to contain the expansion of latently infected cells
in the spleen. 2) Presence of latently infected cells in the spleen might be the
factor responsible for triggering the fibrosis development. 3) Loss of latently
infected cells in the spleen is the trigger for re-population of the spleen.
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3.6. DISCUSSION
The ability of the body to replace dead cells is a primary requirement for survival.
The response towards the loss of cells in tissues is broadly classified as
regeneration and fibrosis. Fibrosis is defined as the replacement of the normal
structural elements of the tissue by distorted, non-functional and excessive
accumulation of scar tissue (Diegelmann and Evans, 2004). The cascade of events
leading to the development of fibrosis include excessive tissue injury and cell
loss, infiltration of inflammatory cells, generation of growth factors, attraction and
proliferation of extra cellular matrix (ECM) producing cells, laying down and
organisation of ECM. The cellular response and micro-environment following
tissue injury and cell loss are also critical in the pathogenesis of fibrosis. It has
been recognised that the Th2 type of T-lymphocyte response and subsequent
alternate activation of macrophages are crucial in the genesis and maintenance of
a strong fibrotic response (Wynn, 2004)
The cellular, virological and molecular events taking place in the spleen during
the development and resolution of fibrosis described earlier is schematically
presented in figure 3.6.1. The observations made during the current investigation
on splenic fibrosis will be discussed around the following themes.
1. Cell loss as a trigger
2. The role of gamma interferon
3. Alternate activation of macrophages
4. The role of virus
3.6.1. CELL LOSS AS A TRIGGER FOR SPLENIC FIBROSIS
Earlier studies on splenic fibrosis following MHV-68 infection in IFNyR"/_ mice
reported that there were 10-100 fold fewer cells in the fibrotic spleen at the height
of fibrosis. The drop in cell numbers occurred in B-cell, CD4+ and CD8+ T-
lymphocyte populations (Dutia et al., 1997;Ebrahimi et al., 2001). Though all the
three subsets of lymphocytes showed a reduction, consideration of their relative
number in the spleen suggested that loss of B-lymphocytes would have
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Figure 3.6.1. The cellular, virological and molecular events involved in the
pathogenesis and resolution of splenic fibrosis in MHV-68 infected
IFNyR"'" mice.
Day 08 - The spleen does not show any obvious changes in the spleen. Note the
presence of different cell populations in their respective normal
locations (B-lymphocytes in lymphoid follicles, T-lymphocytes in
PALS , erythrocytes in the red pulp and macrophages mainly in the red
pulp and marginal zone )
Day 12 - The spleen shows significant changes in the architecture of spleen. Note the
presence of latently infected cells in the spleen along with invasion of
T-lymphocytes and alternatively activated macrophages. Productively
infected cells can be seen in the marginal zone of spleen.
Day 20 - The spleen shows 'fibrotic cage' formation around the shrunken lymphoid
follicles packed with latently infected cells.
Day 35 - The spleen shows recovery phase characterised by re-population of
lymphoid follicles with B-lymphocytes and absence of latently
infected cells. Re- appearance of other cell - populations in their
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more impact than other sets of lymphocytes. The survey of histopathological
changes and cellular characterisation in the spleen during the current investigation
identified key events, which are relevant to the development and resolution of
fibrosis in the spleen. One of the key observations was the sequential reduction in
the size of lymphoid follicles in the spleen and development of fibrosis centred on
the shrinking lymphoid follicles ('fibrotic cage'). Day 20 p.i. is the peak time
point where the highest level of fibrotic changes were seen coupled with shrunken
white pulp nodules. The majority of the cell population in the shrinking lymphoid
follicles are B-lymphocytes. From day 30 p.i. onwards the spleen gradually
regains its normal structure, which became clear as early as day 35 p.i. and
maintains this 'recovery' state until the last time point of the experiment. The
recovery phase is characterised by re-population of different subsets of cells in the
spleen and most profoundly, the B-lymphocytes in the lymphoid follicles. These
observations underline the fact that gradual depletion and subsequent re-
population of mainly B-lymphocytes is the primary event taking place during the
development and resolution of fibrosis respectively. Thus, one possibility is that
the sequential reduction in the number of B-lymphocytes in the spleen is the
primary trigger for the development of fibrosis.
3.6.2. THE ROLE OF GAMMA INTERFERON
Failure in the signalling of IFNy is absolutely central to the pathogenesis of
splenic fibrosis following MHV-68 infections. Splenic fibrosis is not observed in
mice with a normal IFNy signalling system. In the bone marrow chimera
experiments, replacing the BMDC in the IFNyR"7" mice with normal cells with
ability to respond to IFNy could prevent the development of fibrosis in the spleen
following MHV-68 infection. Even though the replacement of BMDC from wild
type mice into IFNyR"7" mice could prevent the development of splenic fibrosis,
replacing the BMDC of wild type mice with BMDC from IFNyR"" mice showed
no obvious effect following MHV-68 infection. The reason for such a phenotype
in wild type chimera mice (IFNyR"7" => 129 Sv/Ev) could be the partial success in
the formation of chimera state. In other words, presence of a comparatively lower
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number of BMDC with ability to respond to IFNy could prevent the development
of fibrosis.
In the light of above argument, the questions to be considered on the role of IFNy
in the pathogenesis, specifically for the initial trigger of cell loss include: 1)
whether the absence of IFNy signalling contributes to the actual increased cell
loss? Or 2) is absence of IFNy response contributing to prevent the signalling
required for the stimulation of haematopoietic stem cells (HSC) in the bone
marrow and subsequent transfer of cells to the spleen?
The number of productively infected cells detected by immunohistochemical
techniques was comparatively low to account for a massive cell loss. Moreover,
the location of productively infected cells in the spleen was mainly in the
marginal zone and the main area of cellular depletion was noticed in the lymphoid
follicles. The majority of latently infected cells are found in the lymphoid follicles
and latent infection is not known to cause cytolytic destruction of cells. In fact, the
strategy adopted by gammaherpesvirus during the establishment of latency is to
provide survival signals in the form of specific viral gene products to promote the
survival of infected cells. The IFNyR7" mice infected with MHV-68 show a
progressive increase in the number of latently infected cells during the
development of fibrosis. Thus, it appears that, either productive or latent virus
infection of the splenocytes as such is not responsible for enhanced cell loss
observed in IFNyR_/" mice following infection with MHV-68
IFNy is a cytokine with anti-fibrotic activity. The known mechanisms by which
IFNy acts as an anti-fibrotic cytokine is by interfering with the downstream
signalling of pro-fibrotic cytokines like TGFp and IL-13 (See figure 1.4). While
considering the role, if any of defective IFNy signalling contributing to the
increased cell loss in the lymphoid follicles, it is necessary to assess the type of
cell loss taking place in the lymphoid follicles responding to an antigen. The
lymphoid follicles respond to an invading antigen in the form of GC reaction.
The GC is a dynamic micro-environment where B-lymphocytes responding to
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adequate antigenic signals rapidly expand and differentiate through a pathway of
centroblasts and centrocytes to either plasma cells or memory B cells. T-
lymphocyte and follicular dendritic cells contribute immensely to sustain this
response. B-lymphocytes, which do not receive adequate signals in this micro-
environment, undergo cell death in the form of apoptosis. TBM, the resident
professional scavengers in the GC will quickly remove the apoptotic cells in this
environment (Guzman-Rojas et al., 2002). During the process of B-cell
transformation, somatic hyper- mutation of IgVn and isotype switching from IgM
to other isotypes take place. IFNy is involved in the process of immunoglobulin
isotype regulation (Snapper and Paul, 1987). IFNyR_/" mice immunised with live
attenuated pseudorabies virus produced highly reduced IgG2a type antibody
confirming the role of IFNy in isotype switching of immunoglobulin during
immune response (Huang et al., 1993). Reduced levels of IgG2a type antibody
was also reported in IFNyR"/_ mice immunised with type II collagen in a study to
determine the role of gamma interferon signalling in collagen induced arthritis
(Kageyama et al., 1998).
MHV-68 elicits virus-specific antibody, and non-specifically activates B-cells to
produce antibody through a CD4+ T-cell dependent process. The antibody
response is predominated by IgG2a and IgG2b isotypes (Sangster et al., 2000).
The influence of defective IFNy signalling on the level and type of antibody
response following MHV-68 infections was not investigated. Such an
investigation would clarify the role of IFNy in the stimulation of B-cells for
antibody production following MHV-68 infections. The possibilities with regard
to type of antibody response in the absence of IFNy signalling include reduced
IgG2 type antibody response and/or shifting of the antibody response towards
IgGl type characterised by Th2 type cytokine stimulation. If the antibody
response had shifted to similar levels of IgGl type, it can be assumed that the B-
cells are receiving sufficient stimulatory signals of a different kind required for
their survival. On the other hand, if the antibody response had not shifted towards
IgGl type and remained at a low level of the IgG2 type, this would suggest that
the population of B-cells not receiving adequate signals required for their
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transformation and survival would undergo apoptosis. This hypothetical scenario
would support a contributory role for the absence of IFNy signalling leading to
enhanced cell death in the spleen.
The level of apoptosis among splenocytes during the course of infection with
MHV-68 in IFNyR"" mice was investigated by the terminal deoxynucleotide
transferase-mediated dUTP nick end labelling (TUNEL) technique and concluded
that the tempo, level and location of TUNEL positive cells in the spleen was
similar in IFNyR"7" mice and wild type mice (Ebrahimi et al., 2001). This
observation suggests that splenic cell loss is not the result of increased cell death
through the apoptotic pathway. The current investigation also approached the
issue of increased cell death in the spleen during the development of fibrosis by
way of estimating the average number of TBM in the spleen and found that, there
was no obvious difference in the number of TBM in the spleen of IFNyR"7" mice
and 129 Sv/Ev infected mice. This observation supports the earlier conclusion
that increased cell death is not responsible for the cell loss in the spleen. However,
it should be noted that the techniques employed in the current investigation as
well as the TUNEL technique are not conclusive enough to estimate the level of
apoptosis in an in vivo system. The histological snapshots detected by TUNEL
staining and TBM counting techniques definitely give a flavour of apoptosis
taking place in a tissue. However, the kinetics of apoptotic cell death and their
phagocytic removal remains to be completely characterised in lymphoid organs
where routine apoptosis of non-responsive lymphocytes and their subsequent
removal are taking place. Based on the available evidence so far, it is possible to
conclude that, defective IFNy signalling is not contributing to enhanced splenic
cell death in mice infected with MHV-68.
Another issue to be considered is: whether the absence of IFNy signalling during
MHV-68 infection in the spleen is responsible for preventing the stimulation of
bone marrow haematopoietic stem cells (HSC) required for replacing the lost cells
in the spleen? This aspect was considered earlier by measuring the cellularity of
the femoral bone marrow during infection of IFNyR"7" mice with MHV-68 and
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concluded that bone marrow cellularity was comparable between wild type and
IFNyR"7" mice (Ebrahimi et al., 2001). This observation suggests that bone marrow
suppression is not a reason for splenic cell loss either. Viral infections responsible
for lymphopenia are known to cause bone marrow suppression as well. For
example, Human immunodeficiency virus (HIV) infection, which causes
progressive CD4+T-lymphocyte depletion in the peripheral circulation, also
causes bone marrow suppression responsible for chronic cytopenia and
progression to the acquired immune deficiency syndrome (AIDS). The bone
marrow suppression observed during HIV infection is due to infection of bone
marrow cells themselves, HIV suppressive proteins and altered cytokine milieu,
which shifts towards a Th2 type response [Reviewed in (Panoskaltsis and
Abboud, 1999)]. Even though, there was no difference observed in the bone
marrow cellularity between IFNyR"/_ mice and wild type mice infected with MHV
-68 infections (Ebrahimi et al., 2001), it would be worthwhile examining the
infection status of bone marrow cells during intranasal infection of mice with
MHV-68.
In spite of the lack of a difference in the cellularity of the bone marrow, profound
leukocytosis characterised by neutrophilia at day 10 p.i and lymphocytosis at day
14 p.i which peaked at day 23 p.i was reported during MHV-68 infection of
IFNyR~/_ mice (Ebrahimi et al., 2001). Furthermore, cross transfer studies with
peripheral blood leukocytes (PBL) taken from !FNyR /_ mice infected with MHV-
68 (at day 23 p.i.) showed that, PBL were unable to enter the spleen of infected
IFNyR" mice at the height of fibrosis indicating that a basic defect exists in the
trafficking of lymphocytes back in to the spleen. In contrast, PBL were able to
reach the spleen in IFNyR"'* mice prior to the development of fibrosis at day 10
p.i. The factors responsible for such a defective trafficking of lymphocytes into
the spleen needs to be identified. These factors could be viral gene products
under the strict regulatory control of IFNy.
In summary, the contributory role of defective IFNy signalling during MHV-68
infections for excessive cell loss as an initiator of fibrosis remains to be
182
CHAPTERS CHARACTERISATION OF SPLENIC FIBROSIS
delineated. The role of IFNy as an anti-fibrotic cytokine inhibiting the signalling
of pro- fibrotic cytokines like TGF-P and IL-13 also should be taken into
consideration.
3.6.3. ALTERNATE ACTIVATION OF MACROPHAGES
Infiltration of inflammatory cells is a characteristic feature of the pathogenesis of
fibrosis. In IFNyR"7" mice infected with MHV-68, the invasion of lymphoid
follicles with T-lymphocyte (both CD4+ and CD8+) and different subsets of
splenic macrophages was noticed from day 12 p.i. Depletion of T-lymphocytes
prior to and during the course of infection of IFNyR"7" mice with MHV-68
abrogated the development of fibrosis (Dutia et al., 1997). Several studies have
shown the role of the T-lymphocyte in the development of different forms of
pulmonary fibrosis. Intratracheal administration of bleomycin in rodents, a model
for IPF results in interstitial fibrosis accompanied by a significant infiltration of T
and B-lymphocytes (Zhu et al., 1996). In this model of IPF, it has been also
demonstrated that the depletion of lymphocytes inhibited the development of
fibrosis (Sharma et al., 1996).
The current investigation identified the activation profile of different subsets of
macrophages during the course of infection in IFNyR"7" mice prior to the
development of fibrosis. This observation indicates the operation of the alternate
pathway of activation of macrophages. This study confirmed the positive
contribution of macrophages in the pathogenesis of fibrosis through their alternate
activation pathway characterised by arginase-I expression. The concept of an
alternative pathway of macrophage activation by the Th2 type cytokines
[Interleukin - 4 (IL- 4) and IL - 13] has gained credence in the past decade to
account for a distinctive macrophage phenotype that is consistent with their role in
tissue repair. It is reasonable to assume that in the absence of signalling towards a
Thl response, the immune response following MHV-68 infections is skewed
towards a Th2 type response. However, earlier study on infection of IFNyR"7" mice
with MHV-68 did not show an obvious switch to a Th2 response (Ebrahimi et al.,
2001). In this context, it would be important to further characterise the T-
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lymphocytes identified (both CD4+ and CD8+) in the GC of the spleens from
IFNyR7" mice infected with MHV-68 to delineate their Thl/Tcl or Th2/Tc2
polarisation. It is highly likely that the different subsets of T-lymphocytes
observed in the GC of spleen are polarised towards Th2/Tc2 type. Interestingly, a
recent study identified transcripts of IL-13 in the spleen of IFNyR7" mice infected
with MHV-68 (Personal communication from Dr. B.Ebrahimi, University of
Liverpool, United Kingdom). In addition, a recent study reported that following
intranasal infection of IFNyR7" mice with MHV-68, high levels of IL-4, IL-5 and
IL-10 were produced in the lung (Mora et al., 2005).
Gammaherpesviruses are known to encode chemokine homologues capable of
driving Th2 type immune response [reviewed in (Alcami, 2003)]. It is possible
that, MHV-68 may be encoding gene products which may facilitate the attraction
of Th2 polarised lymphocytes into the GC. The conclusive evidence shown in this
study for arginase-I expression strongly indicates the shift of immune response
towards Th2 type. The up-regulation of arginase-1 in IFNyR7" mice following
MHV-68 infection has other roles than supporting the development of fibrosis.
Arginase-I up-regulation has been shown to protect against infection with HSV
and pseudorabies virus by depleting the source of arginine required for virus
replication (Mistry et al., 2001;Wang et al., 2005). The other contribution of
arginase-I is in the regulation of T-lymphocyte activation. It has been shown that
macrophages stimulated to produce arginase-I cause rapid depletion of
extracellular levels of arginine leading to diminished proliferation of T-
lymphocytes and decreased expression of CD3^. (Rodriguez et al., 2003). Thus it
could be argued that arginase-I up-regulation is a different type of host response
mechanism important in controlling the activation of T-lymphocyte and expansion
of viral load. The role of arginase-I expression in down regulating the CD3
expression on T-lymphocyte could explain our inability to detect CD3 positive
lymphocytes in the spleen of IFNy7" mice infected with MHV-68 at day 16 p.i and
day 20 p.i. A further possibility is that failure to detect CD3 positive lymphocytes
may be due to their absence in the GC during these time points.
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Tingible Body Macrophages
The quantification of TBM showed no obvious difference between two groups of
mice over the initial course of infection from day 8 to 20 p.i. The process of
removal of apoptotic cells by phagocytic cells can contribute to the pathogenesis
of fibrosis by releasing pro-fibrotic cytokines like TGFp (Savill and Fadok, 2000).
It would be possible to explain the development of fibrosis in spleen of the
IFNyR"" mice with the contribution from TGFp released through this process in
the absence of anti-fibrotic effect from IFNy.
The role of macrophages in this scenario is further complicated due to their latent
infection with MHV-68 (Flano et ah, 2000). Around 1/104 splenic macrophages
at 14 day p.i. with MHV-68 are infected with virus (Marques et ah, 2003).
Interestingly, infected macrophages showed a different profile of latent viral gene
transcription compared with B-lymphocytes. The transcripts of latency associated
genes like ORF73 was not detected in macrophages whereas, ORF 50 and ORF 6
transcripts were detected, which are lytic and reactivation associated. It was also
shown that, the ligand responsible for stimulating CD8+ T-cells which is
expressed in latently infected GC activated B-cells is not present in latently
infected macrophages (Flano et al., 2000). The infection status of macrophages in
mice deficient in IFNyR has not been determined. In the current study, the
productively infected cells were detected by immunohistochemical techniques in
the marginal zone of the spleen. The productively infected cells could be MZM,
MM or MZB-lymphocytes. These observations warrant further detailed study on
the role of macrophages to delineate their status of latent infection and activation
profile.
3.6.4. ROLE OF VIRUS
The profile of latently infected cells showed dramatic differences between two
groups of mice over the course of infection. The number of latently infected cells
reached a peak around day 18 to 22 p.i, which is mirrored by the peak of fibrotic
changes in the spleen. This exponential increase in the number of latently
infected cells shows a dramatic decline to negligible numbers at day 30 p.i and
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subsequent time points. Interestingly, this decline in latently infected cells is
mirrored by the re-population of spleen. This information suggests that the
presence of virus in the centre of the lesion maintains the fibrotic state and its
removal leads to recovery of fibrosis characterised by re-population of different
subsets of cells in the spleen especially the follicular area with B-lymphocytes.
This observation highlights a direct cause effect relationship of virus and
pathogenesis of fibrosis.
The aetiological role of virus in the pathogenesis was further confirmed by our
recent studies with mutant viruses (Appendix. 3). Four independent mutant
viruses with insertions and/or deletions in the left hand end of the MHV-68
genome failed to induce splenic fibrosis in spite of their ability to establish latency
in the spleen of IFNyR"7" mice (Dutia et al., 2004). The study utilised the following
MHV-68 mutant viruses: MHV-76, which lacks the Ml, M2, M3, M4 and tRNA
molecules in the left hand end of the viral genome (Macrae et al., 2001), VI virus
which has an insertion at viral tRNA3, V2 virus which lack Ml and vtRNA 1-4
(Simas et al., 1998) and LHAgfp virus, which has an insertion of gfp cassette in
place of nucleotide 1- 3223 at the left hand end of the genome . Interestingly,
though the mutant viruses were able to establish latency detected by infective
centre assay, they did not show an exponential increase in the number of latently
infected cells shown by wild type virus in IFNyR" mice. This suggests that the
mere presence of latent virus in the spleen is not sufficient to cause the fibrosis;
instead it is the number of latent cells that matter in fibrosis induction. More
interestingly, Northern analysis of RNA extracted from the viruses grown in an in
vitro system has identified two novel transcripts in the wild type virus with their
notable absence in mutant viruses (Dutia et al., 2004). Further characterisations of
these novel transcripts and their effect in an in vivo system will clarify their role in
the pathogenesis of splenic fibrosis.
In summary, this investigation has emphasised the positive contribution from the
virus, especially during the latent phase of infection in the pathogenesis of splenic
fibrosis in IFNyR"7" mice infected with MHV-68. The viral gene products could
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contribute at two points in the cascade of events leading to the development of
fibrosis. The first is at the level of preventing the re-population of lymphoid
follicles. Homing of B-lymphocytes into lymphoid follicles of spleen is regulated
by a well characterised chemokine system. The stromal tissues in the lymphoid
follicle, especially follicular dendritic cells (FDC) express B-lymphocyte
chemoattractant (BLC)/B-cell attracting chemokine-1 (BCA-1)/CXCL13 and B-
lymphocytes express its receptor, CXCR5. The interaction between CXCL13 and
CXCR5 is critically important in homing of B-lymphocytes into lymphoid
follicles (Legler et al., 1998;Ansel et al., 2000). It is possible that, intervention of
this chemokine network by antagonising either the chemokine or its receptor
would disrupt the chemokine gradient and prevent the re-population of lymphoid
follicles with B-lymphocytes.
MHV-68 encodes two gene products which could interfere with the chemokine
network. M3 gene is one of the MHV-68 specific genes, and its product is a well
characterised secretary protein with ability to bind a wide range of chemokines
(Parry et al., 2000;Van Berkel et al., 2000). Interestingly, M3 protein is capable of
binding to C, CC and CX3C chemokines but showed binding with limited or
lower affinity to CXC group of chemokines except human CXCL8. Considering
the lower affinity of M3 gene product to bind CXC chemokines, its ability to
interfere with the chemokine network responsible for the homing of B-
lymphocytes into lymphoid follicles is limited. However, it will be interesting to
extend the investigation on the binding ability of M3 to CXCL13 (BCA-1) to
explore its potential role in preventing the homing of B-lymphocytes into
lymphoid follicles. The MHV-GPCR encoded by ORF74 shows significant
homology (28%) with CXCR2, which binds to CXCL8. MHV-GPCR can bind
with 12? I labelled CXCL1 (Verzijl et al., 2004) and its ability to bind other
chemokines has not been investigated in detail. However, the related human
gammaherpesvirus, KSHV encoded GPCR (KSHV-GPCR), though constitutively
active (Arvanitakis et al., 1997) showed binding ability to a wide range of CXC
chemokines such as growth related oncogene-a (Gro-a/CXCLl), epithelial cell
derived neutrophil activating-78 (ENA-78/CXCL5), neutrophil activating peptide-
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2 (NAP-2/CXCL7) and stromal cell derived factor-1 (SDF-1/CXCL12)
[Reviewed in (Couty and Gershengorn, 2004)]. In addition, KSHV-GPCR can
bind to CC chemokines such as CCL1 and CCL5. Considering the capacity of
KSHV-GPCR to bind a wide range of chemokines, it appears highly likely that
MHV-GPCR may bind CXCL13 and disrupt the chemokine gradient required for
the homing of B-lymphocytes into the lymphoid follicles. MHV-GPCR is
expressed during the latent stage of in vivo infection in laboratory mice (Wakeling
et al., 2001) and the current investigation indicated that viral gene products
expressed during latency are likely to play a role in the pathogenesis of fibrosis.
Investigation into the antagonising ability of MHV- GPCR on murine CXCL13 is
required to prove this hypothesis.
The second area in which the viral gene products could influence the pathogenesis
of splenic fibrosis would be in driving the immune response towards a Th2 type
response. Macrophage inflammatory proteins (MIP) are highly related members
of chemokine family. KSHV encodes three MIP homologues (ORF K6 - vMIP-I
/vMIPla; ORF4-vMIP-II/vMIP -ip and ORF 4.1 - vMIP-III). One of the general
functional properties of MIP homologues is their ability to block Thl polarised
lymphocyte driven immune responses. vMIP-II selectively attracts Th2 polarised
lymphocytes expressing CCR3 (Sozzani et al., 1998). vMIP-I and vMIP-III bind
CCR8 and CCR4 respectively which are Th2 lymphocyte associated chemokine
receptors (Dairaghi et al., 1999;Endres et al., 1999;Stine et al., 2000).
Homologues of MIPs were not identified in MHV-68. However, there are unique
genes in the left hand end of the genome like Ml and M4 as well as other
uncharacterised transcripts (Dutia et al., 2004) for which a function is yet to be
defined. The current study identified the alternate pathway of activation of
splenic macrophages of IFNyR" " mice indicative of a Th2 polarised immune
response. It is possible that, MHV-68 encodes a protein similar to MIP
homologues encoded by KSHV, which might be responsible for attracting Th2
type cells into the splenic lymphoid follicles. Further characterisation of CD4+
and CD8+ lymphocytes observed in the splenic germinal centres are required to
identify their Thl/Th2 phenotype.
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In addition to delineating the cellular, virological and molecular mechanisms
involved in the pathogenesis and resolution of fibrosis in the spleen of MHV-68
infected IFNyR" " mice, the study also highlighted a significant observation with
regard to the host response towards latent gammaherpesvirus infection. The
fibrosis generated with significant contribution from alternatively activated
macrophages was able to contain the expansion of latently infected cells in the
spleen. This is a novel observation. Fibrosis as a host response mechanism is
known to occur against bacterial, fungal and parasitic pathogens specifically to
contain the expansion of pathogens. Such a response against latent
gammaherpesvirus infection has not been documented before. The molecular
mechanism by which the fibrotic response achieves this containment of expansion
of latent virus infection would be an interesting area for future study.
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CHAPTER FOUR: OTHER PATHOLOGICAL
CHANGES IN IFNyR ' MICE INFECTED WITH MHV-68
4.1. PATHOLOGICAL CHANGES IN THE LUNG
4.2. PATHOLOGICAL CHANGES IN THE LIVER
4.3 CHRONIC ARTERITIS
4.4. BONY METAPLASIA IN THE SPLEEN
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4. OTHER PATHOLOGICAL CHANGES IN IFNyR"'" MICE INFECTED
WITH MHV-68
In addition to causing fibrotic changes in spleen, intranasal infection of IFNyR"7"
mice with MHV-68 also causes other pathological changes in spleen, mediastinal
lymph node, lung, and liver. The documented pathological change other than
fibrosis in the spleen of IFNyR"'" mice infected with MHV-68 includes bony
metaplasia (Dutia et al., 1997). Resolving fibrotic changes in the mediastinal
lymph node, lung and liver was also reported following intranasal infection of
IFNyR"7" mice with MHV-68 (Ebrahimi et al., 2001). The primary feature of
IFNyR"7" mice infected with MHV-68 via the intraperitoneal route is chronic
arterits affecting the base of the aorta leading to significant mortality (Week et al.,
1997).
The current study investigated the pathological changes in the lung, liver, base of
the aorta and bony metaplasia in the spleen of IFNyR"7" mice intranasally infected
with MHV-68.
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4.1. PATHOLOGICAL CHANGES IN THE LUNG
The intranasal infection of MHV-68 in laboratory mice results in a productive
infection of the lung, the virus being associated mainly with alveolar epithelium
(Sunil-Chandra et al., 1992a). Long-term persistence/latency in the alveolar
epithelium has also been reported (Stewart et al., 1998b;Sunil-Chandra et al.,
1992a). The kinetics of a productive virus infection in the lung of IFNyR"7" mice
followed the same pattern as in wild type mice. Similar to 129 Sv/Ev mice, no
infectious virus was detected by plaque assay in the lung of IFNyR"" mice beyond
day 10 p.i. (Dutia et al., 1997). Interstitial fibrosis accompanied by pulmonary
phlebitis was reported in IFNyR"7" mice with severe pathological changes
occurring at day 14 p.i. and resolving by day 45 p.i. (Ebrahimi et al., 2001). More
recently, it was shown that IFNyR"7" mice on the C57BL/6 background intranasally
infected with MHV-68 developed progressive and multifocal pulmonary fibrosis.
The lung developed sub-pleural fibrosis by day 45 p.i that changed to interstitial
fibrosis by day 150 p.i. Thickening of the alveolar wall and pleura was much more
evident at day 180 p.i. There was no evidence of fibrosis in wild type mice
infected with MHV-68 and the fibrosis that developed in IFNyR"7" mice did not
show spontaneous resolution (Mora et al., 2005).
In the current study, the pathological changes in the lung of mice intranasally
infected with MHV-68 were evaluated from day 8 p.i to day 120 p.i (Experiment
No.l and 2 as described in Materials and Methods section 2.4). The investigation
focused on the extent of histopathological changes with reference to interstitial
fibrosis, characterisation of cellular infiltrates in the lung during the course of
infection and the level of productive virus infection determined by
immunohistochemical techniques using a polyclonal antibody against MHV-68.
4.1.1. HISTOPATHOLOGICAL CHANGES IN THE LUNG OF MICE
INFECTED WITH MHV-68
Multifocal to coalescing areas of interstitial pneumonia (IP) was observed at day 8
p.i in both groups of mice. The changes were more intense and extensive in






Figure.4.1.1. Histopathological changes in the lung of mice infected
with MHV-68
Haematoxylin and Eosin staining.
The focus of interstitial pneumonia (arrows) is more intense and
extensive in IFNyR-/- mice compared to 129 Sv/Ev mice at day 08 p.i.
On day 12 p.i. in IFNyR-/- mice in addition to the interstitial
pneumonia and foci of interstitial fibrosis, intense perivascular cuffing
of pulmonary blood vessels (BV) was noticed (C). In 129 Sv/Ev mice at
day 12 p.i., the lung is relatively clear with occassional foci of IP (D).
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The coalescing areas of IP were seen adjacent to the bronchial lumen suggestive
of bronchointerstitial pneumonia, which was more pronounced in IFNyR"7" mice.
The inflammatory cells in the interstitium contained mainly lymphocytes and
macrophages. Desquamated alveolar epithelium and inflammatory cells were also
seen in the alveolar lumen. By day 10 p.i., there were more macrophage/
mesenchymal type cells in the interstitium in both groups of mice.
The extent of IP was minimal from day 12 p.i onwards in 129 Sv/Ev groups of
mice and some had no lesions at all. The odd mouse at day 40 p.i., and day 50 p.i.
showed areas of type II pneumocyte hyperplasia and a mild degree of interstitial
fibrosis. Occasionally, a focus of alveolar adenoma was observed in 129 Sv/Ev
mice at day 120 p.i. The foci appeared as a circumscribed, unencapsulated mass.
The cells were arranged in tubular or acinar pattern and were relatively uniform in
size with round hyperchromatic nuclei and acidophilic cytoplasm. Mitotic figures
were rare.
Perivascular and peribronchiolar cuffing by inflammatory cells along with foci of
IP and interstitial fibrosis was the prominent feature in the lung of IFNyR"7" mice
at day 12 p.i (Figure. 4.1.1C and D). The infiltrating cells mainly consisted of
mononuclear cells and occasional focal collections of neutrophils. One of the mice
in IFNyR"7" group showed an area of necrosis of the bronchiolar epithelium
surrounded by inflammatory exudates and fibroblasts. Another focus had an area
of chronic abscess with necrotic mass in the centre encircled by fibroblast type
cells. The IFNyR"7" mice at day 14 and 16 p.i. showed focal areas of fibroblast
proliferation in the alveolar wall. In addition, at day 16 p.i. a few of the
pulmonary vessels showed trafficking of inflammatory cells mainly neutrophils
across the vessel wall suggestive of vasculitis. The perivascular and
peribronchiolar infiltration of inflammatory cells was present until day 20 p.i. and
showed resolution of these changes from day 30 p.i. onwards (Figure.4.1.2).
Occasional foci of IP, type II pneumocyte hyperplasia and alveolar fibrosis were
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Figure. 4.1.2. Vasculitis in the lungs of IFNyR-/- mice infected with
MHV-68
Haematoxylin and Eosin staining.
A, Day 12 p.i. B, Day 16 p.i. C, Day 30 p.i. Note the presence of
infiltrating inflammatory cells around the blood vessels. Crossing over of
the vessel wall with inflammatory cells is more prominent at day 16
p.i.(B) Clearing of perivascular lesion noticed from day 30 p.i. onwards
(C).
For image A, magnification 100X. For images B and C, magnification
200X
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4.1.2. CHARACTERISATION OF CELLULAR INFILTRATION IN THE
LUNG OF MICE INFECTED WITH MHV-68
All the lung sections of mice from experiment no.l and 2 were stained for F4/80
(macrophages), CD45R/B220 (B-lymphocytes) and CD3 (T-lymphocytes) as
described in Materials and Methods section 2.6. to characterise the cellular
changes taking place in the lungs during the course of infection.
The infiltrating cells mainly consisted of B and T-lymphocytes and macrophages
during early infection (Day 8 p.i. and Day 10 p.i) in IFNyR"" mice and T-
lymphocytes and macrophages in 129Sv/EV mice (Figure 4.1.3). The
macrophages were always found around the blood vessels. The number of
infiltrating B-lymphocytes and macrophages were negligible in 129 Sv/Ev mice
during the entire course of infection. The perivascular and peribronchial
infiltration phase of the infection in IFNyR"7" group of mice included mainly B and
T-lymphocytes with occasional macrophages (Figure.4.1.4).
4.1.3. DISTRIBUTION OF VIRUS INFECTED CELLS IN THE LUNG OF
MICE INFECTED WITH MHV-68
All sections of lung from both groups of mice from experiment No.l and 2 were
stained with polyclonal rabbit anti-MHV-68 antiserum. The level of virus-infected
cells were scored (0 to ++++, see table legend for details) and the data from
experiment no.l. is presented in table 4.1. The level of infection in the lung was
separately scored for the positivity of alveolar epithelial cells and infiltrating
mononuclear cells in the lung using the above scoring system.
In IFNyR"7" mice, viral antigen positive cells could be seen up to day 20 p.i.,
although there was a clear shift in the tropism of virus infection from alveolar
epithelial cells towards infiltrating mononuclear cells around the blood vessels
(Figure 4.1.5). In 129 Sv/Ev groups of mice, viral antigen positive cells were
mainly confined to alveolar epithelial cells and rarely found after day 10 p.i.
suggestive of clearing of the infection. In experiment No.2, viral antigen positive
cells were seen up to day 30 p.i. in IFNyR"7" mice but were not observed at later
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Table 4.1. Viral antigen positive cells/foci in the lung and incidence of
interstitial fibrosis - Experiment No.1.
Day Animal Number Alveolar Mononuclear Fibrosis
IFNyR-/-
8 GM1241 0 0
GF1249 ++++ +
10 GM 1242 +++ ++
GM1236 ++ +
GF1246 + +
12 GM1240 + +++ V
GM1234 + ++ V
GF1245 + ++ V
14 GM1238 ++ +++ S
GF1247 0 +++ V
16 GM1237 + ++ V
GF1243 0 ++ V
18 GM1239 0 +
GF1248 0 +
20 GM1235 0 +
GF1244 0 ++
129 Sv/1Ev
8 WM1257 ++++ +
WF1259 ++++ +
10 WM1258 0 0
WM1252 ++ 0
WF1260 ++ 0
12 WM1256 0 0
WM1253 0 0
WF1265 0 0
14 WM 1251 0 0
WF1263 0 0
16 WM1255 0 0
WF1262 0 0
18 WM1250 0 0
WF1264 0 0
20 WM1254 0 0
WF1261 0 0
0 = No positive cells, + Occasional positive cells, ++ Few positive cells/foci, +++
Large number of positive cells/foci, ++++ Very large number of positive cells/foci
GM - IFNyR7" male, GF - IFNyR"7" female,
WM- 129 Sv/Ev male, WF - 129 Sv/Ev female
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Figure. 4.1.3. Characterisation of cellular infiltrates in the lungs of
mice infected with MHV-68 at day 8 p.i.
A,B and C, IFNyR-/- mice D, E and F, 129 Sv/Ev mice. A and D,
CD45R/B220 staining . B and E, CD3 staining . C and F, F4/80
staining. BV, Blood vessel. Red colour in A,B, E and F indicate
positive staining (Vector novared). Brown colour in C indicate positive
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Figure.4.1.4. Characterisation of cellular infiltrates in
the lungs of IFNyR-/- mice infected with MHV-68 at
day 12 p.i.
A,CD45R/B220 staining. B, CD3 staining. BV,
Blood vessel. Note the infiltrating cells around the
blood vessels. Red colour indicate positive staining.
Magnification 200X
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Figure.4.1.5. Viral antigen positive cells in the lung of mice
infected with MHV-68
Immunohistochemistry with polyclonal antiserum against MHV
-68 raised in rabbit. A and C IFNyR-/- mice. B, 129 Sv/Ev mice.
A and B day 8 p.i. C, Day 12 p.i. Note the presence of
productively infected mononuclear cells (Brown colour) around
the blood vessels in IFNyR-/- mice at day 12 p.i. (C).
Magnification 200X
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time points, whereas in 129 Sv/Ev mice viral antigen positive cells were seen
among epithelial cells in one mouse at day 60 p.i., possibly indicative of
reactivation from a latent infection
The incidence of interstitial fibrosis was also tabulated along with the level of
viral antigen positive cells in the lung (Table No. 4.1.). It appeared that there was
a window of time p.i. (between day 12 p.i and day 16 p.i.), which correlated with
the infection of mononuclear cells in the lung and development of interstitial
fibrosis.
4.1.4. DISCUSSION
The pathological changes in the lung of IFNyR~/_ mice were more intense and
extensive than 129/Sv/Ev mice, especially around day 8 to day 10 p.i. In addition,
the lungs of IFNyR"/_ mice also showed distinct pathological features at day 12 p.i
such as degeneration and necrosis of bronchiolar epithelium, cuffing of blood
vessels and bronchial lumen by lymphocytes (both T and B-lymphocytes) and
multiple foci of interstitial fibrosis. Taken together, it appears that, the absence of
IFNy signalling is responsible for more severe as well as distinct pathological
changes in the lung in comparison to 129 Sv/Ev mice.
It has been previously reported that infection of IFNyR-/" mice with MHV-68
resulted in interstitial fibrosis accompanied by pulmonary phlebitis which peaked
at day 14 p.i and was resolved by day 45 p.i. (Ebrahimi et al., 2001). The current
observations agree with this report. A recent report showed that, intranasal
infection of IFNyR7" mice on the C57/B6 background developed chronic
unresolving fibrosis in the lung (Mora et al., 2005). The observations made in our
study do not support this observation. The identification of a window of time
correlating with the infection of mononuclear cells and development of interstitial
fibrosis is interesting. It may be possible that, infection of mononuclear cells with
MHV-68 causes the release of pro-fibrotic cytokines leading to the development
of fibrosis. The cell type infected during the mononuclear phase of infection needs
to be identified. A recent study showed that, in addition to type II alveolar
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epithelial cells, alveolar macrophages were also productively infected with MHV-
68 following intranasal infection (Mora et al., 2005).
An earlier study on the kinetics of viral titres in the lung of IFNyR"7" mice and
129/Sv/Ev mice showed no significant difference between the two groups of mice
with complete clearance of productive infection at day 10 p.i. (Dutia et al., 1997).
The current study with immunohistochemical techniques to investigate the profile
of productively infected cells also showed a similar trend at day 8 and day 10 p.i.
between the two groups of mice. However, in IFNyR"7" mice, the virus persisted up
to day 30 p.i. primarily among mononuclear cells seen around the pulmonary
blood vessels. It is surprising to note that, in spite of the difference in the extent of
pathological changes in the lung between two groups of mice, the level of
productively infected cells detected by immunohistochemistry in the current study
and virus load estimated by conventional plaque assay (Dutia et al., 1997) showed
little difference. It implies that, in spite of a similar level of virus replication in
both groups of mice, the pathological damage in the lung of mice is linked to a
failure in the IFNy response or biasing of the immune system towards a Th2 type
cytokine profile.
A distinct pathological change observed in the lung of IFNyR"A mice from day 12
p.i. onwards was a clear targeting of pulmonary blood vessels and bronchial tree
by T and B-lymphocytes and occasional collections of polymorphonuclear (PMN)
cells. Some of the neutrophils were seen crossing over the intimal layer of blood
vessels. These observations support the vascular tropism of the virus, which is
mainly expressed in the absence of IFNy signalling. The gammaherpesviruses are
known to have a tropism for vascular structures. A major microscopic pathology
of MCF, a disease caused by A1HV-1 or OvHV-2 in ruminants is characterised by
lymphoid proliferation and infiltration associated with necrotising vasculitis
(Liggitt and DeMartini, 1980).Considering the sporadic clinical outbreaks of this
condition in natural situations, it would be interesting to explore the contribution
of any defect in the IFNy responsiveness as a susceptibility factor for MCF.
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4.2. PATHOLOGICAL CHANGES IN THE LIVER
Per oral and/or intranasal infection of outbred laboratory mice of various age
groups (suckling to 21 days old) with MHV-68 resulted in recovery of virus from
liver at later times p.i. Occasional viral antigen positive parenchymatous and
Kupffer cells in the liver were detected by immunofluorescence studies
(Blaskovic et al., 1984;Rajcani et al., 1985). Infection of BALB/c mice through
the intranasal route did not result in hepatic infection; however infectious virus
could be recovered from the liver following intravenous infection with MHV-68
(Sunil-Chandra et al., 1992a).
The current study was undertaken to assess the pathological changes in the liver
during the course of infection from day 8 p.i. to day 120 p.i. with special emphasis
on histopathological changes, characterisation of cellular infiltrates and
distribution of virally infected cells detected by immunohistochemical and in situ
hybridisation techniques.
4.2.1. HISTOPATHOLOGICAL CHANGES IN THE LIVER OF MICE
INFECTED WITH MHV-68
Multifocal non-zonal mixed inflammation was the prominent histopathological
change in mice of both groups at day 8 and 10 p.i, although the intensity of the
response was greater in IFNyR"7" mice. In IFNyR" mice, from day 12 p.i. onwards
the mixed inflammatory reaction showed targeting to the portal area with
mononuclear and neutrophilic infiltration. The infiltrating cells were seen mainly
around the bile ducts. Proliferation of bile ducts around the major intrahepatic
and occasional extrahepatic bile ducts was noticed from around day 16 p.i. in
IFNyR"7" mice. Hyperplastic bile ducts were surrounded by inflammatory cells
composed of focal collection of neutrophils among the mononuclear cell
infiltrates. In IFNyR"7" mice, the bile duct hyperplasia around the major
intrahepatic bile ducts was a consistent feature from day 20 p.i. (Figure 4.2.1 A
and table no.4.2.1). Some of the proliferating bile ducts showed degenerative
changes and infiltration of inflammatory cells predominated by neutrophils.
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Table 4.2.1. Incidence of bile duct lesions in the liver






















1 8 0/2 0/2 0/2 0/2
2 10 0/3 0/3 0/3 0/3
3 12 0/3 0/3 0/3 0/3
4 14 0/2 0/2 0/2 0/2
5 16 1/2 0/2 0/2 0/2
6 18 2/2 0/2 0/2 0/2
7 20 2/2 0/2 0/2 0/2
Experiment Vo.2
1 12 0/3 0/3 0/3 0/3
2 20 2/3 0/3 0/3 0/3
3 30 1/4 0/4 0/3 0/3
4 35 5/5 0/5 0/3 0/3
5 40 4/4 0/4 1/4 1/4
6 45 1/3 0/3 0/3 0/3
7 50 3/3 1/3 1/3 1/3
8 60 3/3 1/3 0/3 0/3
9 80 3/3 1/3 0/3 0/3
10 120 5/5 2/5 1/4 1/4
Total 32/52 5/52 3/48 3/48
(61.5%) (9.61%) (6.25%) (6.25%)
'Onion Skin' type fibrosis around the necrotic bile ducts in the intrahepatic
location was also observed at later time points. Mononuclear cells encircled the
fibrotic foci. (Figure 4.2.IB and table 4.2.1.). Bile duct hyperplasia was
occasionally observed in some of the 129 Sv/Ev mice at later time points. One
mouse each at day 40 p.i., day 50 p.i and day 120 p.i. showed a focus of necrotic
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Haematoxylin and Eosin staining. A, Day 20 p.i. B, Day 50 p.i.
At day 20 p.i., the prominent feature is proliferation of intrahepatic bile
ducts (Arrow) and infiltration of inflammatory cells around them (hollow
arrow). At later time points some of the bile ducts undergo necrotic
changes (arrow) and encircling 'onion skin' type fibrosis was noticed . In
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4.2.2. CHARACTERISATION OF CELLULAR INFILTRATE IN THE
LIVER OF MICE INFECTED WITH MHV-68
The cellular infiltrates around the proliferating bile ducts of IFNyR" ~ mice were
characterised with special reference to B and T-lymphocytes and macrophages.
The results are shown in Figure 4.2.2. No specific chronological order was
observed in the appearance of different subsets of mononuclear cells into the
lesion. The observation of both B-lymphocytes and macrophages at this site is
interesting in the context of spread of infection. Both B-lymphocytes and
macrophages in the spleen are latently infected with MHV-68 (Sunil-Chandra et
al., 1992b;Flano et al., 2000). Infection status of these macrophages and B-
lymphocytes are required to clarify this point. The T-lymphocytes noticed at this
site also needs to be further characterised to identify their Thl/Th2 polarisation.
4.2.3 DISTRIBUTION OF PRODUCTIVELY AND LATENTLY
INFECTED CELLS IN THE LIVER OF MICE INFECTED WITH
MHV-68
All the liver sections of both groups of mice from experiment no. 1 and 2 were
stained with polyclonal antibody against MHV-68 raised in rabbits. Very few
positive cells were identified in the liver. The hepatocytes or cholangiocytes were
never found positive for viral antigen. The positive staining was observed among
the occasional mononuclear cells in the hepatic sinusoids and infiltrating cells in
the portal area (Figure. 4.2.3A). In situ hybridisation with riboprobe specific for
viral tRNA 1-4 to detect latently infected cells in the liver of IFNyR_/" mice from
experiment 1 and 2 was also carried out. The hepatocytes and cholangiocytes
were negative for latent virus infection. Occasional collections of latently
infected mononuclear cells were observed among the infiltrating cells around the
proliferating intrahepatic bile ducts (Figure. 4.2.3B)
4.2.4. DISCUSSION
The inflammation and fibrosis around the bile ducts seen in the IFNyR"" mice
infected with MHV-68 shows similarity to primary sclerosing cholangitis (PSC)
in human beings. PSC is a chronic cholestatic liver disease of unknown cause
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Figure. 4.2.2. Characterisation of cellular infiltrates around
the proliferating bile ducts of IFNyR-/- mice infected with
MHV-68 .
A representative sample of liver sections from mice at day 20
p.i. is presented. The infiltrating cells included B-
lymphocytes (A), T- lymphocytes (B) and macrophages (C).
For image A, magnification lOx. For image B and C,
magnification 200x
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Figure. 4.2.3. Presence of virus infected cells in the liver of IFNyR-/-
mice infected with MHV-68
A, Immunohistochemistry with anti rabbit anti-MHV-68 serum
showed occasional viral antigen positive cells (arrow) among the
mononuclear infiltrate around the bile duct (BD). The image obtained
from the liver of mice sacrificed at day 18 p.i. magnification 400X. B,
In situ hybridisation with a riboprobe against vt RNA 1-4 molecule of
MHV -68 showed latently viral infected mononuclear cells among the
infiltrating cells (Arrow). The images obtained from the liver of mice
sacrificed on day 20 p.i. magnification 100X
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characterised by ongoing inflammation, destruction and fibrosis of intrahepatic
and extrahepatic bile ducts [Reviewed in (Lee and Kaplan, 1995)]. Bile ducts are
the major targets in both acute and chronic hepatic graft versus host disease
(GVHD) and the histological features of intrahepatic bile ducts resemble that of
primary biliary cirrhosis (PBC) (Epstein et al., 1980). There is considerable
overlap between the clinical, biochemical and histological features of PBC and
PSC (Wiesner et al., 1992). GVHD is initiated by alloreactive donor T-cells
recognising major and/or minor histocompatability antigen of the host.
(Nonomura et al., 1998) proposed a mouse model of GVHD across minor
histocompatibility barriers, which characteristically exhibits bile duct histology
resembling PSC. They injected spleen and bone marrow cells (9:1) of congenic
B10.D2 mice into sublethally irradiated BALB/c mice and the histological
features of liver were studied for up to 14 months after transplantation. Both
intrahepatic and extrahepatic bile ducts were severely involved in the GVHD
process and showed histological features resembling PSC.
The immunohistochemical and in situ hybridisation studies to detect viral
infection in the liver showed very few numbers of cells positive for MHV-68. The
hepatocytes or cholangiocytes were never positive for viral antigen. The positive
cells were the mononuclear cells present in the sinusoids and portal area of liver.
This shows the absence of tropism for the main parenchymal cells of the liver for
MHV-68. In the absence of a direct correlation of infectious agent, the hepatic
lesions of mice from our study could also be the result of an immunopathological
mechanism. It is known that MHV-68 infection leads to the generation of an IM
like syndrome. The IM like disease initiated by MHV-68 is unique in the manner
of MHC haplotype independent expansion of CD8+ cells, the majority of which
utilise V|34 chains in the ap TCR. The ligand driving the VP4 expansion is
unknown (Hardy et al., 2000). Further characterisation of the cellular infiltrates
around the proliferating bile ducts are required to be carried out to clarify whether
the cellular infiltrates and CD8+ T-lymphocytes found in the peripheral
circulation during IM phase of infection are similar.
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4.3. CHRONIC ARTERITIS
Severe large vessel pan - arteritis was the phenotype reported in the IFNyR"'" mice
infected intraperitonealy with MHV-68 (Week et al., 1997). Severe large vessel
arteritis was also observed in mice with a null mutation in IFNy gene also infected
intraperitoneally with MHV-68. Studies on IFNyR"7" mice or IFNy"7" mice
intranasally infected with MHV-68 had not reported pathological changes in
blood vessels (Dutia et al., 1997;Sarawar et al., 1997). However, infection of
apolipoprotein E deficient mice (apoE"7") (which shows a naturally high rate of
atherosclerosis) with MHV-68 showed an accelerated rate of atherosclerosis
lesion development with virus present in the lesion (Alber et al., 2000;Alber et al.,
2002). This observation further confirms the vascular tropism of MHV-68.
During the course of this investigation, one of the IFNyR"7" mice in the experiment
No.2 was found dead on day 34 p.i. Detailed post mortem examination and
histopathological examination confirmed severe chronic arteritis primarily
targeting the base of the aorta as the cause of death. Hence, it was decided to
study the pathology of the base of the aorta in mice at subsequent time points of
that experiment (Day 35, 40, 45, 50, 60, 70, 80 and 120 p.i.) as well as experiment
No.3 ( see Materials and Methods section 2.4.).
4.3.1. INCIDENCE AND PATHOLOGY OF CHRONIC ARTERITIS IN
IFNyR-'- MICE INFECTED WITH MHV-68
The incidence of chronic arteritis observed in the base of aorta of IFNyR'7' mice
from part of experiment no.2 and experiment No.3 is presented in table 4.3.1.
None of the mice in the 129 Sv/Ev group showed any sign of arteritis in the base
of the aorta. Out of the four cases of arteritis observed in this study, only one
caused the death of a mouse and others were observed during histopathological
examination.
The primary pathological change was noticed in the tunica media of the blood
vessel. There were necrotic patches restricted to the tunica media throughout the
course of the blood vessel. A chronic inflammatory response resulted in
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Table 4.3.1. Incidence of chronic arteritis
Experiment Days post Number of Positive for Chronic arteritis
No. infection mice







Total 26 3 (11.5%)




Total 16 1 (6.25%)
thickening of the blood vessel wall resulting in a narrowing of the lumen. The
inflammatory cells in the tunica adventitia mainly consisted of lymphocytes and a
few neutrophils. The immunohistochemical staining with anti-rabbit polyclonal
MHV-68 antibody showed viral antigen positive cells in the tunica media of the
blood vessel. The morphological features of the some of the viral antigen positive
cells suggested a smooth muscle cell phenotype (Figure. 4.3.1).
4.3.2. DISCUSSION
The observation of chronic arteritis lesions in IFNyR"7" mice infected with MHV-
68 suggests the tropism of the virus towards the blood vessels and role of IFNy
signalling in regulating this tropism. This observation has added significance as it
has been seen in mice intranasally infected with the virus, which mirrors the most
probable natural route of infection rather than the earlier report of chronic arteritis
in IFNyR" mice infected with MHV-68 via intraperitoneal route (Week et al.,
1997). The incidence of chronic arteritis and associated mortality was much lower
than that reported in mice infected via intraperitoneal route. Thirty of 30 IFNyR"7"
mice (infected via intraperitoneal route) that died 1.5 to 14 weeks after infection
had large vessel arteritis. In the current experiment, only one mouse died of
chronic arteritis and others were detected during histopathological examination
after sacrificing the mice at stipulated time points.
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Figure. 4.3.1. Chronic arteritis in the base of the aorta in IFNy R-/-
mice infected with MHV-68.
Formalin fixed paraffin embedded tissue sections of the base of aorta
from IFNyR-/- mice infected with MFTV -68 were stained with
polyclonal antiserum against MHV -68 raised in rabbit. Note the viral
antigen positive splindle shaped cells (arrow) in the tunica media of the
blood vessel (M). Infiltration of chronic inflammatory cells in the tunica
adventitia (A) and thickening of the tunica intima (I) and subsequent
narrowing of the lumen (L) is present.
Magnification 40X
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The role of IFNy responsiveness in regulating the tropism of the virus to the large
blood vessels is interesting. It has been shown that IFNy itself can elicit
arteriosclerosis in SCID/beige mice (Tellides et al., 2000) and IFNy potentiates
atherosclerosis in apoE"" mice (Gupta et al., 1997). The interesting feature of
chronic arteritis observed in the IFNyR"'" mice infected with MHV-68 is its
similarity to the pathology of Takayasu arteritis. Takayasu arteritis is a chronic
vascular inflammatory disease of unknown aetiology mainly involving the aorta.
The prevalence of this condition is particularly high in south Asian women, even
though the condition is reported in other parts of the world. The pathological
changes involve all layers of the blood vessel and destruction of medial layer is a
common feature (Iwai et al., 2000). Hence, the infection of IFNyR"'" mice with
MHV-68 is a potential small animal model to explore the aetiological relationship
of human gammaherpesviruses and Takayasu arteritis.
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4.4. BONY METAPLASIA IN SPLEEN
The first report on splenic fibrosis induced by MHV-68 in IFNyR"7" mice also
reported that in one of the mice at day 31 p.i. showed areas of bony metaplasia
(Dutia et al., 1997). The current study extended this information to ascertain the
incidence of this condition in the spleen of mice (both IFNyR~/_ mice and 129
Sv/Ev mice) irrespective of whether they are infected with MHV-68 or not. The
sections of spleen from various experiments were used as the material for
studying the incidence of bony metaplasia (Table 4.4.1).
The histogenesis of the bony metaplasia observed in the spleen of MHV-68
infected IFNyR-/- mice had not been investigated before. Ectopic bone formation
is a serious disease condition affecting different tissues in humans with conditions
such as fibrodysplasia ossificans progressive (FOP) (Virdi et al., 1999). One
possibility for the development of these lesions is the trans-differentiation of adult
parenchymal cells to osteogenic cells. The other possibility is the differentiation
of locally present or recruited adult mesenchymal stem cells to osteoblast series
cells and the development of bone. The recently identified mesenchymal stem
cells in the spleen with committed lineage to osteogenic potential (Kodama et al.,
2005) suggests that the resident stem cells present in the spleen may be
responding to the altered micro-environment for its differentiation. The type of
micro - environment favouring such differentiation of stem cells in the spleen was
shown to involve IL-5. A major phenotype shown by the mice constitutively over
expressing IL-5 from their T-lymphocyte is bone nodule formation mainly in the
spleen along with perturbations in the normal bone metabolism (Macias et al.,
2001).
One of the signalling molecules favouring the osteogenic differentiation of stem
cells is bone morphogenic protein-4 (BMP^l). BMP^l is a member of the BMP
group of TGFP super family [Reviewed in (Wozney, 2002)]. Apparently, in an in
vivo system, interaction between different BMPs and other cellular factors may be
involved in the sequential events leading to mature bone formation. Significant
molecules to be considered in this context are TGFP and CTGF. It has been
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shown recently that CTGF has opposing effects on BMP-4 and TGF(3. CTGF can
antagonise BMP-4 activity by preventing its binding to receptors and promotes
the activity of TGFp by enhancing its receptor binding (Abreu et al., 2002).
In the current study, in addition to ascertaining the incidence of bony metaplasia
lesion in the spleens of MHV-68 infected and uninfected mice, the expression
pattern of BMP - 4 in the spleen was studied by immunohistochemical methods.
4.4.1. INCIDENCE OF BONY METAPLASIA IN THE SPLEEN OF MICE
The incidence of bony metaplasia in the spleen was estimated by the
histopathological evaluation of spleen sections from three independent groups of
infected mice and an uninfected group of mice (Table No. 4.4.1.). The study
showed that, the incidence of bony metaplasia was higher in IFNyR"'" mice
infected with MHV-68 (12.5% in experiment No.l, 16.6% in experiment No.2
and 25% in experiment no.3). In 129 Sv/Ev mice infected with MHV-68, the
incidence was 0% in experiment no.l and 6.45% in experiment no. 2. None of the
uninfected control mice from both groups of mice (donor mice in the bone
marrow chimera experiment) showed bony metaplasia in their spleen. However,
IFNyR"''" mice mock infected with uninfected BHK lysate developed bony
metaplasia. The development of bony metaplasia lesions occurred very late
during the infection in 129 Sv/Ev mice (Day 80 p.i). Whereas, the IFNyR"7" mice
showed bony metaplasia as early as day 12 p.i. These observations suggest that
bony metaplasia lesion observed in the spleen can develop independent of
fibrosis.
4.4.2. CHARACTERISATION OF BONY METAPLASIA
Some of the bony metaplasia lesions were observed grossly as small pinhead
shaped white nodules on the surface of the spleen and others were observed
during routine histopathological examination. The bony metaplastic lesion in the
spleen showed a focal distribution pattern with only one or two foci of bony
metaplasia in the whole section of spleen. The individual focus of the lesion
varied in size and level of mineralization.
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Table 4.4.1. Incidence of bony metaplasia in spleen





















Overall incidence 6/36 (16.6%) 2/31 (6.45%)
Bone marrow Chimera experiment (Donor mice - uninfected)
0 0/9 0/9
Overall incidence 0/9 (0%) 0/9 (0%)
Experiment No. 3
Days post infection IFNyR7" mice infected IFNyR"/_ mice mock






Overall incidence 4/16(25%) 2/16(12.5%)
The maximum size of the lesion covered more than two third width of the spleen
at a given point of bony metaplasia. The bony tissue was demarcated from the
surrounding cells of the splenic parenchyma. Osteoid matrix of the bony tissue
carried irregularly placed osteocytes as embedded within the calcified matrix
(Figure 4.4.1 A). The presence of calcium in the bony tissue was demonstrated
with the Van Kossa method of staining (Figure 4.4. IB).
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Figure. 4.4.1 . Bony metaplasia in the spleen .
A, Haematoxylin and Eosin staining. IFNyR-/- mice infected with
MHV-68, day 120 p.i. Note the presence of osteocytes embedded in the
osteoid (arrow). B, Von Kossa method of staining to demonstrate
calcium in the bony tissue (Black colour) . IFNyR-/- mice infected with
MHV-68, day 18 p.i. For image A, magnification 10X. For Image B,
magnification 200x.
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4.4.3. EXPRESSION OF BONE MORPHOGENIC PROTEIN-4 IN THE
SPLEEN OF IFNyR '- MICE INFECTED WITH MHV-68
The presence of BMP^l positive cells in the spleen from all spleens of IFNyR""
mice from experiment no.2 was investigated by immunohistochemical methods.
Large numbers of BMP- 4 positive cells were noticed in the red pulp of the spleen
in clusters (Figure. 4.4.2). The BMP- 4 positive cells were seen in close proximity
to bony tissue as well as elsewhere in the splenic parenchyma. The positive cells
were round to oval and spindle in shape with centrally placed nucleus. The
morphology and distribution pattern of these positive cells suggest them as red
pulp macrophages.
The number of BMP- 4 positive cells in the spleen sections was scored in a scale
of 0 to ++++ is presented in table 4.4.2. (0 for absence of positive cells, + for
small number of positive cells and ++++ for large number of positive cells). The
score for BMP-4 positive cells in the spleen with bony metaplasia ranged from 0
to ++++, even though the majority of the spleens with bony metaplasia lesion had
a score of ++++. More interestingly, the spleens without any visible bony
metaplasia lesion had BMP-4 positive cells in the range of 0 to ++++. This
indicates that there is no direct correlation between the presence of BMP-4
positive cells and the incidence of bony metaplasia. It may be because the
signalling through BMP-4 molecule for the differentiation of putative stem cells
to osteoblast series of cells is complex involving interaction with various other
factors. It may also be due to delay in the expression of BMP-4 and development
of bony metaplasia. Since there was no direct correlation between the presence of
BMP-4 positive cells and the incidence of bony metaplasia lesion in IFNyR"7" mice
infected with MHV-68, further staining of the sections from 129Sv/Ev mice was
not carried out.
4.4.4. DISCUSSION
The current investigation revealed that the development of bony metaplasia lesion
is not confined to the spleens of IFNyR"7" mice infected with MHV-68 alone.
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Table 4.4.2. Distribution of BMP-4 positive cells in the spleen of
IFNyR'" mice infected with MHV-68
Day Animal Score Bony
metaplasia
Day Animal Score Bony
metaplasia
08 GM 1241 0 35 GM 1316 +
GF 1249 0 GM 1314 ++
10 GM 1242 0 GM 1322 ++
GM 1236 0 GF 1329 +++ V
GF 1246 0 GF 1327 +++
12 GM 1240 0 40 GM 1303 +++
GM 1234 +++ GM 1309 +++
GF 1245 ++++ GF 1328 ++++
GM 1309 ++++ V GF 1325 +
GM 1306 ++++ 45 GM 1313 ++
GF 1326 0 GM 1318 +++
14 GM 1238 ++++ GF 1330 +
GF 1247 +++ 50 GM 1308 +++
16 GM 1237 ++++ V GM 1310 ++
GF 1243 ++++ GF 1332 ++
18 GM 1239 + V 60 GM 1320 +++
GF 1248 0 GM 1312 ++
20 GM 1235 ++++ GF 1337 ++
GF 1244 +++ 80 GM 1321 ++ V
GM 1311 ++ GM 1319 ++ V
GM 1304 0 GF 1323 +
GF 1334 0 120 GM 1301 +
30 GM 1315 ++ GM1302 0
GM 1317 +++ V GM1305 +
GF 1331 +++ GF1336 0 V
GF 1338 ++ GF 1324 + V
Bony metaplasia lesions were observed in IFNyR"" mice mock infected with BHK
cell lysate and in 129Sv/Ev mice infected with MHV-68, but at a lower incidence
compared to IFNyR7" mice infected with MHV-68. The detection of bony
metaplasia lesions as early as day 12 p.i in IFNyR7" mice as well as in 129 Sv/Ev
mice infected with MHV-68 suggest that the development of bony metaplasia
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Figure. 4.4.2. Bone morphogenic protein - 4 (BMP-4)
expression in the spleen of IFNy R-/- mice infected with MHV-
68 at day 30 p.i.
Collection of BMP-4 positive cells were seen in the red pulp of
the spleen both in association with bony tissue (arrow) (A) as
well as independent of bony tissue (B). W, White pulp. R, Red
pulp. Magnification 400X for image A and 200X for image B
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lesion is independent of fibrosis. The observation of increased incidence of bony
metaplasia lesion in the spleen of IFNyR_/" mice infected with MHV-68 also
argues that, the cytokine micro-environment conducive to the alternate activation
of macrophages (Th2 cytokines, IL-5 is an example) is a favourable micro-
environment for the differentiation of mesenchymal stem cells in the spleen
towards osteogenic lineage.
BMP-4 has important roles in both embryonic development and bone formation. It
has been shown recently that transfection of a retroviral vector encoding human
BMP-4 into muscle derived stem cells (MDSC) can produce functional BMP-4
and initiate differentiation of stem cells to an osteogenic lineage (Wright et al.,
2002). BMP-4 is found in primitive mesenchymal and chondrocytic cells, the
cambium layer of the periosteum, the marrow cavity and the muscles adjacent to
the fracture site (Nakase et al., 1994). There has been no description of BMP-4
secreting cells in the spleen. It needs to be explored whether the BMP-4 positive
cells detected in the spleen are actual mesenchymal stem cells or macrophages in
the red pulp. The absence of any clear correlation between the detection of bony
metaplasia lesion and presence of BMP-4 positive cells in the spleen indicate the
complex in vivo signalling mechanisms involved in the osteogenic differentiation.
This in vivo system of infection of IFNyR_/" mice with MHV-68 provides a
suitable small animal model system to study the biology of signalling reactions







The objective of the current study was to investigate the role of IFNy in the
pathogenesis of MHV-68. The investigation was carried out in a knock out mice
with a defect in responding to IFNy (IFNyR~'~mice) (Huang et al., 1993). Infection
of IFNyR_/" mice with MHV-68 develops significant pathological changes in
spleen and large elastic arteries (Dutia et al., 1997;Weck et al., 1997). The
emphasis of the current investigation was to delineate the cellular, molecular and
virological events associated with the pathological changes occurring in the spleen
following intranasal infection of IFNyR"7" mice with MHV-68. In addition to
investigating the pathological changes in the spleen, the study was also extended
to investigate the pathological changes in the lung, liver and aorta.
Fibrosis was the main pathological change observed in the spleen of IFNyR_/" mice
infected with MHV-68. The pathogenesis of fibrosis involves three overlapping
phases. An acute or chronic injury is the initiating event. The injurious agent
could be mechanical, infectious or an aberrant autoimmune reaction. An
inflammatory phase intimately follows injury and the character of the
inflammatory reaction directs the tissue response towards fibrosis. T-helper-2
(Th2) cell response mainly promotes a pro-fibrotic response. In contrast, Thl type
immune response driven by cytokines such as IFNy is antagonistic towards a
fibrotic response. Polymorphisms in the IFNy gene as well as IFNy receptor gene
in human beings are pre-disposing factors leading to severe fibrotic disease
following Schistosoma mansoni infection in endemic areas (Dessein et al.,
1999;Chevillard et al., 2003). The final phase in the pathogenesis of fibrosis
involves attraction and proliferation of ECM producing cells, production and
lying down of ECM.
'The injury' phase of the splenic fibrosis induced by MHV-68 in IFNyR_/" mice is
characterised by the depletion of B-lymphocytes in the lymphoid follicles, which
constitute the major type of cells in the spleen. The reduction in the number of B-
lymphocytes could be either due to enhanced cell death or defective production
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and trafficking of new cells into the spleen. The enhanced cell death in the splenic
GC could arise either due to massive infection of splenocytes and subsequent
cytolysis or due to massive apoptosis of B-lymphocytes which are unable to
respond to an antigenic stimulus. The reduced level of B-lymphocyte turnover
from the bone marrow could occur in the event of bone marrow suppression. The
last possibility would be a defective trafficking of cells into the spleen due to
disruption of a chemokine gradient required for homing of cells into the spleen.
All the above possibilities were investigated during earlier studies and concluded
that defective trafficking of cells to the spleen occurs at the height of splenic
fibrosis (Dutia et al., 1997;Ebrahimi et al., 2001). The current study re-examined
the role of productive infection and apoptosis of B-cells in the spleen by different
techniques such as immunohistochemistry and counting of TBM respectively. The
conclusions from these studies concurred with earlier observations.
As discussed in section 3.6, the GPCR homologue encoded by MHV-68 could
potentially interfere with the chemokine gradient required for homing of
lymphocytes into the spleen. Why do these events occur only in mice with defect
in IFNy signalling? Whether cellular IFNy response gene products are able to
regulate the transcription and/or translation of the proposed viral gene product or
the IFNy response gene products are able to directly nullify the actions of these
putative viral gene products? Interestingly, murine IFNy inducible protein-10 (IP-
10), a key IFNy response gene product can inhibit the actions of MHV-GPCR
(Verzijl et al., 2004) similar to human IP-10 inhibiting the constitutive signalling
of KSHV-GPCR (Geras-Raaka et al., 1998). The ability of IP-10 to inhibit the
actions of virus encoded GPCR would explain the development of fibrotic
changes occurring more specifically in lymphoid organs like spleen in the MHV-
68 infected mice, in the absence of IFNy signalling.
Characterisation of the cellular and molecular events taking place in the spleen of
IFNyR"7" mice infected with MHV-68 showed a shifting of the immune response
towards Th2 type. Shifting of immune response towards Th2 type was
characterised by alternate activation of macrophages recognised by the up-
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regulation of marker molecule, arginase -1 at both transcript and protein level.
This was further confirmed by detection of transcripts of key Th2 cytokine, IL-13
in the spleen of MHV-68 infected IFNyR"7" mice (Personal communication from
Dr. B.Ebrahimi, University of Liverpool, United Kingdom). This observation
implies that immune response against a gammaherpesvirus infection can shift
towards Th2 type in the event of a defect in driving an immune response towards
Thl type.
The immune response to viruses is predominantly Thl type. A viral infection in a
host with an already polarised Th2 type immune response or a genetic defect in
mounting a Thl type of response presents an awkward scenario to the host
immune system. Such a scenario of natural viral infection of humans and animals
are always possible. For example, patients with an overload of helminths and
other multicellular parasites are likely to have an already tuned immune response
towards Th2 type. The congenital defect in the system of IFNy response can occur
at multiple levels ranging from the defect in IL-12 production, the ability of cells
to respond to IL-12 and produce IFNy, polymorphism in the molecule of IFNy, its
ability to bind to the receptor, defect in the receptor units, failure in the signal
transduction machinery and finally production of IFNy response gene products
from IFNy responding cell populations. All the above situations would ultimately
result in the failure of the host towards mounting a Thl type immune response.
Thl responses following tetanus toxoid injections were found to be subdued in
subjects living in endemic areas of schistosomiasis or onchocerciasis (Sabin et al.,
1996;Cooper et al., 1997). Intracellular pathogens, which require a Thl type
response to control the infection in patients with Th2 biased immune response or
defective Thl type immune response has shown to develop more severe disease
(Lienhardt et al., 2002;Actor et al., 1993).
The decision to mount either a Thl or Th2 immune responses rests with the host.
Various factors are involved in such a decision making process. It is argued that
the type of polarisation begins at the level of antigen presenting cells (APC) itself,
which subsequently bias the T-lymphocyte response according to its polarisation
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(Moser and Murphy, 2000). Most importantly, properties of the pathogen dictate
the type of immune response mounted against it. For example, multicellular
pathogens mount a Th2 type response (Urban, Jr. et al., 1992). In contrast,
bacterial organisms like Listeria induces the production of IL-12 that drives a Thl
type immune response (Hsieh et al., 1993). Antigen dose may be a factor involved
in the choice of effector functions. Increasing the antigen dose may switch the
immune response from type 1 to type 2 and vice versa (Hosken et al., 1995).
Soluble or particulate nature of antigen is another factor involved in the decision.
The chemokines and their receptor expression also modulate the shift of immune
response towards Thl or Th2 type. Genetic background of the host is another
major factor involved in the decision to drive the immune response to either Thl
or Th2 type. For example, BALB/c mice tend to produce a Th2 type response
against Leishmania major. At the same time B6 and C3H strain of mice mount a
Thl polarised immune response against the same pathogen (Wilson et al., 2005).
Reversal of polarisation from Thl to Th2 or vice versa in an in vivo situation is
controversial. It is argued that, such a reported reversal of polarisation may be
from the naive T-lymphocytes [Reviewed in (Lafaille, 1998)]. However, shifting
of the immune response from Thl type to Th2 type is reported during granuloma
development following schistosoma infection (Wynn et al., 1993).
It would be interesting to explore the factors contributing to the shifting of the
immune response towards Th2 type against MHV-68 in IFNyR"7" mice.
Progressive increase in the number of latently infected cells noticed in the spleen
would have contributed to the shift of immune response. As the virus remains in a
'hidden' form during latent infection, the selectively expressed viral gene
products during latency would be the ideal candidate to contribute to such a shift
of immune response. Such putative viral gene products may be directly
influencing the chemokine gradient required for selective attraction of Th2 type
cells. In wild type mice, CD4+ T-lymphocytes are induced during MHV-68
infection and are critically important for the control of replication and latency
(Christensen et al., 1999;Flano et al., 2001;McClellan et al., 2004;Sparks-Thissen
et al., 2004). More specifically, it has been shown recently that IFNy producing
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Thl polarised CD4+ T-cells are sufficient for control of MHV-68 infection
(Sparks-Thissen et al., 2005). By comparison, relatively little is known about the
role of Th2 type responses in MHV-68 infections. As discussed above, in the
absence of IFNy signalling to drive Thl type immune response, the immune
response in the spleen of IFNyR"/_ mice following MHV-68 infection has shifted
towards Th2 type characterised by secretion of IL-13 and alternate activation of
macrophages. Other than artificially biasing the immune response towards Th2
type as a result of defect in the IFNy receptor, viral gene products also could
favour shifting of immune response towards Th2 type. For example, KSHV
encoded vMIP-II is a promiscuous chemokine homologue capable of binding to
many CC and CXC chemokine receptors and most of such chemokine receptor
interactions are antagonistic (Kledal et al., 1997). vMIP-II antagonises CCR5 and
CXCR3, which is used by IP-10 to attract Thl polarised lymphocytes, thereby
driving the immune response towards Th2 type (Lindow et al., 2003;Singh et al.,
2004). MIP homologues are not identified in MHV-68. Functions of the putative
homologue of MIP-II in MHV-68 could contribute to the Th2 type immune
response generated in the spleen of IFNyR"7" mice infected with MHV-68.
Invasion of lymphoid follicles carrying latently infected cells with Th2 polarised
T-lymphocytes and alternatively activated macrophages were observed in the
spleen from day 12 p.i to day 16 p.i. At the same time, marked expansion in the
number of latently infected cells in the spleen of mice until day 18 - 22 day p.i
compared to wild type controls. This suggests that, the Th2 type cellular response
as such is not able to control the expansion of latently infected cells. However,
another type of tissue response mediated by Th2 type immune response
characterised by fibrosis was able to control the expansion of latently infected
cells. This is a novel observation. The molecular mechanism by which fibrosis as
a host response achieves this phenomenal effect needs to be investigated. The
possibilities include stress induced apoptosis operating in the tightly packed
latently infected cells trapped within the 'fibrotic cage'. The stress may be due to
the limited supply of nutrients entering into the spleen at the height of fibrosis.
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Other pathological manifestations seen the IFNyR"" mice infected with MHV-68
appears to have bearing on a Th2 type immune response generated in the host.
One of the other significant pathological changes observed in the spleen of
IFNyR"" mice infected with MHV-68 was bony metaplasia. The only other
documented evidence of bony metaplasia occurring in the spleen of mice was in
transgenic mice constitutively expressing IL-5, a key Th2 type cytokine (Macias
et al., 2001). This suggests that the constitutive expression of Th2 type cytokine is
driving the differentiation of mesenchymal stem cells in the spleen towards an
osteogenic lineage. Our data argues that the induced Th2 cytokine milieu
developed in the spleen of MHV-68 infected mice may be responsible for the
differentiation of mesenchymal stem cells in the spleen. The incidence of bony
metaplasia was much higher in IFNyR"7" mice infected with MHV-68 which has
mounted a Th2 type immune response compared to wild type mice infected with
the virus.
The pathological changes observed in the liver of IFNyR"7" mice infected with
MHV-68 showed similarities to the lesions seen in the liver of patients with PSC.
PSC is a chronic cholestatic liver disease characterised by intrahepatic and/or
extrahepatic bile duct proliferation and concentric fibrosis around necrotic bile
ducts. Approximately 75% of patients with PSC have inflammatory bowel
disease. The suggested model of etiopathogenesis of PSC involves memory T—
lymphocytes generated in the colon during an inflammatory reaction directed
against a foreign antigen binding to biliary epithelial cells in response to the same
foreign antigen. This binding initiates a strong lymphocytic response. The
proliferating T-lymphocytes secrete multiple chemokines and cytokines,
predominantly TNFa. The cascade also initiates B-lymphocytes to secrete
immunoglobulins including autoantibodies against biliary epithelial cells
[Reviewed in (Aoki et al., 2005)]. The lesions seen in the liver of IFNyR"7" mice
infected with MHV-68 also appears to be lymphocyte mediated. Characterisation
of lymphocyte population around the proliferating intrahepatic bile ducts showed
both T and B-lymphocytes. It is possible that the memory T-lymphocytes
generated against MHV-68 infected splenocytes may be binding to the biliary
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epithelial cells in association with the viral antigen or through a process of
'molecular mimicry' and initiates the cascade of events leading to the
development to PSC like lesions in the liver. Epitope mapping of the T-
lymphocytes observed around the proliferating bile ducts need to be carried out to
prove this hypothesis.
Chronic arteritis and cuffing of pulmonary blood vessels observed in IFNyR"7"
mice infected with MHV-68 suggest tropism of the virus towards vascular
structures in the absence of protective effect from IFNy. Tunica media of blood
vessels is an immunoprivtlaged site due to the inability of T-lymphocytes and
macrophages to enter the site (Dal Canto et al., 2001). The altered tropism of the
virus to an immunoprivilaged site in the absence of IFNy signalling may be a
consequence of spleen becoming a 'no go area' for the virus after elimination of
latently infected cells mediated by the fibrotic response. Whether spleen has
become a 'no go area' for the virus needs to tested by re-infecting the recovered
animals with higher dose of virus to compromise the neutralising viral antibodies
in the system.
In conclusion, it appears that shifting of immune response towards Th2 type in
IFNyR"'" mice infected with MHV-68 resulted in mounting a fibrotic response,
which in turn was able to control the expansion of latently infected cells in the
spleen. This control of expansion of latently infected cells resulted in recovery
phase characterised by re-population of different subsets of resident cells in the
spleen. This system of induction of fibrosis and recovery following the
elimination of virus infected cells from the centre of the lesion provides an
excellent model system to explore the potential link between gammaherpesvirus
infection and fibrosis, both at the level of induction and resolution. Other
pathological changes observed in the spleen, aorta and liver also deserves further
attention as a model system for important disease conditions affecting humans.
Diseases such as primary sclerosing cholangitis and Takayasu arteritis are
important disease conditions without a known aetiological factors and hence
effective therapy. The fact that pathological manifestations mimicking those
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disease conditions were observed following infection of a host with defect in the
immune system suggest that inherent defects in the chain of IFNy production to
response may be a pre-disposing factor in the pathogenesis of these disease
conditions in humans. It is highly likely to be true as gammaherpesviruses are
widely prevalent in adult human population (>95%) and only very tiny fraction of
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Infection with the murine gammaherpesvirus MHV-68 has profound effects on splenic and
mediastinal lymph node pathology in mice which lack the interferon-y receptor (IFN-y R-/~). In
these mice MHV-68 infection causes fibrosis and loss of lymphocytes in the spleen and the
mediastinal lymph node as well as interstitial pulmonary fibrosis and fibrotic changes in the liver. The
changes are associated with transient elevated latent virus loads in the spleen. Four independent
virus mutants with insertions and/or deletions in the left end of the genome fail to induce the
pathological changes and establish latency at normal levels in the spleen. The data indicate that
the pathology does not correlate with any of the known genes encoded within this region of the
genome, genes M1 -M4 and the eight vtRNAs. Northern analysis of mRNAs transcribed by
wild-type and mutant viruses shows that at least two uncharacterized transcripts are encoded
Received 16 December 2003 within this region. These transcripts are absent in the mutant viruses and are candidates for the virus
Accepted 1 March 2004 genes responsible for the aberrant pathology in IFN-y R~/_ mice.
INTRODUCTION
In immunocompetent mice, the murine gammaherpesvirus
MHV-68 causes an acute lung infection which is rapidly
cleared, followed by a longer lymphoproliferative phase
including lymphadenopathy of the mediastinal lymph
nodes, splenomegaly and an infectious mononucleosis like
phase involving proliferation ofCD8 + T cells (Sarawar et al,
1996; Sunil-Chandra et al., 1992a; Tripp et al., 1997). CD8 +
T cells play a major role in clearance of the lung infection
and CD4+ T cells are crucial for long-term control of
infection, probably via interferon-y (IFN-y) (Christensen
et al., 1999). The virus establishes a latent infection in lung
epithelial cells, B lymphocytes, macrophages and dendritic
cells which persists for the lifetime of the animal (Flano et al.,
2000; Stewart et al., 1998; Sunil-Chandra et al., 1992b; Week
et al., 1999).
In mice which lack the interferon-y receptor (IFN-y R_/~
mice), the lymphoproliferative phase is associated with
severe pathological changes (Dutia et al., 1997; Ebrahimi
et al., 2001; Weck et al., 1997). Following intranasal infection
of these mice, the mediastinal lymph nodes draining the
lung and the spleen exhibit a drastic drop in cell numbers and
tPresent address: Department of Medical Microbiology, University of
Liverpool, Duncan Building, Daulby Street, Liverpool L69 3GA, UK.
become fibrotic (Dutia et al., 1997). These changes are
associated with an acute latent load 10-100 times higher
than that seen in wild-type mice. After intraperitoneal
infection, severe arteritis associated with high mortality
occurs (Week et al., 1997). In this instance splenic patho¬
logy is found in 60% of mice (Clambey et al., 2000).
The induction of splenic pathology is dependent on CD8 +
and CD4+ T cells and the drop in spleen cell numbers
is accompanied by lymphocytosis and the exclusion of
circulating T and B cells from the spleen and mediastinal
lymph node (Ebrahimi et al., 2001).
The left end of the unique region of the MHV-68 genome is
important for virus pathogenesis (Macrae et al., 2001). This
region contains the four unique protein-coding genes, Ml-
M4, as well as genes for eight tRNA-like molecules (vtRNAs)
(Bowden etal, 1997; Virgin etal., 1997). In a previous study,
Clambey etal. (2000) constructed two Ml deletion mutants:
Ml.LacZ, in which the lacZgene replaced nt 1893-2402; and
M1A511, which lacks nt 1893-2402. These viruses also lack
the first 100 nt ofthe unique region ofthe genome. Ml.LacZ
did not cause splenic pathology or mortality in IFN-y R_/_
mice although it did cause severe vasculitis of the great
arteries. The outcome of infection of IFN-y R~'~ mice with
M1A511 or the marker rescue virus was not determined
(Clambey et al., 2000). Thus, mutations in the viral genome
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in the region of Ml appeared to have an effect on splenic
pathology in the IFN-y R_/~ system.
This study aimed to extend the observations of Clambey
et al. utilizing mutants of MHV-68 in order to clarify the
potential role of the Ml gene product in splenic pathology in
IFN-y R~/_ mice. Wild-type 129/Sv/Ev (WT) and IFN-y R_/~
mice were infected with wild-type MHV-68, with V2 virus
(Simas et al., 1998) or LHAgfp virus both of which lack Ml
and 4 or 5 of the vtRNA molecules respectively, with VI
virus which has an insertion in vtRNA3, or with MHV-76
which lacks M1-M4 and the tRNAs (Macrae et al., 2001)
and the consequences of infection on the spleen virus latency
and/or pathology were examined. The data indicate that the
Ml gene product is not involved in the pathological changes
which occur in IFN-y R_/~ mice following MHV-68
infection. Northern analysis of transcripts in wild-type
and mutant infected cells has identified two candidate
transcripts present in wild-type infected cells but not in cells
infected with mutant virus.
METHODS
Mice. Wild-type 129/Sv/Ev mice and IFN-y R~'_ 129/Sv/Ev (Huang
et al., 1993) were purchased from B & K Universal (Hull, UK) and
bred in-house.
Virus and cells. Virus working stocks were prepared by infection
ofBHK-21 cells as described previously (Sunil-Chandra et al., 1992a).
The viruses used are as follows: MHV-68 clone g2.4 (Efstathiou
et al., 1990) VI and V2 (Simas et al., 1998) and MHV-76 (Macrae
et al., 2001). LHAgfp was constructed by co-transfection of viral
DNA with DNA containing a human cytomegalovirus (HCMV)
immediate-early promoter-driven green fluorescent protein cassette
(CMV-GFP) into BHK cells. Resulting recombinant plaques were
isolated and purified on the basis of fluorescence under UV illumi¬
nation. Detailed mapping of the viral genome was performed using
Southern analysis, PCR amplification and sequencing. This deter¬
mined that the viral genome was intact except that the CMV-GFP
cassette had inserted by illegitimate recombination at the left end of
the unique portion of the genome resulting in the deletion of nt
1-3223 (Fig. 1).
Infection and sampling. Age- and sex-matched mice were anaes¬
thetized with Halothane (Rhone Merieux) and inoculated intrana-
sally with 4 x 105 p.f.u. virus in 40 pi sterile PBS. At various times
after infection mice were killed by cervical dislocation and tissues
harvested for virus assays or histology.
Latent virus assays. Numbers of latently infected cells were deter¬
mined by the infective centre assay as described previously (Dutia
et al., 1997).
Molecular cloning and sequencing. VI virus stock was digested
with Proteinase K and, after heat inactivation of the protease, the
Ml gene coding region (nt 2023-3282, Virgin et al., 1997) was
amplified by PCR using the following primers: Ml coding for 5'-
GCATCATTGAGCGGCGA-3' (nt 1999-2020); Mlcoding rev 5'-
CAGGCTTAGGACTGCTGCCCA-3' (nt 3290-3270). PCRs contained
1-5 U recombinant Taq DNA polymerase (Invitrogen), manufac¬
turer's buffer, 100 mM dNTPs, 2-0 mM MgCl2 and 50 pmol primer
in a total reaction volume of 50 pi. The cycling parameters were as
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Fig. 1. Genome structures of MHV-68 and the four mutant viruses, V1 and V2 (Simas et al., 1998), LHAgfp and MHV-76
(Macrae et at., 2001). Solid line represents unique sequence, filled boxes represent repeats. Genome coordinates taken from
Virgin et al. (1997) given above the line. Approximate positions of genes M1-M4 and vtRNAs given below line.
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follows: 94 °C 45 s, 55 °C 45 s, 72 °C 120 s, 35 cycles with a final
extension time of 7 min at 72 °C. The PCR product was cloned into
pCRII using a TA Cloning Kit (Invitrogen) and three clones were
sequenced on a Licor 4000L automated sequencer.
Preparation of RNA from infected cells and RT-PCR analy¬
sis. BHK-21 cells were infected with 5 p.f.u. per cell virus, incubated
at 37 °C for 20 h and harvested by addition of RNAzolB
(Biogenesis). Total cell RNA was prepared from the RNAzolB lysates
according to the manufacturer's instructions and the integrity of the
RNA was determined by agarose gel electrophoresis. cDNA was pre¬
pared as described previously (Roy et al, 2000). PCRs contained
cDNA transcribed from approximately 0-1 pg RNA, 1-5 U recom¬
binant Taq DNA polymerase (Invitrogen), manufacturer's buffer,
100 mM dNTPs, 2-0 mM MgCl2 and 50 pmol primer in a total
reaction volume of 50 pi. Cycling parameters were as for PCR of
the Ml coding region. Primers were as follows: Ml for 5'-CAGA-
ACCTTACCAGTCATGTG-3' (nt 2686-2708), Mlrev 5'-GTTACT-
AGGACATACAGTGG-3' (nt 2947-2966), product 278 bp; M2for
5'-TAATAGGAAGACGTATCTCAGG-3' (nt 4077-4098), M2rev 5'-
CTGCTTCCTTAGCCAGTCTC-3' (nt 5856-5875), product 589 bp;
M3for 5'-TGGCACTCAAACTTGGTTGTGG-3' (nt 6566-6587),
M3rev 5 '-TAACAGGCAGATTGCCATTCCC-3' (nt 6904-6925),
product 359 bp; M4for 5 '-CCTGGAGAAGATGATGATATTC-3'
(nt 8616-8637), M4rev 5'-AAAGTCATAAATCTCAATACC-3' (nt
9739-9759), product 1143 bp; murine /J-actin for 5'-TGTGATGG-
TGGGGAATGGGTCA-3', murine j3-actin rev 5'-TTTGATGTC-
ACGCACGATTTC-3', product 514 bp. Control reactions included
PCR on samples from cDNA synthesis reactions carried out without
addition of reverse transcriptase and PCRs without addition of
template. PCR products were separated on a 1 % (w/v) agarose gel
and visualized by ethidium bromide staining. In the case of the
M2, the PCR product was transferred to charged nylon membrane
(Hybond-N; Amersham) and probed with an M2-specific probe as
described previously (Usherwood et al., 2000).
Northern analysis. RNA was prepared from BHK cells infected or
mock-infected for 20 h at a m.o.i. of 5 p.f.u. per cell as described
above. Poly(A)-enriched RNA was prepared from total RNA by
Oligotex (Qiagen) and 10 pg of each sample was run on a MOPS/
formaldehyde gel (Sambrook, 2001). RNA was transferred to Nylon
membrane and probed with 32P-labelled gel-purified PCR product
or restriction fragment in Ultrahyb (Ambion) according to the
manufacturer's instructions. Size determinations were made with an
RNA ladder (Invitrogen). Membranes were exposed to X-ray film at
-70 °C.
Histopathology. Spleens were fixed in neutral buffered formalde¬
hyde, processed routinely to 5 pm paraffin wax-embedded sections,
stained with haematoxylin and eosin or Masson's trichrome and
examined by light microscopy.
RESULTS
Pathological changes in spleens of IFN-y R '
mice infected with mutant viruses
In order to assess the role of individual MHV-68 genes in the
pathological changes which occur in the spleens of IFN-y
R /_ mice, we infected wild-type 129/Sv/Ev mice and IFN-y
R 1 mice with wild-type MHV-68 or recombinant viruses
and monitored the acute latency load, spleen cell numbers
and histopathological changes. Fig. 2 shows the kinetics of
latency and spleen cell numbers in wild-type and IFN-y R_/~
mice infected with wild-type virus or V2 virus. V2 virus has
Fig. 2. Spleen cell numbers and latently infected cells (infective
centres) in wild-type 129/Sv/Ev (WT) and IFN-y R~'~ 129/Sv/Ev
(yR_/_) mice infected with 4 x10s p.f.u. wild-type MHV-68 (wt)
or V2 virus (V2) at various times post-infection. Data are repre¬
sentative of three experiments.
a deletion of MHV-68 nt 1-1571 and an insertion of the
lacZ gene leftwards under control of the HCMV immediate-
early promoter replacing MHV-68 nt 2028-3432. It thus
retains the viral tRNA gene vtRNA5 and the first 6 nt of the
Ml open reading frame but lacks vtRNAsl-4 and the major
part of the Ml gene (Fig. 1). On days 13, 16, 21 and 29 post¬
infection spleens were removed and assessed for patholo¬
gical changes. As described previously, MHV-68 infection
resulted in a significantly higher latent load in IFN-y R~'~
mice than in wild-type mice and caused a drastic drop in
spleen cell numbers (Fig. 2a, b). V2, on the other hand, did
not cause an increase in latent virus load or a drop in cell
numbers. These data indicate that a gene or genes at the left
end of MHV-68 is required for the pathological changes
which occur in the lymphoid tissue of IFN-y R_/~ mice.
To examine this further, mice were infected with two other
recombinant viruses with mutations in the left end of the
Mouse WT WT yR ' yR '
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genome, VI and LHAgfp. VI has the lacZ gene under the
control of the HCMV immediate-early promoter inserted
leftwards within vtRNA3 (nt 940). LHAgfp has MHV-68 nt
1-3223 replaced with the green fluorescent protein under
the HCMV promoter in the rightwards direction (Fig. 1).
Spleens were removed on days 16, 20 and 24 and examined
for pathological changes. By day 16 post-infection, wild-
type virus infection had produced the expected increase in
latent virus load and the decrease in spleen cell numbers
in IFN-y R_/~~ mice (Fig. 3). However, IFN-y R~'~ mice
infected with V1 and LHAgfp had similar cell numbers and
infective centres to wild-type mice.
VI virus established latency and caused splenomegaly in
wild-type mice with kinetics indistinguishable from wild-
type MHV-68 (Fig. 3). Both V2 and LHAgfp consistently
showed delayed onset of latent infection in the spleen.
However, they both replicate with similar kinetics to wild-
type virus in the lung and with identical kinetics of infection
to wild-type virus in vitro (Simas et al, 1998; S. Selvarajah,
personal communication), suggesting that the deleted
region plays a role in trafficking of virus to the spleen or
in the establishment of latent infection. Interestingly, these
changes in kinetics are not evident in IFN-y R mice.
To address the possibility that there was delayed onset of
splenic changes following infection with the mutant viruses
infection was monitored up to day 29 for V2 virus and day
24 for VI and LHAgfp. No elevated latency load or decrease
in cell numbers was observed. It is unlikely therefore that the
failure to cause severe splenic pathology is due to delayed
kinetics of virus infection.
The lack of splenic pathology following infection of IFN-y
R~'~ mice with VI, V2 and LHAgfp was confirmed by
examination of spleen sections stained with Masson's
trichrome, which stains collagen. Spleen sections from
mice infected with a further mutant virus, MHV-76 (Macrae
et al., 2001), which lacks the MHV-68-specific genes Ml,
M2, M3 and M4 and all eight vtRNAs, were also examined.
Fig. 4 shows that while wild-type MHV-68 infection of
IFN-y R-/~ produced characteristic changes in the spleen
structure, including contraction of the white pulp, destruc¬
tion of the red pulp and deposition of collagen, these
changes did not occur following infection with the three
mutant viruses and MHV-76. No evidence of pathological
changes was found up to day 35 post-infection.
M1 gene sequence
Because Ml has been implicated in the pathogenesis of
splenic atrophy in IFN-y R~'~ mice (Clambey et al., 2000)
we considered the possibility that VI virus had, in addition
to the insertion in vtRNA3, a mutation in the Ml gene.
Therefore, the coding region of the Ml gene ofVI virus was
amplified by PCR, cloned and sequenced. Three indepen¬
dent clones were sequenced, each of which was identical in
sequence to the Ml gene of wild-type MHV-68. This
established that VI virus did not have a mutated Ml gene.
Fig. 3. Spleen cell numbers and latently infected cells (infective
centres) in wild-type 129/Sv/Ev (WT) and IFN-y R-/~ 129/Sv/
Ev (yR~'~) mice infected with 4x105p.f.u. wild-type MHV-68
(wt), V1 virus (V1) or LHAgfp virus (LHAgfp) at various times
post-infection. Data are representative of three experiments.
Expression of M1 gene in mutant virus
infections
We then considered the possibility that, while the coding
sequence for Ml was intact, either the insertion into vtRNA3
or a mutation in the promoter meant that the Ml gene was
not transcribed. A further possibility was that the insertions/
deletions upstream of Ml had altered transcription of other
genes in the region. The transcription of M1-4 genes from
wild-type, VI, V2 and LHAgfp viruses was examined in
lytically infected BHK cells by RT-PCR as described in
Methods. Controls were PCR on cDNA reactions incubated
without reverse transcriptase, PCR without cDNA and RT-
PCR on mock-infected cell RNA. These were negative in all
cases. Ml, M3 and M4 RT-PCR products were visible as
single bands on ethidium bromide-stained gels. The M2
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Fig. 4. Histology of wild-typo (a) and IFN-y R ' (b-f) mice 20 days after infection with wild-type MHV-68 (a, b), V2 (c), V1
(d), LHAgfp (e) or MHV-76 (f). WP, white pulp; RP, red pulp; C, collagen.
gene is expressed at very low levels in lytically infected cells
and hence only a weak signal was detectable on an ethidium
bromide-stained gel. The presence of the M2 RT-PCR
product was examined by Southern hybridization. Fig. 5(a)
shows that the four viruses tested, wild-type, VI, V2 and
LHAgfp, all transcribed M2, M3 and M4. As predicted, V2
and LHAgfp did not transcribe Ml. Ml transcription was
readily detected in wild-type virus and VI-infected cells.
Thus the insertion in the VI virus had not resulted in lack of
transcription of the Ml gene.
Transcription in BHK cells infected with wild-type virus, VI
virus and LHAgfp was examined further by Northern
blotting. Poly(A) RNA from infected and mock-infected
cells was transferred to Nylon membrane and probed with a
probe spanning the M1 gene. This showed that transcripts of
the expected length were present in VI-infected cells and
that the quantity of transcript was similar to that present in
wild-type virus (Fig. 5b).
Identification of novel transcripts
In order to investigate the possibility that there are other
undefined transcripts encoded within the vtRNA region of
the genome, the Northern blot was probed with a probe
spanning the vtRNA 1-4 region (nt 106-1517). In wild-type
virus-infected cells four major transcripts were detected
(Fig. 6). These included the vtRNAs, which were seen as
small transcripts of <0-24 kb, a small transcript of 0-5 kb
which is detectable on probing of Northern blots of total
RNA with this probe (Bowden et al, 1997; unpublished
observations) and two transcripts of approximately 4-3 and
3-2 kb. The 4-3 and 3-2 kb transcripts were present in low
abundance and were not evident when total RNA rather
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Fig. 5. Transcription of genes M1-M4 of MHV-68 and mutant viruses, (a) RT-PCR analysis of genes M1-M4 and /J-actin
transcription in BHK cells infected for 20 h with wild-type or mutant MHV-68 viruses. Lane 1, mock-infected; 2, wild-type
virus; 3, LHAgfp; 4, V1; 5, V2; 6, no cDNA. A further control (not shown) in the absence of reverse transcriptase was negative,
(b) Northern analysis of M1 and jl-actin transcription in BHK cells infected for 20 h with wild-type MHV-68, V1, LHAgfp or
mock-infected.
than mRNA was probed. They were absent in cells infected
with VI virus or LHAgfp. However, novel transcripts of 10,
6-8, 5-3 and 4-2 kb were detected in cells infected with VI
and a single 5-2 kb transcript was detected in LHAgfp-
infected cells. These transcripts were also found in MHV-68-
infected owl monkey kidney cells (data not shown). The
vtRNAs were absent from LHAgfp-infected cells but present
in the VI-infected cells. LHAgfp does not encode vtRNAs
1-5 but the genes for vtRNAs 6-8 are present in the genome.
The result indicates that vtRNAs 6-8 are not detected by the
vtRNAl-4 probe. VI lacks vtRNA 3 but expression of
vtRNAs 1, 2 and 4 occurs. The 0-5 kb transcript was absent
from both VI- and LHAgfp-infected cells. This transcript
may be related to vtRNA 3 or to other changes in the
transcription pattern in these mutants.
DISCUSSION
The experiments described here show that the pathological
changes that occur in IFN-y R-/~ mice following infection
with MHV-68 can be ascribed to genes encoded in the left
end of the genome. MHV-76, which lacks nt 1-9538 of
MHV-68 encoding genes M1-M4 and the eight vtRNAs
does not cause splenic pathology. V2 and LHAgfp, which
also have large deletions in this region of the genome and
lack the Ml gene and four or five vtRNAs, do not cause
splenic pathology. VI, which has a large insertion at nt 940
disrupting vtRNA3 but encodes the M1-M4 genes, also lacks
the ability to cause the pathology. While the data from V2
virus and LHAgfp, like that described previously for Ml
(Clambey et al., 2000), implicate the Ml gene in the process
of atrophy, the results from VI virus suggest that Ml is
unlikely to be the primary virus gene involved in the
induction of splenic pathology.
VI virus, like the other mutant viruses investigated here,
does not express vtRNA3. The function of the vtRNAs is
unknown but as they are not aminoacylated it is unlikely
that they function in translation (Bowden et al., 1997). It is
more likely that the vtRNAs have a regulatory function
during infection. Moreover, a recombinant MHV-76 virus
into which we have inserted vtRNAs 1-5 does not cause
splenic pathology in IFN-y R_/~ mice (unpublished data).
This recombinant virus expresses vtRNA3 (Anna Cliffe,
personal communication). It is therefore unlikely that
vtRNA3 is involved in induction of splenic pathology. More
likely is the possibility that the insertion into vtRNA3 is





Fig. 6. Northern analysis of transcripts present in BHK cells
infected for 20 h with wild-type MHV-68, V1, LHAgfp or mock-
infected. Blot probed with dsDNA probe MHV-68 nt
106-1517. *, Novel transcripts in wild-type virus-infected cells;
O, novel transcripts in V1- and LHAgfp-infected cells.
disrupting transcription of an unidentified mRNA. Both
Epstein-Barr virus and Kaposi's sarcoma-associated her¬
pesvirus encode multi-exon mRNAs which are transcribed
across the terminal repeats (Choi et al., 2000; Laux et al.,
1988; Sample et al., 1989) and there is evidence for an
equivalent transcript in MHV-68 (Husain et al., 1999). We
have identified two novel transcripts in wild-type MHV-68-
infected BHK cells. These transcripts are expressed at a low
level and are not detected when total RNA is probed
(Bowden et al., 1997, unpublished data), but can be detected
when 10 pg of poly(A) RNA is used for analysis. Although
MHV-68 infection of BHK cells is lytic, some transcription
of latency-associated genes may occur. The M2 gene, for
example, is latency-associated but can be detected at low
levels in lytically infected cells. Hence these novel transcripts
may be latency-associated genes and are candidates for
virus genes involved in the induction of splenic pathology
which is associated with latent infection. Cells infected with
mutant viruses contain novel transcripts which may be the
result of aberrant processing.
A third possibility is that the insertion of the HCMV
immediate-early promoter is altering virus gene transcrip¬
tion. There is evidence for both MHV-68 and mouse CMV
that insertion of the lacZ gene under control of the HCMV
promoter-enhancer can alter the ability of the virus to
replicate (Clambey et al., 2000; Stoddart et al., 1994).
However, the fact that MHV-76 also fails to induce atrophy
argues that a gene or genes involved in the induction of
atrophy are encoded at least in part within the first 9538 bp
of MHV-68.
The replication of VI and V2 has been characterized
previously in BALB/c mice. In these mice no differences
between the mutants and wild-type MHV-68 were detected.
In contrast, the experiments reported here show a clear dif¬
ference from wild-type virus phenotype in IFN-y R_/~ mice,
highlighting the importance of host phenotype in studies of
virus mutants. V2 and LHAgfp have a distinct phenotype
in 129/Sv/Ev mice consistently showing delayed kinetics of
latent virus infection in the spleen. The viruses lack four or
five vtRNA molecules respectively and the Ml gene product.
Studies with an Ml deletion mutant have implicated the
Ml gene product in suppression ofvirus reactivation. These
studies are not directly comparable to those described here
as virus was inoculated via a different route. No evidence of
increased reactivation was found following infection with
V2 and LHAgfp; however, the data are consistent with a role
for Ml or a closely related gene in latency.
The data presented here provide evidence for transcripts
across the left region of the genome which encodes the
vtRNAs. These genes are candidates for novel latency-
associated genes and for viral mediators of splenic patho¬
logy. Studies to characterize these genes are under way and
will clarify these issues further.
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